The Oscillating Lateral Hypothalamus and the Orexinergic System by Azeez, Idris Ayodeji
  
 
 
 
 
 
UNIVERSITA’ DEGLI STUDI DI VERONA 
 
DEPARTMENT OF NEUROSCIENCE, BIOMEDICINE AND MOVEMENT SCIENCES 
 
 
GRADUATE SCHOOL OF LIFE AND HEALTH SCIENCES 
DOCTORAL PROGRAM IN NEUROSCIENCE 
 
CYCLE XXX 2014-2017 
 
 
THE OSCILLATING LATERAL HYPOTHALAMUS AND THE 
OREXINERGIC SYSTEM 
 
 
 
S.S.D. BIO/17 
 
 
 
Coordinator: Prof. Leonardo CHELAZZI 
 
Supervisor: Prof. Marina BENTIVOGLIO 
 
 
     Dott. Idris Ayodeji AZEEZ 
         
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is licensed under a Creative Commons Attribution-NonCommercial- 
NoDerivs 3.0 Unported License, Italy. To read a copy of the licence, visit the web 
page: 
  
http://creativecommons.org/licenses/by-nc-nd/3.0/ 
 
Attribution — You must give appropriate credit, provide a link to the license, and 
indicate if changes were made.  You may do so in any reasonable manner, but not in 
any way that suggests the licensor endorses you or your use. 
NonCommercial — You may not use the material for commercial purposes. 
NoDerivatives — If you remix, transform, or build upon the material, you may not 
distribute the modified material. 
 
 
The oscillating lateral hypothalamus and the orexinergic system – 
Dott. Idris Ayodeji AZEEZ 
PhD Thesis 
 
 
 
 
 
3 
 
Contents 
 
I. Acknowledgements ................................................................................... 6 
II. Thesis abstract ........................................................................................ 8 
III. List of abbreviations ........................................................................... 10 
1. General introduction ............................................................................. 12 
1.1 The orexins / hypocretins and the orexinergic system ................................ 12 
1. 1.1.1 The intermingling with melanin-concentrating hormone neurons
 ........................................................................................................... 20 
2. 1.1.2 Wiring and modulation of orexinergic neurons: intra- and extra-
hypothalamic inputs ........................................................................... 21 
3. 1.1.3 Diurnal changes in the orexinergic system ............................... 28 
4. 1.1.4 The orexinergic system and circadian regulation ..................... 31 
5. 1.1.5 Plastic changes in the synaptic wiring of orexinergic cell bodies
 ........................................................................................................... 35 
1.2 Orexin and the control of sleep and wake ................................................... 39 
6. 1.2.1 The role of orexin in vigilance states ........................................ 39 
7. 1.2.2 Deficient orexinergic signalling in narcolepsy ......................... 41 
1.3 Orexins in aging and aging-related neurodegenerative disorders ............... 44 
8. 1.3.1 Orexins in the normal aging brain ............................................ 44 
9. 1.3.2 Orexins in Alzheimer’s disease and Parkinson's disease .......... 46 
1.4 Extracellular matrix in the brain .................................................................. 49 
10. 1.4.1 Components of the brain extracellular matrix .......................... 52 
11. 1.4.2 Involvement of the extracellular matrix in neuroinflammation and 
neurodegeneration .............................................................................. 58 
1.5 Specific objectives of the experimental studies........................................... 60 
2. Study of the synaptic wiring of orexinergic neuron soma in the 
periods of sleep or wake predominance in adult mice ............................. 61 
2.1 Introduction ................................................................................................. 61 
2.2 Materials and methods ................................................................................. 62 
12. 2.2.1 Animals and experimental design ............................................. 62 
13. 2.2.2 Electroencephalography recording ........................................... 63 
14. 2.2.3 Tissue processing and immunofluorescence............................. 63 
15. 2.2.4 Microscopy and quantitative analyses .......................................... 64 
4 
 
2.3 Statistical analyses ....................................................................................... 65 
2.4 Results ......................................................................................................... 66 
16. 2.4.1 Sleep and wake states ............................................................... 66 
17. 2.4.2 Excitatory and inhibitory presynaptic elements ....................... 66 
18. 2.4.3 Postsynaptic markers ................................................................ 70 
2.5 Discussion ................................................................................................... 74 
2.6 Tables .......................................................................................................... 79 
2B. Addendum: preliminary data on astrocytes in the lateral 
hypothalamus during day and night ............................................................ 80 
2B.1 Purpose ..................................................................................................... 80 
2B.2 Materials and methods .............................................................................. 80 
19. 2B.2.1 Animals .................................................................................. 80 
20. 2B.2.2 Tissue processing and immunofluorescence .......................... 80 
21. 2B.2.3 Microscopy and data analysis ................................................ 81 
2B.3 Results ....................................................................................................... 82 
2B.4 Comments ................................................................................................. 87 
3. Synaptic wiring of orexinergic neuronal cell bodies during day and 
night: from adult to aged mice and study of a murine model of 
Alzheimer’s disease .......................................................................................... 89 
3.1 Introduction ................................................................................................. 89 
3.2 Materials and methods ................................................................................. 91 
22. 3.2.1 Experimental design and animals ............................................. 91 
23. 3.2.2 Tissue processing and immunofluorescence............................. 92 
24. 3.2.3 Microscopy and quantitative analyses ...................................... 93 
3.3 Statistical analyses ....................................................................................... 95 
3.4 Results ......................................................................................................... 95 
25. 3.4.1 Triple immunofluorescence of orexinergic neurons and 
glutamatergic or GABAergic presynaptic terminals ......................... 95 
26. 3.4.2 Quantitative analyses of the input to orexinergic cell bodies ... 97 
3.5 Discussion ................................................................................................. 106 
3.6 Tables ........................................................................................................ 110 
4. Extracellular matrix in the lateral hypothalamus and other brain 
regions: diurnal organization in basal conditions and in experimental 
sleeping sickness .............................................................................................. 112 
4.1 Introduction ............................................................................................... 112 
5 
 
4.2 Materials and methods ............................................................................... 114 
27. 4.2.1 Animals and infection ............................................................. 114 
28. 4.2.2 Brain tissue processing and immunofluorescence .................. 115 
29. 4.2.3 Microscopy and quantitative analyses .................................... 115 
30. 4.2.4 Western blot ............................................................................ 116 
4.3 Statistical analyses ..................................................................................... 116 
4.4 Results ....................................................................................................... 116 
31. 4.4.1 Diurnal organization of the extracellular matrix in the lateral 
hypothalamus and other regions in basal conditions ....................... 116 
32. 4.4.2 Western blot analysis .............................................................. 121 
33. 4.4.3 Diurnal organization of the extracellular matrix in the lateral 
hypothalamus of Trypanosoma brucei brucei-infected animals...... 122 
4.5 Discussion ................................................................................................. 124 
5. Summary and conclusions .................................................................. 126 
6. References ............................................................................................. 128 
 
 
  
6 
 
I. Acknowledgements 
All glory and adorations are due to the God Almighty for seeing through the course 
of the Doctoral program and making the completion of this Thesis a reality. 
I highly appreciate my parents for their unrelenting support over the years. I pray 
they live long to enjoy the fruits of their labor. I am also grateful to my other family 
members who have been supportive all along. 
A very special gratitude to my supervisor, Prof. Marina Bentivoglio, whom for a 
certain, I cannot thank well enough, other than ‘’to pray that God bless her with 
long life, good health, eternal joy and peace in all’’. She has been very supportive 
all through the period of this Doctoral program. She has trained me with every 
resources at her disposal in the last six years, hence turning me to a ‘budding 
neuroscientist and a fine researcher’. Molto grazie! 
My sincere gratitude goes to my mentor, the Dean, Faculty of Veterinary Medicine, 
University of Ibadan, Prof. James Olopade, who has been instrumental to this 
success story from the very onset. I can only wish him more of God’s blessings in 
all his endeavors. Many thanks to Dr (Mrs) Funmi Olopade and members of the 
Neuroscience unit, Department of Veterinary Anatomy, University of Ibadan. 
To the members of ‘Bentivoglio unit’- Prof. Gigliola Grassi-Zucconi, Drs. Anna 
Andrioli, Tiziana Cotrufo and Chiara Tesoriero, I value you so much especially for 
your ‘listening ears’, encouragement and willingness to help at all times. Also, I 
highly appreciate the help of Drs. Claudia Laperchia, Federico Del Gallo and 
Grygoriy Tsenov. Thanks are due Dr. Erika Lorenzetto for her technical assistance 
at the confocal microscopy. To our MSc students, Lejdi Jaupaj and Filippo Corghi, 
all the best as you round off your program. 
My stays in Naples (in 2015 and 2016) were fruitful owing to the tutorship of Dr. 
Luigia Cristino on the analyses of synaptic wiring of orexinergic neurons, and the 
technical assistance of Dr. Roberta Imperatore. You are both highly appreciated. 
Big thanks to Dr. Raffaella Mariotti for the opportunity to use her unit for Western 
blot procedures whenever I so wish and Dr. Ilaria Scambi for her tireless effort and 
technical assistance from time to time. 
All members of staff of the Department of Neuroscience, Biomedicine and 
Movement Sciences, Section of Anatomy and Histology, are well appreciated for 
their kindness and enabling working environment, from the Director- Prof. Andrea 
Sbabarti, to the secretarial staff- Mrs Nadia Lovato, Sarah Caloi and Emanuela 
Grandis, and many more others. 
I so much appreciate the Dean, Faculty of Veterinary Medicine, University of Jos, 
Prof. Lami Lombin, the Head- Prof. Hambolu Olajide and the academic staff, 
Department of Veterinary Anatomy for their invaluable support. 
7 
 
Gratitude to Prof. Tomas Hokfelt of the Karolinska Institute, Stockholm, Sweden 
and Prof. Alexej Verkhratsky of the University of Manchester, England for their 
precious time and efforts in painstakingly reviewing this Doctoral Thesis. 
Thank you, Adeola for being my best friend. 
Grazie mille a tutti! 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8 
 
II. Thesis abstract 
 
Neurons which release the orexins (OX)/hypocretins peptides and are located in the 
lateral hypothalamus (LH) are key regulators of energy metabolism, arousal and 
sleep-wake stability, motivated behaviors. This thesis presents three data sets 
focused on the synaptic wiring of OX-A cell bodies in relation to state-dependent 
behavior in mice.  
The first study (Chapter 2; Laperchia et al. 2017) tested the hypothesis of synaptic 
plasticity phenomena of OX soma innervation in basal conditions. Adult mice were 
sacrificed during day or night periods in which sleep or wake predominance, 
respectively, were assessed by electroencephalography in matched mice. Excitatory 
and inhibitory terminals on OX somata were evaluated with multiple 
immunofluorescence. The total number of these terminals did not vary between day 
and night, but glutamatergic terminals prevailed at night and GABAergic ones at 
daytime. The findings thus revealed a striking daily fluctuation in the axosomatic 
wiring of OX neurons, with a switch from prevalent excitatory innervation during 
wake to prevalent inhibitory innervation during sleep.  
An addendum to Chapter 2 presents methodological approaches to the analysis of 
astrocytes surrounding OX neurons, at day and night time points in antiphase as 
above, and preliminary observations.  
The second study (Chapter 3) tested the hypotheses that the above diurnal 
fluctuation could be altered during aging and in the pathology that characterizes 
Alzheimer's disease (AD). The same paradigm and approaches of the first study 
were applied to 3 month-old and 20 month-old TASTPM mice, which provide a 
model of AD and in which main pathological features were investigated, and to 
matched wild-type (WT) mice. The day/night fluctuation in the 
inhibitory/excitatory wiring of OX somata was replicated in young WT and 
TASTPM mice, but was lost in aged WT mice and TASTPM mice. In addition, an 
overall decrease of presynaptic terminals on OX cell bodies was found in aged WT 
and TASTPM mice vs young ones, and in TASTPM mice vs WT ones (all sampled 
during daytime). In 15 month-old TASTPM mice stereological OX cell counts 
revealed significant loss (34% decrease), and densitometric evaluation showed a 
significant enhancement OX immunosignal intensity, suggesting a potential 
compensatory increase of peptide synthesis. 
The third study (Chapter 4) tested the hypothesis that extracellular matrix (ECM) 
components, reported to be among the players regulating neural plasticity, could be 
involved in the daily reorganization of OX cell body wiring. The study was 
conducted in healthy mice and in a murine model of the parasitic encephalitis 
African trypanosomiasis or sleeping sickness. The ECM was labelled by Wisteria 
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floribunda agglutinin (WFA) immunofluorescence. Marked day/night variations 
were observed in confocal microscopy, with a diffuse ECM distribution at daytime, 
and a more compact organization and condensation around OX cell bodies at night. 
Furthermore, WFA expression in the LH, evaluated with Western blotting, was 
significantly enhanced at night compared to day. This diurnal variation of ECM 
organization was not found in other brain areas (suprachiasmatic nucleus, 
neocortex, hippocampus), and was lost in the LH after African trypanosome 
infection. These findings indicate regional day/night fluctuation of the ECM in the 
LH, and its disruption in a chronic neuroinflammatory pathology which leads to 
sleep-wake dysregulation. 
 
Keywords: orexin, lateral hypothalamus, synaptic plasticity, circadian timing, 
aging, Alzheimer’s disease, extracellular matrix, African trypanosomiasis 
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1. General introduction 
The experimental work presented in this thesis is focused on the synaptic wiring of 
orexinergic neuronal cell bodies, which are located in the lateral hypothalamus 
(LH), with particular reference to their diurnal plasticity in basal conditions. The 
study has been performed in the healthy brain, in adult and aged mice, and in a 
murine model of Alzheimer's disease (AD). On the basis of the findings that will be 
here presented, the phenotype of the extracellular matrix (ECM) surrounding 
orexinergic neurons in the LH was also investigated during day and night, and 
compared with the ECM in other brain areas. Current knowledge on these topics is 
highlighted in the first chapter of this thesis. 
1.1 The orexins / hypocretins and the orexinergic system 
Orexin (OX)-A and B, also known as hypocretin 1 and 2, are a unique pair of 
alternatively spliced neuropeptides derived from a single common precursor 
encoded by the prepro-orexin gene. OX peptides in the brain are synthesized by 
neurons located exclusively in the hypothalamus (lateral hypothalamic area and 
perifornical area). They were first reported in two independent publications in 1998. 
One group designated the peptides as ‘hypocretins’ because of their hypothalamic 
location and similarity with the gut peptide secretin (de Lecea et al. 1998). The other 
group named the peptides ‘orexins’ (from the Greek orexis: appetite), because they 
were found to stimulate food intake (Sakurai et al. 1998). In particular, the 
intracerebroventricular (icv) injection of orexins during the light period induced 
feeding behavior in rats and mice (Sakurai et al. 1998). 
Orexinergic neurons are projection cells, variable in size (the cell body diameter 
ranges from 15 to 40 μm) and shape (spherical, fusiform or multipolar), and have 
been assumed to number around 3,000-4,000 in the rat brain, and approximately 
30,000–70,000 in the human brain (Thannickal et al. 2000; Sakurai 2007; Brownell 
and Conti 2010; Callander et al. 2013). The OX peptides are highly conserved, with 
identical OX-A sequences and just two amino acid substitutions in OX-B in humans 
and mice. Nonhuman vertebrates, including the zebrafish (which contains 16-60 
OX neurons in the LH of larvae and adults, respectively) (Elbaz et al. 2013), 
produce OX, although OX-like peptides seems to lack in invertebrates (Sakurai et 
al. 1998; Scammell and Winrow 2011). The OX peptides are unique in that they do 
not have significant structural similarities to known families of regulatory peptides, 
hence other neuropeptides, such as neuropeptide Y (NPY), secretin, and similar 
peptides have not been shown to bind to OX receptors (OXRs) (Holmqvist et al. 
2001). 
OX-A consists of 33 amino acids with two disulfide bridges, while OX-B is a linear 
peptide of 28 amino acids with two alpha helices (Lee et al. 1999). The OX-A 
peptide has C terminus amidation and N terminus cyclisation with a pyroglutamyl 
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residue. Before synaptic release, the peptides undergo packaging into dense core 
vesicles (de Lecea et al. 1998).  
OX-A and B are largely colocalized in the same neurons, and OX-A is more stable 
and biologically active than OX-B, possibly due to post-translational modifications 
(de Lecea et al. 1998; Sakurai et al. 1998; Nixon and Smale 2007). Henceforth, the 
acronym OX will be here used to refer to both OX-A and OX-B or to OX-A only, 
unless specified otherwise. 
A wealth of evidence, including phenotyping and ultrastructural data, indicates that 
orexinergic neurons are excitatory and utilize glutamate as neurotransmitter. 
Orexinergic cell bodies show glutamate immunoreactivity (Abrahamson et al. 
2001), orexinergic axon terminals establish mainly asymmetric synapses (de Lecea 
et al. 1998; Peyron et al. 1998; Diano et al. 2003; Torrealba et al. 2003) and 
glutamate is stored at the presynaptic terminal in small, clear, synaptic vesicles 
different from the vesicles which contain the peptide (Torrealba et al. 2003). 
Orexinergic neurons also produce the peptide dynorphin, and other neuropeptides 
co-derived from prepro-dynorphin (Chou et al. 2001). In the rat LH, dynorphin was 
found to be expressed only in OX neurons, with 96% of them containing dynorphin 
at both the mRNA and peptide levels. In the LH of mice, a similar degree of 
expression was observed as in rats (Chou et al. 2001). Mice with targeted deletion 
of the prepro-orexin gene still had neurons highly expressing  prodynorphin 
mRNA, whereas OX/ataxin-3 mice, in which OX neurons degenerate selectively in 
early adulthood (Hara et al. 2001), lack both prepro-orexin and prodynorphin 
mRNAs in the LH (Chou et al. 2001). Little is known about the conditions that 
facilitates the release of these co-neurotransmitters (Liu et al. 2002; Crocker et al. 
2005). Recent data indicate, however, that dynorphin can be involved in the 
regulation of OX neuron activity during vigilance states (Ferrari et al. 2018) (see 
1.1.2). 
Another neuropeptide, neurotensin, which is involved in neuroendocrine and 
feeding behavior regulation and in reward mechanisms, is co-expressed in OX 
neurons (Furutani et al. 2013). In addition, neurotensin-immunoreactive fibers 
contact OX neurons and could be implicated in maintaining their activity (Furutani 
et al. 2013). 
Furthermore, orexinergic neurons secrete neuronal activity-regulated pentraxin 
(NARP, also called NP2 or NPTX2) (Reti et al. 2002), a protein involved in the 
clustering of -amino-3-hydroxy-5-methylsoxazole-4-propionate (AMPA) 
glutamate receptors, which is involved in circadian synaptic changes (see 1.1.3 and 
1.1.4) of OX neurons (Appelbaum et al. 2010). 
The actions of OX are mediated by orexin-1 receptor (OX1R) and orexin-2 receptor 
(OX2R) via two G-protein coupled receptors that have 7-transmembrane domains 
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and some similarity to other neuropeptide receptors (Fig. 1.1) (Sakurai and Mieda 
2011; Inutsuka and Yamanaka 2013). OX1R is thought to couple to Gq, and OX2R 
can signal through Gq or Gi/Go, but coupling mechanisms seem to differ in 
different cell types and have not been thoroughly examined in neurons (Scammell 
and Winrow 2011). 
 
Fig. 1.1: a: Sequence of orexin (OX)-A (the same sequence has been identified in 
different mammals) and OX-B in different species, with indication of the topology of the 
two intrachain disulfide bonds of OX-A. Shadows indicate amino acid identity. b: OX-
A and OX-B are derived from a common precursor peptide, prepro-orexin. OX receptor 
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(R)-1 is coupled to the Gq subclass of heterotrimeric G proteins, whereas OXR-2 is 
coupled to Gi/o and/or Gq. c. Diagram illustrating the integrative physiological roles of 
OX neurons. They regulate the hypothalamic nuclei involved in feeding behavior. They 
regulate sleep and wake, promoting wakefulness, through connectivity with neurons of 
the preoptic area, and brain stem. Abbreviations are in the generalist list; other 
abbreviations: LHA, lateral hypothalamic area; POMC, proopiomelanocortin. Sources: 
Sakurai and Mieda 2011; Inutsuka et al. 2013. 
 
OX1R and OX2R are highly conserved across mammals, with 94% identity in the 
amino acid sequences between humans and rats. OX1R has greater affinity (∼100-
fold higher) for OX-A over OX-B, whereas OX2R, which shares 64% amino acid 
homology with OXR-1, accepts both ligands with similar affinities (Sakurai et al. 
1998). OX1R and OX2R mRNAs have a different complementary distribution, 
which suggests that these receptors have distinct physiological roles through 
different neuronal pathways (Marcus et al. 2001). Of note, the only identified OXR 
in zebrafish corresponds structurally to the mammalian OX2R (Elbaz et al. 2017a). 
The efferent projections of OX neurons match the expression pattern of OXRs 
throughout the brain. The dorsomedial nucleus of the hypothalamus (DMN), 
paraventricular nucleus of the hypothalamus (PVH), and locus coeruleus (LC) 
highly express OX1R mRNA, whereas OX2R mRNA is prominent in the neocortex, 
septal nuclei, hippocampus, and some other hypothalamic nuclei, including the 
histaminergic tuberomammillary nucleus (TMN), express only OX2R mRNA 
(Marcus et al. 2001; Yamanaka et al. 2010) (see also 1.2.1). 
From the LH, the orexinergic neurons project extensively to other brain structures 
(sparing the cerebellum), and to the spinal cord (Peyron et al. 1998) (Fig. 1.2), 
constituting the central orexinergic system (Nuñez et al. 2009). The term 
‘’orexinergic system’’ usually refers to the OX peptides and their receptors as well 
as to OX neurons and their projections to different parts of the central nervous 
system (CNS). 
Orexinergic neurons not only give origin to long-range projections (Fig. 1.2), but 
also contribute to local networks in their target areas, where they modulate 
functional activities. OX can act presynaptically to induce release of -aminobutyric 
acid (GABA) or glutamate, thus generating effects on downstream neurons 
(Scammell and Winrow 2011).  
Research on OX has focused on the CNS, where these peptides have been 
discovered, but their occurrence in the periphery has also been reported. For 
example, small amounts of OX may be produced, and OXRs expressed, elsewhere, 
such as in the testes (Jöhren et al. 2001) and in the adrenal gland (Randeva et al. 
2001). OX-producing neurons have also been described in the submucosal and 
myenteric plexuses of the stomach and small intestine (Kirchgessner and Liu 1999), 
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although this is controversial as these neurons may contain an OX-like peptide that 
could cross-react with anti-OX antisera (Baumann et al. 2008; Scammel and 
Winrow 2011). 
 
Fig. 1.2: The orexinergic system: OX cell bodies (black dots) reside in the lateral 
hypothalamus area and project widely to the neuraxis. The thickness of arrows represents 
the relative abundance of projections. Abbreviations are in the general list. Reproduced 
from Tsujino and Sakurai 2009. 
 
Hypothalamic neurons containing the OX peptides (Fig. 1.3) have been implicated 
in multiple functions (Fig. 1.1), especially related to the control of a variety of 
homeostatic functions including energy expenditure (Date et al. 1999; Sakurai 
2014). The broad range of functions influenced by the orexinergic system has led 
to the description of these neurons as ‘’physiological integrators’’ (Fig. 1.1C) (de 
Lecea et al. 1998; Inutsuka and Yamanaka 2013). 
As mentioned above, these peptides were recognized as regulators of feeding 
behavior since their identification. Subsequent studies showed that OX plays a 
crucial role in sleep and wake regulation (see 1.2.1) and, as it will be dealt with 
below (see 1.2), OX deficiency produces symptoms of the sleep disorder narcolepsy 
(Peyron et al. 2000; Scammell et al. 2012; Tsunematsu and Yamanaka 2012) (see 
1.2.2). OX2R has been thought to have a major role in maintaining wakefulness, 
and OX1R is likely to be involved in a broad range of other functions, including 
emotion, reward and autonomic regulation (review in Sakurai 2014). 
Fasting induces upregulation of prepro-orexin mRNA levels (Sakurai et al. 1998) 
and transgenic (Tg) mice lacking the OX neurons fail to rouse in response to lack 
of food, supporting the appetite-regulating role of the OX peptides (Yamanaka et 
al. 2003a). In addition, chemogenetic activation of OX neurons simultaneously 
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increases locomotor activity and food intake (Inutsuka et al. 2014) and blockade of 
OXRs reduces food intake (Haynes et al. 2000) and binge eating behavior (Piccoli 
et al. 2012). However, other studies indicate that following icv administration OX-
A stimulate only modestly food intake compared to other orexigenic peptides like 
NPY and galanin, and the effects of OX-B on food intake were found to be 
inconsistent (Edwards et al. 1999; Taheri et al. 1999, 2000).  
 
 
Fig. 1.3: Selective location of orexin-A-containing neurons (at different magnifications) 
in the lateral hypothalamus of 3 month-old mouse (nickel-intensified 
immunohistochemistry). From archival lab material. 3V, third ventricle; denotes the 
fornix. 
 
While OX antagonists may block the physiological roles of these peptides, the 
coreleased neurotransmitters may still be able to exert their physiological roles 
(Scammell and Winrow 2011). For instance, Tg mice lacking OX neurons (OX 
neuron ablated mice) have stronger tendencies toward obesity when compared with 
Tg mice lacking the OX encoding genes (prepro-orexin knockout mice) (Hara et 
al. 2001). 
In OX/ataxin-3 mice, in addition to sleep/wake cycle abnormalities, the disruption 
in energy homeostasis leads to late-onset obesity, even if they eat less than their 
wild-type (WT) littermates, pointing to a key role of OX in energy homeostasis 
(Hara et al. 2001). In WT mice despite an orexigenic effect of acute OX treatment, 
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chronic icv OX infusion does not lead to weight gain (Yamanaka et al. 1999). 
Moreover, recent findings have revealed that OX neuron activity decreases after 
eating onset and their silencing leads to eating facilitation (González et al. 2016), 
which is in line with the obesity observed in OX-deficient mice (Hara et al. 2001). 
OX plays a role in the maintenance of wakefulness during food searching and in 
reward-related food consumption (Cason et al. 2010), which highlights the 
importance of OX in the control of different aspects of food intake  (Blasiak et al. 
2017). 
In addition, OX regulates autonomic functions and neuroendocrine axes, including 
the hypothalamic-pituitary-adrenal axis (HPA), as well as plasticity mechanisms 
related to reward (Jászberényi et al. 2000; Kuru et al. 2000). Documented results 
clearly indicate a role for orexinergic neurons in reward processing, arousal, drug-
related effects and addictive behaviors. Orexinergic neurons are directly activated 
by corticotropin releasing hormone (CRH) and stress (Winsky-Sommerer et al. 
2004) and are involved in stress-induced overconsumption of food (Piccoli et al. 
2012), and reinstatement of alcohol- and drug-seeking behavior (Kastman et al. 
2016; Schmeichel et al. 2016). The functional link between the HPA axis and OX 
neurons is reciprocal, since OX induce c-fos mRNA (which reveals neuronal 
activity; see 1.1.3) in the PVH, and an increase in plasma levels of 
adrenocorticotropic hormone (ACTH) and corticosterone in rats (Kuru et al. 2000). 
These pathways may be involved in stress-induced over-activation of OX neurons, 
leading to reward-based binge eating behavior (Blasiak et al. 2017). 
The stimulation of the LH was found to potentiate the effect of an ineffective dose 
of morphine and induced morphine sensitization (Razavi et al. 2014). In the rat, 
chemical stimulation of the LH by unilateral administration of a cholinergic agonist 
resulted in a change in conditioned place preference suggesting the involvement of 
OX in drug-seeking behavior (Taslimi et al. 2011). The administration of OX in the 
ventral tegmental area (VTA) also induced conditioned place preference in a dose-
dependent manner in rats (Taslimi et al. 2012; Riahi et al. 2013; Haghparast et al. 
2017). In the same area, the VTA, OX administration increases the number of N-
methyl-D-aspartate (NMDA) receptors in the cell membrane, rendering the neurons 
more responsive to the excitatory effects of glutamate for several hours (Borgland 
et al. 2006, 2008; Scammell and Winrow 2011). 
The orexinergic system also plays a role in cognitive processes. A mechanism for 
this could be represented by the control of neurotransmission in the hippocampus 
by direct and indirect modulation of various pathways (Stanley and Fadel 2012). In 
particular, OX-mediated modulation of GABA and glutamate release in the 
hippocampus could be a potential contributor to cognitive performances  (Stanley 
and Fadel 2012). 
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In vitro and in vivo studies have shown that OX is neuroprotective and has anti-
apoptotic properties, reducing neuronal damage caused by ischemia or oxidative 
insult in hypothalamic, hippocampal, and cortical tissues (Yuan et al. 2011; 
Butterick et al. 2012; Sokołowska et al. 2012; Nixon et al. 2015). While the 
mechanism is not fully defined, OX appears to increase resistance to oxidative 
stress by upregulation of hypoxia-inducible factor 1 alpha (HIF-1α) (Sikder and 
Kodadek 2007; Yuan et al. 2011; Butterick et al. 2013; Feng et al. 2014). HIF-1α is 
a transcription factor that alters mitochondrial activity by increasing ATP 
production through oxidative phosphorylation, and affects the expression of 
transferrin, a protein important in the regulation of iron metabolism in the brain 
(Semenza 2001; Weinreb et al. 2013). 
In addition, recent evidence suggests an anti-cancer role for OX (Graybill and 
Weissig 2017). In an experimental model of glioblastoma multiforme, an 
aggressive brain cancer, findings confirmed the presence of both OXRs. 
Interestingly, treatment of these cells with OX-A, and not OX-B, resulted in a dose-
dependent significant decrease in the rate of cell viability (Biegańska et al. 2012). 
Orexinergic neurons link forebrain structures involved in the processing of emotion 
and motivation and the brain stem regions which regulate wakefulness and reward 
(review in Sakurai 2014). As such, cues associated with reward and arousal have 
been demonstrated to stimulate OX neurons (Sakurai et al. 1998; Harris et al. 2005). 
High OX level in the cerebrospinal fluid (CSF) has been associated with increased 
purposeful behaviour. For instance, it has been shown that yard play produces a 
substantial increase in CSF OX levels in dogs, although no significant increase 
beyond baseline was found following comparable treadmill locomotion (Wu et al. 
2011; Boddum et al. 2016). 
In particular, orexinergic neurons link forebrain structures implicated in the 
processing of emotion and motivation, such as the amygdala, bed nucleus of the 
stria terminalis (BNST) and nucleus accumbens, with brain stem regions that 
regulate wakefulness (Sakurai 2014). The activation of orexinergic neurons by the 
limbic system maintains wakefulness during emotional arousal. In humans, 
increased levels of OX, measured in the amygdala, have been found during social 
interactions and in connection with social-induced positive emotions (Blouin et al. 
2013). Experimental studies have associated the involvement of the orexinergic 
system in emotion and emotional memory with the abundant input received by the 
orexinergic neurons from the limbic system (Hara et al. 2005; Harris et al. 2005; 
Flores et al. 2014; Wu et al. 2014). 
Orexinergic neurons also innervate brain regions related to nociception, especially 
the LC. The central administration of OX reduces nociceptive responses in mouse 
models of thermal, inflammatory and visceral pain and a role for OX in the direct 
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link between nociception and analgesia has been identified (Bingham et al. 2001; 
Yamamoto et al. 2002; Inutsuka et al. 2016). 
The connectivity of the orexinergic system with multiple neuronal systems implies 
that OX neurons provide links for different brain functions. It has been envisaged 
that a multiparametric perspective, such as genetics, receptor subtype-selective 
pharmacology, optogenetics and chemogenetics, would be needed to further 
unravel the integrative physiological roles of the orexinergic system (Mieda 2017). 
1.1.1 The intermingling with melanin-concentrating hormone neurons  
OX neurons are intermingled in the LH with neurons expressing the peptide 
melanin-concentrating hormone (MCH) (Bittencourt 2011) (Fig.1.4). There are 
about 12,000 MCH-expressing neurons in the rat (Modirrousta et al. 2005). 
Altogether, the OX and MCH neurons account for a low proportion (less than 1%) 
of LH neurons (Broberger et al. 1998; Sakurai 2007; Hassani et al. 2009). This 
highlights the heterogeneity of the LH, which is very rich in neuronal subsets 
containing different peptides (Gerashchenko and Shiromani 2004). 
MCH neurons have been implicated in some of the same homeostatic functions as 
OX neurons, such as energy balance and sleep regulation (Pissios et al. 2006; 
Peyron et al. 2009; Kessler et al. 2011). Although they anatomically overlap in 
distribution in the LH (Fig.1.4), functionally, OX and MCH neurons play opposite 
roles, in particular in the regulation of sleep/wake states (see 1.2.1). 
 
Fig. 1.4: Confocal microscopy image of the neuronal populations containing orexin-A 
(orange) or melanin-concentrating hormone (green) in the tuberal hypothalamus on a 
coronal section of a mouse brain. ic, internal capsule; f, fornix; opt, optic tract; 3V, third 
ventricle. Reproduced from Peyron and Kilduff 2017. 
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Icv injections of MCH increase food intake in satiated rats (Guesdon et al. 2009), 
MCH knockout mice are hyperactive and lean (Shimada et al. 1998), and fasting 
increases levels of MCH mRNA (Bertile et al. 2003). The optogenetic activation of 
MCH neurons in mice induces sleep, but not food consumption (Konadhode et al. 
2013). However, MCH signalling can promote motivational behaviors leading to 
overconsumption of highly-palatable, calorically-dense food (Georgescu et al. 
2005) and is involved in stress-induced binge eating (Pankevich et al. 2010), 
cocaine (Chung et al. 2009) as well as alcohol consumption (Duncan et al. 2005; 
Karlsson et al. 2016). 
The involvement of MCH in food intake in animals has prompted the investigation 
of potential therapeutic effects of MCH receptor (MCHR) antagonists as anti-
obesity agents in humans, although no compound has hitherto proceeded to Phase 
II (Macneil 2013; Blasiak et al. 2017). In addition, treatment of hippocampal 
neurons with corticosterone in vitro increases MCH expression (Kim and Han 
2016). This implies that MCH neurons constitute another substrate through which 
stressors can affect feeding behavior (Hervieu 2003). Similarly to the orexigenic 
systems, the relationship between MCH signalling and stress is reciprocal. 
Blockade of MCHR1 has strong anxiolytic and antidepressant effects (Borowsky et 
al. 2002; Smith et al. 2006) and MCHR1 knockout mice exhibit reduced depressive-
like behavior (Roy et al. 2007). 
In the genetic rat model of depression provided by the Flinders Sensitive Line, the 
total number of OX neurons was found to be higher (16% increase) compared to 
controls, with no changes in the number of MCH neurons. The increased OX levels 
have been associated with an induction of depressive state, indicating that OX 
negatively modulates emotion (Mikrouli et al. 2011). 
From the perspective of specific experimental manipulations, the estrogen receptor 
α agonist was found to decrease the number of MCH-expressing neurons following 
castration of male mice (Muschamp et al. 2007), indicating a hormonal regulation 
of this peptide. 
1.1.2 Wiring and modulation of orexinergic neurons: intra- and extra-
hypothalamic inputs 
The LH is the most extensively interconnected area of the hypothalamus (Burt et 
al. 2011). As briefly dealt with below, OX neurons receive abundant input from 
structures the limbic system, which could be important for increasing arousal during 
emotional stimuli and are also regulated by various peripheral metabolic cues, 
including ghrelin, leptin and glucose, indicating that OX neurons provide a link 
between energy homeostasis and vigilance states (Sakurai et al. 2005; Yoshida et 
al. 2006; Sakurai 2007). 
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Multiple neuronal systems interact with OX neurons (Sakurai 2007). Anterograde 
tract tracing analyses in rats, based on injections of biotinylated dextran, confirmed 
that many brain regions innervate the OX neurons directly, with the heaviest 
afferents coming from the lateral septum, preoptic area, BNST, and posterior 
hypothalamus (Yoshida et al. 2006). Interestingly, it was also demonstrated that 
hypothalamic regions preferentially innervate OX neurons in the medial and 
perifornical fields, while most projections from the brain stem target the lateral field 
(Yoshida et al. 2006). This indicates that subpopulations of OX neurons may have 
different physiological functions (Inutsuka and Yamanaka 2013). 
In the Tg mouse line with human prepro-orexin promoter, retrograde tract tracing 
with tetanus toxin has identified several areas and neurons in connection with  OX 
neurons, including the basal forebrain (BF) cholinergic neurons, GABAergic 
neurons of the ventrolateral preoptic nucleus (VLPO), and serotonergic neurons in 
the median raphe and paramedian raphe (Sakurai et al. 2005). Retrograde tract 
tracing confirmed that regions involved in emotions, including the amygdala, 
nucleus accumbens and BNST, innervate OX neurons (Sakurai et al. 2005). The 
interactions between the limbic system with inputs from corticotropin releasing 
factor (CRF) neurons, and the orexinergic system have been proposed to maintain 
wakefulness during stressful events (Winsky-Sommerer 2004).  
Of special interest and relevance for the modulation of OX neurons is the synaptic 
wiring of their somata. It has been stated that unraveling the integration onto these 
neurons of synaptic inputs from various brain areas would be important to 
understand the cellular mechanism underlying the essential functions mediated by 
LH (Burt et al. 2011). 
The integrative features of neurons in the CNS strongly depend on the number, 
density and distribution of the synaptic afferents and efferents (Megı́as et al. 2001). 
While the majority of the synaptic inputs in the CNS are received by the dendrites, 
the synaptology of the cell somata is critical for the generation of the action 
potential and therefore the control of the neuron firing (Spruston 2008). Neuronal 
cell bodies in the CNS are either dominated by inhibitory inputs (especially the cell 
bodies of projection neurons), or have an approximate ratio of excitatory to 
inhibitory inputs of 1:1 (e.g. inputs onto the perikarya of interneurons) (Shepherd 
2004; Douglas et al. 2004; Pinto et al. 2004). Of note, ultrastructural and 
electrophysiological studies in mice have reported that OX perikarya receive 
numerous putative excitatory inputs that greatly outnumber inhibitory inputs 
(Horvath and Gao 2005).  
In particular, glutamatergic axons have been reported to account for the majority of 
excitatory inputs on OX soma, although the source of these excitatory synapses 
remains to be determined. They likely derive from local glutamatergic neurons, but 
they may also originate from other hypothalamic and from extra-hypothalamic 
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regions (Li et al. 2002; Horvath and Gao 2005). Some of the excitatory inputs onto 
OX somata originate from CRH-producing hypothalamic neurons, suggesting a 
possible pathway for stress-induced activation of the OX system, given the role of 
CRH neurons in the response to stress (Winsky-Sommerer 2004). 
The observed prevalence of excitatory over inhibitory synapses on the soma of 
orexinergic neurons was found to be in contrast to perikaryal arrangements of 
inhibitory boutons in other hypothalamic areas, such as the arcuate nucleus, where 
inhibitory boutons dominate neuronal perikarya (Horvath and Gao 2005).  
In their study of the synaptic wiring of OX cell bodies, Horvath and Gao (2005), 
did not address, however, the time points of their sampling of the animals. In view 
of the diurnal changes in the activity of orexinergic neurons (see 1.1.3) the issue of 
the balance between excitatory and inhibitory inputs onto OX somata has been re-
examined in the work of this thesis during day and night, taking into account the 
behavioral states of the animals (see Laperchia et al. 2017, Chapter 2). 
Recordings from transgenic mice expressing green fluorescent protein (GFP) in OX 
neurons demonstrate that agonists of ionotropic glutamate receptors activate them, 
while glutamate antagonists inhibit their activity. These results indicate that OX 
neurons are tonically activated by glutamate (review in Inutsuka and Yamanaka 
2013).  
In addition, the local network in the LH plays an important role in OX neuron 
activity regulation. First, regulation of OX neurons is effected within the local 
orexinergic network itself. Immuno-electron microscopy analyses have shown that 
OX neurons are directly innervated by OX neurons (Yamanaka et al. 2010). Results 
from patch-clamp recordings in slice have revealed that OX neurons are directly 
and indirectly activated by OX via OX2R (Fig. 1.5). Furthermore, OX activates 
indirectly OX neurons by increasing in them spontaneous excitatory post-synaptic 
currents (sEPSCs). OX2R is the primary mediator also of this indirect activation 
(Yamanaka et al. 2010). Although OX-B application elicited in OX neurons of 
OX1R−/− mice an activation comparable to that elicited in WT OX neurons, OX 
neurons in OX2R−/− mice failed to respond to OX-B (Yamanaka et al. 2010). These 
results suggest that OX neurons form a positive feedback circuit between them, 
which could be responsible for the maintenance of their high level of activity 
(Yamanaka et al. 2010). 
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Fig. 1.5: Schematic summary of the mechanism underlying orexin (OX)-induced 
activation of OX neurons which give origin to widely distributed projections. OX 
neurons directly innervate other OX neurons activating them through OX2R. This could 
form a positive feedback circuit, to preserve the activity of OX neurons and thus maintain 
arousal. Glutamate receptors include AMPA, NMDA, and metabotropic glutamate 
receptors. Reproduced from Yamanaka et al. 2010.  
 
GABA receptors (GABAAR and GABABR) have a role in the homeostatic 
regulation of neuronal excitability, thus enhancing the stabilization of neural 
networks (Turrigiano 1999). In vitro studies have shown that OX neurons are 
hyperpolarized and inhibited by both GABAAR and GABABR agonists, whereas 
MCH neurons are inhibited by GABAAR agonists (Eggermann et al. 2003; Van Den 
Pol et al. 2004; Xie et al. 2006). 
A recent report has confirmed that OX neurons are inhibited by local GABAergic 
inputs (Ferrari et al. 2018). The local GABAergic neurons send projections onto 
OX neurons during sleep, but their firing is depressed during wakefulness by 
cholinergic disinhibition or by dynorphins released from OX neurons (Ferrari et al. 
2018) (see also 1.1). 
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Studies in epifluorescence and confocal microscopy have revealed somatostatin 
(SST)-immunopositive varicosities and fibers in the vicinity of OX neurons, and 
these frequently appeared to contact their perikarya and proximal dendrites (Toossi 
et al. 2016). GABAergic synapses upon OX somata by SST-immunopositive 
neurons could further provide an inhibitory influence through SST release upon or 
in close proximity to OX perikarya or proximal dendrites and also by co-release 
and action of GABA upon GABAergic synapses on their somata or dendrites 
(Toossi et al. 2016). 
Glycine, a primary inhibitory neurotransmitter in the CNS aside GABA, is widely 
distributed throughout the brain stem and spinal cord. Functional glycine receptors 
(GlyR) and glycinergic synapses onto OX neurons identified by electrophysiology 
and immuno-electron microscopy were found to directly inhibit OX neurons in 
vitro. OX neurons were found to be potently hyperpolarized by glycine in a 
concentration-dependent manner (Hondo et al. 2011). The expression of GlyR at 
glycinergic synapses on OX neurons provides a basis for a functional and molecular 
role of glycine in the physiological regulation of OX neurons (Hondo et al. 2011). 
However, the origin of glycinergic fibers innervating OX neurons in the LH remains 
unknown, so that the neuronal pathways that mediate glycine-induced inhibition of 
OX neurons need to be identified (Hondo et al. 2011; Karnani et al. 2011). 
MCH-containing axon terminals establish asymmetric contacts (Bittencourt et al. 
1992), and contribute to the synaptic inputs onto OX neurons (Guan et al. 2002; 
Burt et al. 2011) (Guan et al. 2002; Burt et al. 2011). It has also been postulated that 
the inhibitory GABA boutons onto OX soma are those that also contain NPY 
(Horvath et al. 1997) and may originate from the arcuate nucleus (Broberger et al. 
1998; Elias et al. 1998; Horvath et al. 1999; Horvath and Gao 2005).  
Some populations of LH neurons besides OX- or MCH-expressing neurons (Fig. 
1.6), such as CRF, NPY, thyrotropin-releasing hormone, neurotensin, and 
GABAergic neurons (see 1.2), express neurotransmitters with known 
electrophysiological actions on OX neurons. The actions of these LH  neuronal 
populations may be important for fine tuning the firing activity of OX neurons to 
maintain optimal levels of prolonged output to sustain wakefulness and stimulate 
consummatory behaviors (review in Burt et al. 2011). 
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Fig. 1.6: A. Regulation of orexin (Orx)-containing neurons by local neurotransmitters. 
The activity of orexinergic neurons is controlled directly or indirectly by positive and 
negative feedback mechanisms mediated by neurotransmitters and neuromodulators 
released by neurons in the lateral hypothalamus. Glutamate (Glut), dynorphin (Dyn), 
nociceptin/orphanin FQ (N/OFQ), endocannabinoids (eCB), MCH-containing and 
GABAergic neurons are depicted. B. Schematic illustration of the regulation of 
orexinergic neurons by astrocytes. Glutamatergic transmission can be stimulated in 
orexinergic neurons via the monocarboxylate transporters (MCTs)- MCT-mediated 
astrocyte-neuron lactate shuttle.  Reproduced from Burt et al. 2011. 
 
Furthermore, leptin receptor-expressing GABAergic neurons have been identified 
among OX neurons in different species and leptin has been shown to affect the 
synaptic organization of other hypothalamic peptidergic systems (Horvath et al. 
1999; Håkansson et al. 1999; Pinto et al. 2004). 
Monoamine neurotransmitters such as dopamine, noradrenaline, and serotonin (5-
HT) hyperpolarize and inhibit OX neurons via D1/D2-, alpha 2-adrenergic and 5-
HT1A receptors (Yamanaka et al. 2003b; Bubser et al. 2005; Messina et al. 2018). 
Other factors that reportedly influence the activity of OX neurons include 
environmental factors such as physiological fluctuations in acid and carbon dioxide 
levels. It should be noted that factors related to feeding (such as glucose, ghrelin, 
and leptin) inhibit the activity of OX neurons. The large variety of neurotransmitters 
and factors that regulate the activity of OX neurons demonstrates the role of these 
neurons in diverse processes, including functions regulated by circadian rhythms, 
such as energy balance and vigilance level (review in Inutsuka and Yamanaka 
2013). 
The local network within the LH and perifornical area consists, as elsewhere in the 
brain, of neurons and glia, and "gliotransmission" also shapes the output of the LH 
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neurons, including orexinergic ones (Fig. 1.7). Modulation and negative feedback 
regulation of excitatory glutamatergic inputs and the release of astrocyte-derived 
factors, such as lactate and adenosine triphosphate (ATP), can affect the excitability 
of OX neurons. OX neurons utilize lactate derived from astrocytes as energy 
substrate (Parsons and Hirasawa 2010). Glutamatergic transmission has been 
proposed to stimulate OX neurons via the astrocyte-neuron lactate shuttle mediated 
through the monocarboxylate transporters (review in Burt et al. 2011). 
 
 
 
Fig. 1.7: A. Local network within the LH. A number of neuronal populations have been 
identified within the LH/PFA in addition to OX-neurons, including those MCH, TRH, 
CRF, neurotensin (NT), galanin (Gal) and leptin receptor (LepRb)-expressing 
GABAergic neurons. Most of these neurotransmitters have been demonstrated to 
modulate the excitability of OX neurons. These neurons, along with astrocytes, 
constitute a local network that can fine-tune the activity levels of this brain area through 
complex interactions. B. Schematic illustration of the fasting-induced plasticity of the 
organization of input to orexinergic neurons: inhibitory is in green and excitatory input 
in red. The regulatory signals for such synaptic changes are not yet well defined. Adapted 
from; Horvath and Gao 2005; Burt et al. 2011. 
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The activation of astrocytes or neurons can induce the release of extracellular ATP, 
which can also act as a transmitter molecule (Fig. 1.7) (Guthrie et al. 1999; Druzin 
et al. 2002; Burt et al. 2011). Extracellular ATP directly depolarizes OX neurons 
via ionotropic purinergic receptors (P2XRs) expressed on the plasma membrane, 
while having little effect on synaptic inputs, whereas hydrolyzed adenosine from 
ATP released from neurons can have direct and indirect synaptic effects leading to 
the inhibition of OX neurons (Wollmann et al. 2005). OX neurons coexpress the 
P2X(2)R subunit, and, conversely, 80% of the P2X(2)R-immunoreactive neurons 
in the LH are also OX-immunoreactive in the rat (Florenzano et al. 2006). 
1.1.3 Diurnal changes in the orexinergic system 
Given the role of the LH in physiological functions critical for survival which 
undergo substantial changes during 24 h (e.g. food intake and metabolism, sleep 
and wake states), it may not be surprising that diurnal (day/night) and circadian 
(circa diem) changes have been reported in the LH. Gene profiling in mice has 
shown some similarities and some differences in gene expression undergoing 
diurnal changes in the LH compared to other hypothalamic regions (Gerstner et al. 
2006). 
It is worth recalling, in this respect, that functional, cellular, molecular fluctuations 
in the hypothalamus during 24 h can be related in different studies to daytime (the 
light period) and night-time (the period of darkness), the animal's rest and activity 
and/or state-dependent behavior (sleep and wake). 
State-dependent behavior, in which all behavioral performances are inscribed, 
consists of three states: wake, rapid eye movement (REM) sleep (also called 
paradoxical sleep), non-REM sleep (also referred to as slow wave sleep, SWS), 
defined by neurophysiological parameters and, in particular by 
electroencephalogram (EEG) recording. REM sleep is preceded by non-REM sleep 
in an obligatory sequence of cycles (non-REM sleep followed by REM sleep) 
repeated during the animal's sleep period. The wake period corresponds to the 
activity phase of the animal, and the sleep period to the rest phase. In nocturnal 
animals, such as laboratory rodents, the activity period, characterized by wake 
predominance, corresponds to the period of darkness, and the rest period, 
characterized by sleep predominance, to the light period. 
The Fos protein (encoded by immediate early gene c-fos) is a marker of neuronal 
activity, induced by different stimuli (Herdegen and Leah 1998). However, Fos is 
also expressed in basal conditions in different cell groups of the brain and undergoes 
in some of these groups a spontaneous oscillation in basal conditions during 24 h 
(Grassi-Zucconi et al. 1993, 1994). 
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In the LH, Fos is expressed in basal conditions in hypothalamic neurons including 
OX, MCH, non-OX and non-MCH neurons (Verret et al. 2003; Modirrousta et al. 
2005). In undisturbed rats maintained under a 12 h light/dark cycle, more Fos-
immunoreactive nuclei in OX neurons during the night than during daytime has 
been reported (Estabrooke et al. 2001). This was also documented when rats were 
maintained under constant darkness, indicating an endogenous oscillation 
(Estabrooke et al. 2001). In addition, with EEG recording a positive correlation 
between Fos expression and the amount of wakefulness and a negative correlation 
with the amount of sleep (non-REM and REM sleep) in the 2 h preceding the animal 
sacrifice were found in OX neurons (Estabrooke et al. 2001). 
The firing of OX neurons has been reported to peak during the active phase in mice 
and rats (Lee et al. 2005; Mileykovskiy et al. 2005; McGregor et al. 2017). 
Conversely, MCH release and unit neuronal activity peak prior to and during the 
inactive phase (Hassani et al. 2009). 
The discharge of OX neurons across the sleep/wake cycle can be determined by 
unit activity and EEG recordings. In rats maintained under a 12 h light/dark cycle, 
single unit recordings of OX neurons showed a relatively high discharge rate during 
active waking with a positive correlation of discharge rate with EEG amplitude. 
Very low discharge rate of OX neurons occurred instead during SWS and REM 
sleep. This further emphasizes the role of OX in the maintenance of wakefulness 
(Lee et al. 2005). In contrast, MCH neurons do not fire during waking, but fire 
sparsely during non-REM sleep and maximally during REM sleep (Hassani et al. 
2009; Toossi et al. 2016), which further shows the sleep-promoting role of MCH 
neurons.  
The OX function in stimulating arousal and increasing energy expenditure, as well 
as the MCH function in decreasing arousal and energy expenditure correlate well 
with Fos expression in OX and MCH neurons as it has been shown that they respond 
differently to sleep deprivation (SD) and sleep recovery (SR) (Modirrousta et al. 
2005). In these paradigms, the number of Fos-immunopositive OX neurons 
significantly decreased following SR as compared to SD, while the number of -Fos-
immunopositive MCH neurons significantly increased during SR as compared to 
SD (Modirrousta et al. 2005). Such findings further illustrate the opposite influence 
of these two neuronal systems. 
Experimental studies have suggested the influence of light on OX neurons (Boddum 
et al. 2016). In the grass rats, a diurnal species, a light pulse has been found to 
stimulate immediate-early gene induction in OX neurons, whereas dim light 
housing conditions lowers OX immunoreactivity in the brain (Adidharma et al. 
2012; Deats et al. 2014). In contrast, in the mouse, which is nocturnal, 6 h daily 
exposure to dark pulses (arousal cues for nocturnal species) for 10-16 days activates 
OX neurons (Marston et al. 2008). Despite the above-mentioned findings indicating that 
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OX neurons are primarily active during the dark phase in mice, it was demonstrated 
that exposure to constant light activates mouse OX neurons during positively 
reinforced tasks (Marston et al. 2008). This is consistent with the lack of the 
arousing effect of light in humans suffering from narcolepsy (see 1.2.1), although 
this was suggested to be an indirect effect since no direct pathway from the retina 
to OX neurons has been found (Hajek et al. 1989; McGregor et al. 2011). 
In rats, a diurnal variation in prepro-orexin mRNA in the hypothalamus and 
significant diurnal variation in OX-A immunoreactivity were observed in the 
preoptic/anterior hypothalamus and the pons, but not in other brain areas, including 
the LH and the posterior hypothalamic regions. This may correlate with changes in 
the synthesis of the OX-B peptide, and it would be interesting to determine whether 
there is diurnal variation in OX-B immunoreactivity as well (Taheri et al. 2000). 
It has been generally assumed that the number of OX or MCH neurons, as well as 
that of cholinergic or histaminergic neurons, detectable by immunocytochemistry 
remain constant across different behavioral states. A recent study indicates instead 
a physiological diurnal variation in the number of OX neurons (McGregor et al. 
2017). A significantly greater number (24% increase) of OX-immunopositive 
neurons, without a variation in soma size, was found in undisturbed mice sacrificed 
during the dark phase compared to the light phase. The finding indicates that OX 
expression does not reach the threshold for immunocytochemical detection in all 
OX neurons during the phase of the animal's rest, further corroborating a diurnal 
oscillation of the peptide expression. In contrast, there was no significant difference 
in the number of MCH-immunoreactive neurons between the animals in either 
phase, but a 15% increase in the soma size of MCH cells was found during the light 
phase compared to the dark phase (McGregor et al. 2017). A diurnal fluctuation in 
number similar to that of OX neurons (34% increase, with no soma size variation) 
was found in the same study in histaminergic neurons of the TMN visualized by 
immunopositivity to histidine decarboxylase (the histamine synthesizing enzyme), 
while the number of cholinergic neurons (evaluated by choline acetyltransferase 
immunohistochemistry) in the nucleus of the horizontal diagonal band did not show 
diurnal variations (McGregor et al. 2017). Given that both OX neurons and TMN 
histaminergic neurons promote wakefulness, the data indicate that the level of 
molecule synthesis parallels neuronal activity.  
A marked diurnal fluctuation was found in the percentage of Fos-expressing OX 
neurons following peripheral glycine administration (Hondo et al. 2011). The 
administration of glycine was found to decrease the activity of OX neurons as 
examined by Fos immunoreactivity. The number of Fos-positive OX neurons in 
glycine-treated mice was significantly lower during both the light and dark periods 
than in saline-treated mice at the same time points (Hondo et al. 2011). There was 
no reduction in number of OX neurons after glycine administration, suggesting that 
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glycine does not exert harmful effects on OX neurons, and the finding points instead 
to diurnal variations in their activation in response to glycine (Hondo et al. 2011). 
OX (OX-A) levels can be reliably detected in the cerebrospinal fluid (CSF). Reports 
from animal studies indicate that the OX release in the CSF presents a circadian 
pattern (McGregor et al. 2011). Concerning clinical correlates of diurnal changes 
in OX levels in the CSF, dampening of this diurnal variation has been reported in 
depressed subjects (Salomon et al. 2003).  Along a similar line, reduced levels of 
OX in the CSF have been reported in people who have attempted suicide, which 
could suggest that a poorly functioning OX system could play a role in mood 
disorders (Brundin et al. 2009). 
Seasonal changes in OX signalling have also been reported besides daily 
fluctuations, indicating that the orexinergic system is subjected to a more long term 
modulation of baseline signalling besides a diurnal modulation, as is the case for 
other neurotransmitter systems such as the serotoninergic system (Sarrias et al. 
1989; Praschak-Rieder et al. 2008).  
In humans, the study of OX levels in the CSF by radioimmunoassay revealed that 
it varies with season, principally correlating with day length period. The monthly 
average of CSF OX values was found to vary between months with a peak in the 
summer and a minimum at winter (Boddum et al. 2016). 
1.1.4 The orexinergic system and circadian regulation 
All the above-mentioned data point to a circadian regulation of the expression, 
activity and release of OX, as it has been repeatedly stated (e.g. Estabrooke et al. 
2001; Deboer et al. 2004; Marston et al. 2008). 
Circadian rhythmic changes are generated in mammals by a master clock which 
resides in the suprachiasmatic nucleus (SCN), lying on the optic chiasm in the 
anterior hypothalamus. This circadian pacemaker receives direct input from the 
retina though the retinohypothalamic tract, which originates from melanopsin-
containing retinal ganglion cells, and entrains endogenous biological rhythms, 
synchronizing them to the light/dark cycle. The firing of SCN neurons varies across 
24 h, regulated by a molecular clock and communicates. In rats, the diurnal 
variation in prepro-orexin mRNA in the hypothalamus and significant diurnal 
variation in OX-A immunoreactivity were observed in the preoptic/anterior 
hypothalamus and the pons, but not in other brain areas, including the LH and the 
posterior hypothalamic regions. This finding may result in changes in the synthesis 
of the OX-B peptide. However, it would be interesting to determine whether there 
is diurnal variation in OX-B immunoreactivity (Taheri et al. 2000), as well as 
temporal signals to the rest of the brain and body through neural pathways and 
humoral factors (van Esseveldt et al. 2000; Antle and Silver 2005; Morin and Allen 
2006). 
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A fundamental property of circadian oscillators is that they require an external 
signal to adjust their rhythm to the external 24 h light/dark cycle (Duffy et al. 2011; 
Najjar and Zeitzer 2017). The external time cues capable of entraining organisms 
are referred to as Zeitgeber (ZT; the German term for "time giver"). Besides light, 
other cues may act as ZT, and the most commonly studied nonphotic entraining 
cues are represented by environmental cues such as temperature, food intake, social 
cues, exercise, and a powerful synchronizing agent is provided by melatonin, the 
hormone secreted by the pineal gland. The light/dark cycle has anyhow a powerful 
entraining effect on the human circadian system (review in Pillai and Leverenz 
2017). 
Almost all SCN neurons express GABA as a primary neurotransmitter (Buijs and 
Kalsbeek 2001; Saper et al. 2005). Based on differential expression of 
neuropeptides along with differences in the afferent and efferent connections, the 
SCN has been subdivided in two main compartments (Antle and Silver 2005). The 
dorsomedial compartment, or shell, comprises small arginine vasopressin (AVP) 
and neurotensin-containing neurons, relatively poor in dendritic arbors. The 
ventrolateral region of the nucleus, or core, is formed by relatively large neurons 
with extensive dendritic arbors, which express vasoactive intestinal polypeptide 
(VIP), besides other peptides and the calcium binding protein calbindin (Moore 
1992; Romijn et al. 1999; Moore et al. 2002). SCN output originates from neurons 
of the shell subregion. 
SCN efferents mostly target a nearby region, the subparaventricular zone along the 
wall of the third ventricle, and from there the information processed in the SCN 
reaches hypothalamic effectors of body temperature, food intake, sleep/wake 
regulation (Saper 2013). Information processed by the SCN is therefore transmitted 
mostly through polysynaptic pathways. 
As for the relationships of OX neurons with the circadian timing system, the 
extensive OX projections target also structures of the neural circadian system 
(McGranaghan and Piggins 2001; Bäckberg et al. 2002). Initial studies of the 
termination of OX fibers indicated that they are densely aggregated in the region 
surrounding the SCN (the peri-SCN region) rather than entering the nucleus itself 
(Peyron et al. 1998). More recent analyses indicate that OX neurons form putative 
synaptic contacts onto SCN neurons, and both OXR transcripts have been found in 
the SCN (Belle et al. 2014). In rodents, the exogenous application of OX was found 
to suppress the electrical activity of the cells of the SCN (Klisch et al. 2009). This 
in turn suggests that OX released in the vicinity of SCN neurons during states of 
arousal can influence the excitability of the master circadian pacemaker (Brown et 
al. 2008; Klisch et al. 2009; Belle et al. 2014; Belle and Piggins 2017). 
Tagging SCN neurons in mice with enhanced green fluorescent protein (EGFP) that 
reports the activity of the Per1 promotor has provided data on the responsivity of 
SCN neurons to OX. In these mice, many SCN neurons express the Per1-driven 
construct (Per1-EGFP+ve), but in some neurons this construct is not detected 
(EGFP−ve) (Kuhlman et al. 2000; Belle et al. 2009). Such heterogeneity also 
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extends to the neurophysiological response of SCN neurons during the day, but not 
at night. Experimental data have revealed that the intrinsic excitability state of Per1-
EGFP+ve and EGFP−ve neurons during the day determines how the SCN cells 
respond to OX (Belle and Piggins 2017). 
It has been reported that OX mediate the presynaptic release of GABA in the SCN 
and that this is critical for the OX modulatory suppression of SCN neuron activity 
during the day (Belle et al. 2014). OX- GABA- GABAAR-mediated action also 
operates to suppress activity in SCN EGFP−ve neurons, eliciting distinct and 
diverse electrical behaviors in these SCN cell populations. The vast majority of 
moderately hyperpolarized action potential-discharging EGFP−ve (~94%) and 
Per1-EGFP+ve (~71%) cells were found to be hyperpolarized and silenced by OX 
(Belle and Piggins 2017). This demonstrates that the magnitude of OX actions on 
the SCN depends primarily on the intrinsic membrane potential of SCN neurons 
(Belle and Piggins 2017). 
Furthermore, OX signalling has been implicated in the integration of non-photic 
communication in the SCN. The activities of structures involved in non-photic 
circadian entrainment are modulated by OX neurons (Pekala et al. 2011; Palus et 
al. 2015) as well as by neurons of the dorsal raphe nucleus (Kohlmeier et al. 2013). 
The phase of the SCN clock can be reset by non-photic/arousal-promoting stimuli 
(Mistlberger and Antle 2011; Hughes and Piggins 2012) during the day. This is 
associated with suppression of SCN cell activity and clock gene expression 
(Maywood et al. 2002; Hamada et al. 2004). 
In the adult brain, NPY has been documented to inhibit SCN electrical activity, 
suppress Per1 expression, and phase-advance the SCN clock during the day (review 
in Belle and Piggins 2017). The suppressive action of OX on SCN electrical activity 
during the day accentuates the actions of NPY to potently inhibit the SCN cell 
activity and phase-shifts the SCN clock (Belle et al. 2014). These effects of OX 
may be important in relieving SCN inhibition of behavioral activity without 
affecting overall circadian rhythmicity (van Oosterhout et al. 2012; Belle and 
Piggins 2017). 
The relationship of the orexinergic network with the local GABAergic circuits in 
the modulation of spiking activity in cells is raising increasing attention. For 
instance, OX action through GABAergic interneurons suppresses the electrical 
activity of MCH neurons. This provides a switching mechanism which isolates 
properly the conflicting signals of sleep/wake. Such local ‘switch control’ has been 
documented experimentally to operate in the SCN circuit as well, presumably 
acting to avoid conflicts between circadian and arousal signals in animals. 
However, investigation of how a ‘switch control’ is achieved by the SCN in vivo to 
govern behavior remains to be studied (Belle et al. 2014; Apergis-Schoute et al. 
2015; Belle and Piggins 2017). 
Mediators of the HPA axis are key regulators of response to stress, and influence 
the circadian timing system and brain centers regulating the control of food intake 
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(Fig. 1.8) (Dallman et al. 1995; Balsalobre et al. 2000; Segall et al. 2009; Nader et 
al. 2010). Disturbances in the circadian rhythmicity of the HPA axis functioning 
could be caused by chronic exposure to stress, artificial light exposures and 
reduction in sleep hours, among others (Stevens and Zhu 2015; Koch et al. 2016). 
Also, the disruption in food intake-related processes could be caused by 
psychological stress. As mentioned previously, food intake is under the regulation 
of OX and other related neuropeptides (Fig. 1.8) (Kyrou et al. 2006; Antunes et al. 
2010; Blasiak et al. 2017). 
 
 
Fig. 1.8: Mutual relationship between the biological circadian clock, stress and 
orexigenic peptide systems. Circadian clock structures in the brain are under the direct 
influence of the stress HPA axis mediators: CRH, ACTH and glucocorticoids; therefore, 
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excessive exposure to stress disrupts the circadian rhythmicity of the organism. Through 
excessive release of HPA mediators, chronic stress deregulates the synthesis and action 
of orexigenic brain peptides, which can lead to overconsumption of food, weight gain, 
obesity and stress-related eating disorders. The control of orexigenic peptide synthesis 
during prolonged stress exposure is dysregulated at several levels, since excessive stress 
disrupts circadian rhythmicity, which directly controls both neuropeptide release and 
HPA axis function. The cycle of excessive stress influences on food intake-promoting 
peptide system activity and circadian clock structures is closed by the sensitivity of both 
HPA axis and clock structures to orexigenic peptide system mediators. Reproduced from 
Blasiak et al. 2017. 
 
Altogether the orexinergic system integrates circadian and metabolic influences in 
shaping nutritional states and arousal (Selbach and Haas 2006). The orexinergic and 
circadian timing systems are interconnected. As a result, OX levels in the brain are 
dependent on the SCN circadian patterns (Yoshida et al. 2001; Deboer et al. 2004; 
Zhang et al. 2004) and OX neuron activation (Marston et al. 2008). OX fibers and 
OXRs are present in the SCN (Belle et al. 2014). The activities of SCN neurons are 
influenced by OX, which can cause phase shifts in cultured SCN neurons and 
advances in phase in organotypic brain slices (Klisch et al. 2009). The circadian 
clock control of OX and MCH synthesis makes it necessary to monitor daily 
rhythms in experimental schemes where disturbances of reward and behaviors are 
to be examined (Blasiak et al. 2017). 
Concerning MCH, there are also reports that the action of MCH on the stress axis 
is circadian time-dependent. In the rat, MCH mRNA expression also fluctuates in a 
circadian manner, with a low level during the light/inactive phase and a peak after 
the onset of the dark/active period (Bluet‐Pajot et al. 1995). Innervation of MCH 
neurons by SCN efferents (Abrahamson et al. 2001) allows the influence of the 
circadian master clock on MCH neurons. The potential feedback of MCH on 
circadian structures still needs to be verified, but the presence of MCH-receptors 
on SCN neurons, and reciprocal connections with neurons influencing circadian 
clock function, notably OX neurons, support a reciprocal interaction of circadian 
and OX-MCH systems (Guan et al., 2002; Chee et al. 2013; Blasiak et al. 2017). 
Following icv MCH injections in the early light/inactive phase, activation of the 
HPA axis by activation of CRH neurons and stimulation of ACTH release were 
observed (Jezová et al. 1992). Increased plasma corticosterone levels and anxiety-
like behavior were also observed after icv MCH injection during the light phase 
(Smith et al. 2006). In mice, MCHR1 antagonists reversed the effect of chronic and 
acute stress (Smith et al. 2009; Lee et al. 2011). 
1.1.5 Plastic changes in the synaptic wiring of orexinergic cell bodies  
Neuronal activity is regulated in a homeostatic manner so that increases in activity 
are compensated for by decreases in excitability and decreases in activity by 
increases in excitability (Turrigiano 1999). These changes are mediated in part by 
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changes in GABA-Rs, as well as by reciprocal changes in receptors to the excitatory 
neurotransmitter glutamate (Turrigiano et al. 1998; Kilman et al. 2002; Marty et al. 
2004). 
A key attribute of the hypothalamic circuits is their remarkable ability to undergo 
“synaptic rewiring” to maintain the body’s homeostatic functions, and in particular 
OX functions (Alpár and Harkany 2013). Plastic changes of OX neurons, and in 
particular the presynaptic wiring of their cell bodies, provide a striking example of 
these adaptive properties.  
Following food deprivation, the number of the excitatory input onto OX soma was 
found to increase, and it was proposed that this could result from multiple humoral 
and neuronal signals (Horvath and Gao 2005). Interestingly, re-feeding after fasting 
partially reversed fasting-induced changes in OX synaptology, while leptin 
administration concomitant to food withdrawal prevented fasting-induced plasticity 
(Horvath and Gao 2005). This is similar to a finding documented in 
propiomelanocortin neurons of the arcuate nucleus (Pinto et al. 2004). In ob/ob 
mice (which are leptin deficient and provide a genetic model of obesity), there is an 
imbalance in the excitatory and inhibitory synaptic density in neurons of the arcuate 
nucleus, which is rapidly normalized by systemic administration of leptin (Pinto et 
al. 2004).  
The wiring and fasting-induced synaptic remodeling of the OX neurons correlate 
well with their involvement in the control of arousal and alertness, and it has been 
suggested that synaptic changes in this circuitry could also underlie functional 
alterations, such as insomnia, and metabolic disturbances, including obesity 
(Horvath and Gao 2005).  
Experimental evidence on the involvement of the orexinergic network in 
homeostatic hypothalamic mechanisms was also obtained in nonhuman primates. 
Fasting for 24 h in monkeys was found to reduce by 50% the level of circulating 
leptin levels and to increase Fos expression in neurons of the LH, arcuate nuclei 
and median preoptic area (MnPO) (Diano et al. 2003). A threefold increase of Fos 
expression was found in OX neurons of the fasted monkeys with respect to controls. 
In the arcuate nucleus, the Fos-expressing neurons targeted by orexinergic axons 
contained neuropeptide Y. The presence of leptin receptors on OX neurons and their 
activation during a metabolic challenge, together with innervation of their targets, 
indicates that the orexinergic system integrates environmental cues in the regulation 
of diverse brain activity in nonhuman primates (Diano et al. 2003). 
An excitatory-to-inhibitory switch of synapses on OX cell bodies has been reported 
in obese mice, both in the genetic model represented by ob/ob mice and in mice 
subjected to high-fat diet (HFD), a model of diet-induced obesity (Cristino et al. 
2013). In this study, in which many parameters related to retrograde 
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endocannabinoid signaling were examined, the synaptic changes were found to be 
reversed by leptin administration, indicating that this synaptic wiring changes were 
driven by leptin (Cristino et al. 2013). 
Experimental exposure to HFD is known to induce various forms of functional and 
structural plasticity within the reward circuitry (Sharma et al. 2013). A recent report 
in rats has pointed out plastic changes in OX neurons following exposure to HFD 
(Linehan et al. 2018). A short-term exposure to a HFD increased the level of 
glutamate, thereby priming excitatory synapses to OX neurons to undergo activity-
dependent long-term depression. However, this priming was transient as it 
disappeared following a prolonged exposure to HFD. The observed changes may 
alter OX network properties and could also underlie their physiological role in 
reward-based feeding (Linehan et al. 2018). 
Dynamic remodelling of OX neuron wiring has also been described in response to 
changing physiological needs such as sleep. Ultrastructural analysis of OX soma in 
mice following chronic prolonged wakefulness (SD induced by modafinil 
treatment) showed an increased number of synapses on OX soma, which also 
resulted in an increase in synaptic strength (Rao et al. 2007). This suggests that 
prolonged wakefulness could lead to the reorganization of excitatory synapses on 
OX neurons. As such, experience-dependent plasticity in OX neurons may underlie 
prolonged wakefulness induced by physiological and environmental factors (Rao et 
al. 2007, 2008). 
In vertebrates, the rhythmic expression of various synaptic and trafficking genes 
has been postulated to affect behavior by remodelling synapses across day and night 
(Panda et al. 2002). In the zebrafish, a diurnal vertebrate, live imaging studies have 
demonstrated a diurnal rhythm in the number of synapses on the axons of OX 
neurons. Two-photon imaging of synaptophysin (Syn) (a marker of presynaptic 
terminals) on OX neurons showed dynamic synaptic modifications during day and 
night. The number of synapses on OX axons were under circadian rhythmicity, 
which was proposed to be solely regulated by circadian clock (Appelbaum et al. 
2010). 
Under a condition of SD in the zebrafish, circadian regulation of synapses was 
dominant, with decreases in synapse number from baseline circadian time (CT14) 
to the end of SD period (CT20) as observed in non-sleep-deprived controls. 
However, homeostatic effects were modest (17%), and only observed after 6 h of 
SD. The findings provide in vivo evidence, in a model organism like the zebrafish, 
of the regulation of OX synaptic plasticity (Appelbaum et al. 2010). 
Furthermore, a recent study in zebrafish larvae has reported that the rhythmic 
structural plasticity of inhibitory synaptic contacts on OX neuron dendrites is 
modulated by consolidated wake and sleep, and therefore independent from the 
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circadian clock (Elbaz et al. 2017b). During development, the number of inhibitory 
synapses on the dendrites of OX neurons increases. Live imaging of inhibitory 
synapses on OX neuron dendrites showed that the synapse number increases during 
the night under light/dark conditions and there were no changes under constant light 
or dark conditions. During the night, SD reduced the synapse number and the 
number also increased during the post-deprivation daytime sleep (Elbaz et al. 
2017b). However, it would be important to understand whether these synapses are 
physiologically active or silent (Appelbaum et al. 2010; Elbaz et al. 2017b). 
In mice, following 6 h of SD, enhancement of GABAAR immunostaining and 
increase in the sensitivity to a GABAAR agonist and amplitude of inhibitory post-
synaptic currents (IPSCs) were found in OX neurons (Matsuki et al. 2015). 
Following 4 h SD, the data differed from results in rats, in which in vivo and ex vivo 
studies showed an increase in the amplitude of miniature EPSCs (mEPSCs) in OX 
neurons (Rao et al. 2007). 
In mice, it has been reported that the difference in discharge profiles of the OX and 
MCH neurons is in line with the different homeostatic responses of these neurons 
to SD. SD during the day has been found to result in increased GABAAR and 
GABABR labeling on OX neurons, at variance with MCH neurons (Toossi et al. 
2016). Hence, the different changes in both GABAAR and GABABR after SD 
indicate a homeostatic downscaling after prolonged activity of OX neurons, as 
reflected by studies based on Fos induction and recording, and upscaling after 
inactivity of MCH neurons (Toossi et al. 2016). Following SD, OX neurons show 
changes in GABAARs similar to those reported in cholinergic BF neurons 
(Modirrousta et al. 2007). 
The above findings indicate that the organization of inputs to OX somata is not hard 
wired, but rather changes dynamically in the face of a fluctuating environment or 
physiological demands, as stated by Horvath and Gao (2005). The above data in the 
zebrafish indicate that neuronal circuits involved in OX neuron wiring are plastic 
over the course of the day (Appelbaum et al. 2010). Thus, an intriguing question is 
whether under physiological conditions (i.e. in the absence of any experimental 
manipulation) there could be a state-dependent reorganization of synaptic inputs 
onto OX neuron somata, since, as mentioned above, the study by Horvath and Gao 
(2005) did not address the time points of their sampling, and the studies in the 
zebrafish did not address the diurnal organization of excitatory inputs to OX 
neurons. This issue has been examined by work for the present thesis (see Laperchia 
et al. 2017; Chapter 2). 
Further studies are needed to determine the molecular mechanisms behind dynamic 
changes in the OX soma wiring. These processes could also provide new insights 
in disturbances associated with physiological aging and in neurodegenerative 
diseases, such as AD. Presented in this thesis are data related to the diurnal 
39 
 
organization of the synaptic inputs onto OX neuron somata in aged mice and in a 
murine model of AD. 
1.2 Orexin and the control of sleep and wake 
1.2.1 The role of orexin in vigilance states  
All the data presented above converge on the evidence that OX neurons and their 
extensive connectivity provide a link between energy homeostasis and vigilance 
states. 
As mentioned above (see 1.1), OX1R and OX2R mRNAs show a wide distribution, 
with partly overlapping but complementary patterns, in the brain (Lu et al. 2000; 
Marcus et al. 2001; Mieda et al. 2011). This is consistent with the extensive 
orexinergic projections, which are especially dense in monoaminergic and 
cholinergic nuclei of the brain stem and hypothalamus which play key roles in the 
modulation of sleep/wake states (Peyron et al. 1998; Nambu et al. 1999). These 
nuclei express OX1R and OX2R in a differential manner (Marcus et al. 2001; Mieda 
et al. 2011). As stated previously (see 1.1), histaminergic neurons in the TMN 
exclusively express OX2R, while noradrenergic neurons in the LC exclusively 
express OX1R. In the DR, serotonergic neurons express OX1R and/or OX2R. 
Mesopontine cholinergic neurons of the laterodorsal (LDT) and pedunculopontine 
(PPT) nuclei express OX1R but not OX2R mRNA. Intriguingly, many GABAergic 
neurons expressing OXRs are intermingled with these monoaminergic and 
cholinergic neurons (Mieda et al. 2011, 2017). 
In agreement with the above findings, electrophysiological recording in brain slice 
preparations or isolated cells have shown that neurons of the above cell groups are 
activated by OX in vitro. LC noradrenergic cells, VTA dopaminergic cells, DR 
serotonergic cells and TMN histaminergic cells have all been shown to be activated 
by OX. It is important to note that, as also stated below, many of these 
monoaminergic neurons are implicated in increasing arousal and promoting 
wakefulness (review in Sakurai 2007).  
The wake-active serotonergic neurons send inhibitory projections to OX neurons 
(Li et al. 2002; Muraki et al. 2004; Sakurai et al. 2005). The LC noradrenergic 
neurons have inhibitory effects on OX neurons (Li et al. 2002; Yamanaka et al. 
2006). Histamine seems instead to exert little effect on OX neurons (Yamanaka et 
al. 2003). Interestingly, in rats, a change in the action of noradrenaline on OX 
neurons - from excitation to inhibition - following a 2 h period of total SD has been 
reported (Grivel et al. 2005). It has been proposed that this mechanism could 
contribute to the growing sleepiness that accompanies SD (Yamanaka et al. 2006). 
The activity of monoaminergic neurons in the TMN, LC and DR is known to be 
synchronized and strongly associated with sleep and wake states: the neurons fire 
tonically during wakefulness, less during non-REM sleep, and not at all during 
REM sleep. Such findings indicate that OX-mediated arousal results from the 
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activation of these wake-active monoaminergic neurons. Specifically, OX neuron 
activation during wakefulness exerts an excitatory effect on the wake-active 
neurons, thereby sustaining their activity (Sakurai et al. 2007). 
OX exerts an excitatory effect also on cholinergic neurons. Cholinergic neuronal 
populations of LDT and PPT are involved in the maintenance of wakefulness 
(Shouse and Siegel 1992; Alam et al. 1999; Eggermann et al. 2001). Other 
populations of LDT/PPT neurons are implicated in the regulation of REM sleep and 
muscle atonia during REM sleep. In cats, direct injection of OX into LDT results 
in an increased wake time and a decreased REM sleep time. However, it has lso 
been shown that OX inhibits PPT cholinergic neurons by activating GABAergic 
interneurons. This indicates that OX neurons affect the activities of cholinergic 
neurons directly and indirectly to regulate arousal and REM sleep (review in 
Sakurai 2007). 
Besides the crosstalk with the neural circuits implicated in the promotion of 
wakefulness, OX neurons also receive projections from nuclei involved in sleep 
regulation. It has been reported that OX promotes both wakefulness and energy 
expenditure by interconnecting with the sleep-promoting VLPO (Mavanji et al. 
2015). Neurons of the preoptic area (POA), including the VLPO and MnPO 
GABAergic/galaninergic neurons, are active during sleep. They are considered to 
be a sleep center (Saper et al. 2010). They densely innervate OX neurons (Sakurai 
et al. 2005; Yoshida et al. 2006). The optogenetic stimulation of POA fibers inhibits 
OX neuronal activity (Saito et al. 2013), while the chemogenetic activation of POA 
indeed increases sleep (Saito et al. 2013; Zhang et al. 2015). Importantly, 
VLPO/MnPO neurons and monoaminergic neurons reciprocally inhibit each other 
(Xu et al. 2015; Mieda 2017). Both the GABAAR agonist muscimol and the 
GABABR agonist baclofen strongly inhibit OX neurons (Li et al. 2002; Yamanaka 
et al. 2003; Xie et al. 2006).  
OX neurons are also innervated by BF cholinergic neurons (Li et al. 2002; Sakurai 
et al. 2005; Xie et al. 2006). Carbachol, an agonist at muscarinic receptors, activates 
a subset of OX neurons (Yamanaka et al. 2003; Sakurai et al. 2005). Thus, OX 
neurons are inhibited by sleep-promoting neurons and activated by wake-promoting 
BF neurons. These negative feedback mechanisms may also be important for the 
fine adjustment of OX neuronal activity to stabilize wakefulness (Tabuchi et al. 
2013; Mieda 2017).  
On the basis of all the above data on the relationships with the distributed neuronal 
system of sleep and wake regulation, the orexinergic network plays a critical role 
especially in the transition between vigilance states (de Lecea and Huerta 2014) and 
in the maintenance of wakefulness and its stability.  
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1.2.2 Deficient orexinergic signalling in narcolepsy 
The role of OX neurons in sleep-wake state transitions has been demonstrated by 
the wealth of findings indicating that deficient OX network signalling causes the 
lifelong sleep disorder narcolepsy (Fig. 1.9), in humans and animals (Kilduff and 
Peyron 2000; Peyron et al. 2000; Sutcliffe and de Lecea 2002; Crocker et al. 2005; 
Thannickal et al. 2009). 
Narcolepsy, which affects about 1 in 2000 people, is one of the most common 
causes of chronic sleepiness in humans (Mignot 1998). The onset of this sleep 
disorder is usually peripubertal, between the ages of 10 and 20, with persistent 
daytime sleepiness and often a fragmented sleep at night. The diagnosis is not 
straightforward, with an average time from the onset of symptoms to diagnosis from 
5 to 15 years (Roth et al. 2013; Thorpy and Krieger 2014; Scammell 2015). A 
hallmark of narcolepsy is also represented by disordered regulation of REM sleep. 
The normal sequence of non-REM-REM sleep (see 1.1.3) is disrupted in the so-
called sleep-onset REM periods, which are very frequent in narcolepsy, and in 
which REM sleep is preceded by wakefulness. Furthermore, in narcolepsy REM 
episodes can occur at any period of day, with intrusion also into wakefulness. The 
most dramatic of the REM sleep–like states is cataplexy, which is a sudden episode 
of partial/complete paralysis of voluntary muscles, usually triggered by strong 
emotions (Scammell 2015). 
Soon after the discovery of OX, two animal studies implicated OX signalling in 
narcolepsy: (i) functionally null spontaneous mutations in the OX2R gene were 
found to be responsible for familial canine narcolepsy (Lin et al. 1999), and (ii) 
targeted deletion of OX in mice (orexin−/− mice) were shown to exhibit a 
phenotype of sleep/wake alterations similar to human narcolepsy (Chemelli et al. 
1999).  
The prepro-orexin- and OX2R knock-out mice and the OX2R-mutated dogs 
showed marked narcoleptic symptoms, whereas the OX1R knock-out mice 
exhibited mild or minute sleep/wake abnormality (Willie et al. 2003). Invariably, 
this indicates OX2R has a critically involved in the control of sleep/wakefulness 
(Yamanaka et al. 2010). 
Post-mortem studies of the brain of narcoleptics reported that OX peptides are 
undetectable in the cortex and pons, in which OX innervation is normally found 
(Fig. 1.2), and 80–100% reduction in the number of OX containing detectable 
prepro-orexin mRNA and OX immunoreactivity in the LH (Peyron et al. 2000; 
Thannickal et al. 2000, 2003).  
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Fig. 1.9: Neurobiologic mechanisms of narcolepsy. A. Orexinergic (OX) neurons 
maintain wakefulness by stimulating a variety of wakefulness-promoting neurons in the 
cortex, basal forebrain and brain stem. With loss of OX neurons in individuals with 
narcolepsy, neurons in these target regions may fire less consistently, leading to 
sleepiness and lapses into sleep. B. These neurons also excite brain stem regions that 
suppress rapid-eye-movement (REM) sleep. Strong positive emotions are thought to 
activate neurons in the medial prefrontal cortex that excite OX neurons and the 
amygdala. OX neurons loss lead to imbalance in this pathway, inhibiting brain regions 
that suppress REM sleep, thus permitting the activation of descending pathways that 
strongly inhibit motor neurons; the result is partial or complete cataplexy. Pathways 
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shown in green are excitatory; red are inhibitory. Open circles indicate neuron soma, and 
dotted lines indicate reduced activity. Reproduced from Scammell 2015. 
 
Two types of narcolepsy have been defined: type 1, narcolepsy with cataplexy, with 
severe loss of OX neurons; type 2, narcolepsy without cataplexy, which includes 
most of the symptoms in type 1 but not cataplectic episodes. The discovery that 
narcolepsy type 1 is caused by an almost complete loss of OX neurons has boosted 
research on both the neurobiology of this sleep disorder and on the orexinergic 
system (Trotti et al. 2013; Baumann et al. 2014; Goldbart et al. 2014; Scammell 
2015). 
In patients affected by narcolepsy with cataplexy, the OX level in the CSF is very 
low or undetectable. Therefore, a low CSF level of OX is now one of the diagnostic 
criteria for narcolepsy type I (Nishino et al. 2000; Mignot 2002; Tsujino and Sakurai 
2009). In individuals suffering from narcolepsy without cataplexy, the frequency of 
cases in whom OX concentration in the CSF is low or undetectable is instead much 
lower (Fronczek et al. 2009; Thannickal et al. 2009). 
Since OX neurons contain co-transmitters such as glutamate, dynorphin, and 
neurotensin (see 1.1), the loss of these co-expressed molecules may also contribute 
to the symptoms of human narcolepsy (review in Mieda 2017). Of note, MCH 
neurons are spared in the brain of narcoleptics (Peyron et al. 2000; Thannickal et 
al. 2000; Thannickal et al. 2009). 
Recent reports have indicated that, compared to controls, narcolepsy patients have 
94% more histaminergic neurons in the TMN (review in Shan et al. 2015). This 
increase was found to be higher in narcolepsy patients with >90% OX neuron loss 
than in patients with ≤75% OX neuron loss. Similarly, the number of histaminergic 
TMN neurons was increased (53%) in OX ligand knockout mice compared to WT 
mice, whereas orexin/ataxin-3 transgenic mice showed an intermediate (28%) 
increase (Valko et al. 2013). This may raise interesting hypotheses on compensatory 
mechanisms. The finding of an increase of histaminergic neurons in the TMN of 
the narcoleptic brain, is, however, currently debated (Shan et al. 2015). 
The process that destroys OX neurons in narcolepsy remains unknown, although 
immune-mediated mechanisms are still under discussion and genetic factors are 
clearly important (Liblau et al. 2015). More than 98% of people with type 1 
narcolepsy carry the susceptibility gene HLA-DQB1*06:02, a finding that makes 
this the strongest known association between the disease and human leukocyte 
antigen (HLA). This gene is predicted to enhance the risk of narcolepsy by a factor 
of about 200 (Rogers et al. 1997; Tafti et al. 2014). Recent reports have 
hypothesized that an autoimmune driven process could be implicated in the loss OX 
neurons in narcoleptic patients (Kornum et al. 2011; Mahlios et al. 2013), but no 
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conclusive evidence has been hitherto obtained, and mutations of prepro-orexin- or 
OXR genes are very rare in human narcolepsy.  
Regardless of the cause of neuronal loss, the OX signalling deficiency in narcolepsy 
with cataplexy shows that this neuropeptidergic system has an important role in the 
regulation of sleep and wakefulness, especially in the maintenance of long, 
consolidated awake periods (Crocker et al. 2005; Sakurai 2007). 
1.3 Orexins in aging and aging-related neurodegenerative 
disorders 
1.3.1 Orexins in the normal aging brain 
A number of physiological parameters primarily based on hypothalamic regulation 
change during normal aging. These include changes in the pattern of sleep and in 
the consolidation of vigilance states, metabolism, food intake, endocrine and 
autonomic regulations. As dealt with above, orexinergic signalling is implicated in 
many of these functions. A number of studies in animals and in humans have 
reported a decline in the number of OX neurons and OX signalling during aging, 
involving these neurons and their functional impairment in the process of 
senescence. 
In mice, no age-related changes in the prepro-orexin and prodynorphin mRNA 
levels in the LH have been found in an initial study (Terao et al. 2002). However, 
there was a significant reduction in the OX1R mRNA levels in the hippocampus, 
while OX2R mRNA level was significantly reduced in several brain areas besides 
the hippocampus (thalamus, pons and medulla), with a dampened decrease in the 
hypothalamus, neocortex and BF of aged animals compared to controls. The 
findings indicate that alterations in the expression of OXR mRNAs could be 
implicated in age-related functional impairments (Terao et al. 2002). 
In rats, a significant reduction (28%) has been reported in the number of neurons 
expressing the prepro-orexin gene in aged animals compared to the adults, and it 
has been suggested that this could contribute to aging-related dysfunctions (Porkka-
Heiskanen et al. 2004). Similarly, a marked reduction in OX neuron immunosignal 
intensity and OX mRNA level was found in the LH of the aged animals compared 
to adults (Porkka-Heiskanen et al. 2004). Following 6 h of SD, OX neuron 
immunosignal intensity was found to be significantly upregulated in the adult rats 
compared to aged ones (Porkka-Heiskanen et al. 2004). 
Furthermore, a significant reduction (40%) of OX neurons across all sectors of the 
LH has been documented in aged rats compared to adults (Kessler et al. 2011). 
Similarly, in aged rats a reduction (<30%) in the number of the MCH neurons in 
the medial field of the LH has been reported (Kessler et al. 2011). However, the 
loss of hypothalamic neurons was not global during aging, as the pan neuronal 
marker (NeuN) immunoreactivity revealed no significant difference in the total cell 
number between the adult and aged rats. The pathological mechanisms behind the 
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age-related reduction in the number of defined neuronal subsets remain unclear 
(Kessler et al. 2011). 
The BF neurons, especially the cholinergic neurons, are innervated by the diverse 
neuronal groups within the LH, and OX neurons contribute a substantial proportion 
of the LH input to the BF neurons (Fadel et al. 2005)i. In rats, a significant reduction 
(30%) has been reported in OX inputs onto the cholinergic neurons in aged animals 
compared to adults in which dense OX fibers are present (Stanley and Fadel 2012). 
In addition, there are alterations in the OX innervation of the BF nuclei in the aged 
guinea pigs (Zhang et al. 2005). There was a significant decrease in the 
immunosignal intensities of OX fibers in the nuclei of the diagonal band of Broca 
and the magocellular preoptic nucleus of aged animals, although no difference was 
observed in the medial septal nucleus (Zhang et al. 2005). Although it has been 
hypothesized that the observed changes could result from a decrease in OX peptides 
and/or the loss of the targeted cholinergic neurons, the exact mechanisms behind 
aging-related degeneration of OX fibres remain to be determined. The observed 
alterations could impair OX drive in the modulation of the functional outputs of BF 
neurons, in turn leading to a dysfunctional cholinergic transmission during aging 
(Zhang et al. 2005; Stanley and Fadel 2012). 
In healthy humans, the plasma concentration of OX-A was found to be significantly 
higher in aged individuals than in younger ones (Matsumura et al. 2002). The 
mechanisms behind such increase remain unclear, and could hypothetically be 
related to a decrease in plasma concentration of leptin in aged individuals 
(Matsumura et al. 2002). 
A post-mortem study of human brains has reported a decrease in the total number 
and density of OX neurons across all sectors of the hypothalamus in aged 
individuals compared to adults (Hunt et al. 2015a). In particular, a 23% and 10% 
decrease in the OX neuron immunopositivity was found in the brain of aged 
individuals compared to infants and adults, respectively. In the dorsomedial 
hypothalamus and perifornical area, a significant reduction in the density of OX 
neurons was observed in aged individuals and adults compared to children and 
infants (Hunt et al. 2015a). 
In aged macaque monkeys, besides sleep impairment and locomotor disturbances, 
the density of OX-B fibers innervating the LC was significantly reduced compared 
to adult animals (Downs et al. 2007). However, there were no age-related changes 
in the neuronal number and levels of OX-B concentration in the serum. The 
reduction in OX axonal density innervating the LC in the aged nonhuman primate 
could partly explain the impairment of sleep consolidation in elderly people, 
although it would be necessary to ascertain if there are alterations in OX-A and 
OXR levels in humans as well (Downs et al. 2007). 
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Similarly, aging-related degenerative changes have been documented in OX fibers 
innervating the brain stem in cats (Zhang et al. 2002). Swollen ‘spot like’ 
structures/varicosities indicative of degenerated OX fibers were seen in close 
proximity to perikarya of neurons in the LC, dorsal raphe and tegmental nuclei of 
the aged animals only. The degeneration of OX fibers could implicate a disruption 
in OX system neurotransmission during the aging process (Zhang et al. 2002). 
1.3.2 Orexins in Alzheimer’s disease and Parkinson's disease 
Several reports in the last years have indicated that OX may play a role in some 
aspects of neurodegenerative disease pathogenesis. Loss of OX neurons and sleep 
disturbances are known comorbidities of several neurodegenerative diseases, 
including AD and Parkinson’s disease (PD) (Thannickal et al. 2000; Fronczek et al. 
2007; Nixon and Smale 2007; Nixon et al. 2015).  
AD, the most common cause of dementia, is a chronic, aging-related, progressive 
neurodegenerative disease characterized by two pathological hallmarks: 
extracellular amyloid β (Aβ) deposition (plaques) and intracellular neurofibrillary 
tangles (Serrano-Pozo et al. 2011). The central posit of the ‘‘amyloid hypothesis’’, 
still under discussion, is that amyloid deposition is the causative factor for the 
initiation of the neurodegeneration cascade, which includes inflammation, gliosis, 
neuronal damage, neuronal and synaptic loss (DeMattos et al. 2012). OXR2 
polymorphism has been proposed as a potential risk factor for the development of 
AD, but it should be noted that no increased risk of AD has been reported in 
narcoleptic patients (Scammell et al. 2012; Gallone et al. 2014; Nixon et al. 2015).  
Sleep disturbances and alterations of circadian rhythms have been repeatedly 
reported in AD. These include daytime sleepiness and napping, nocturnal 
awakenings, REM sleep alterations, cyclic agitation, dysregulation of appetite  
(Slats et al. 2013). In AD patients, the severity of dementia correlates with sleep 
impairment and it has been proposed that sleep alterations represent a main reason 
for institutionalization (Pollak and Perlick 1991). 
Neurons of the circadian timing and sleep-wake-regulatory systems are among the 
neuronal populations targeted by AD (Fronczek et al. 2009). Degeneration of the 
SCN, with loss of vasopressin and vasoactive intestinal peptide-expressing neurons 
(see 1.1.4), has been described (Zhou et al. 1995; Farajnia et al. 2012; Pillai and 
Leverenz 2017). Loss of melatonin diurnal rhythm and decreased melatonin levels 
in the serum and CSF have also been documented in AD patients (Liu et al. 1999; 
Zhou et al. 2003). 
In the post-mortem study of brains of AD sufferers, OX neuron number was found 
to be decreased by 40% compared to healthy individuals (Fronczek et al. 2012). 
Despite such quantitative decrease, there were no overt changes in OX cell 
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morphology, distribution and immunostaining intensity of OX-immunoreactive 
neurons between the AD brains and healthy controls (Fronczek et al. 2012). 
The ventricular CSF levels of OX have been found to be reduced by 14% in AD 
subjects compared to controls (Fronczek et al. 2012). No correlation was found 
between AD-associated decrease in OX number and CSF OX levels with age and 
gender (Fronczek et al. 2012). A correlation had, however, been reported between 
impairment in the sleep/wake structure and lumbar CSF levels of OX (Friedman et 
al. 2007). Further studies are required to ascertain the exact correlations between 
OX neuron numbers and OX CSF levels in AD (Fronczek et al. 2012). 
 
 
Fig. 1.10: Correlation of amyloid-ß (Aß) with the sleep-wake cycle, as indicated by the 
findings by Kang et al. 2009 and Roh et al. 2012. A: While sleep quality and amount 
decline with age, Aß aggregation increases in Alzheimer disease (AD) and is associated 
with sleep decrease. B: The levels of Aß in the interstitial fluid (ISF) of mice (which are 
nocturnal animals) and in the cerebrospinal fluid (CSF) of humans show a diurnal 
oscillation, increasing during wakefulness (W) and decreasing during sleep (S). The 
findings obtained in mice indicate that this diurnal oscillation is lost following Aß 
aggregation. Reproduced from Gerstner et al. 2012. 
 
 In a Tg mouse model of AD, the monitoring of the interstitial fluid (ISF) levels of 
Aβ in the hippocampus has revealed diurnal fluctuations with a 75% increase during 
the dark period compared to the light period. The ISF levels correlated positively 
with wakefulness (Fig. 1.10), but there was a negative correlation with the time 
spent asleep (Kang et al. 2009). Similar findings were recorded in the CSF of 
healthy adult humans. Also, in humans with the preselinin gene mutations, the 
diurnal rhythm of CSF Aβ level was observed to be attenuated (Roh et al. 2012). 
Following SD, the Tg mice spent more time asleep, but ISF levels still fluctuated. 
The icv infusion of OX significantly increased the ISF levels of Aβ in the light 
period. However, infusion of OXRs antagonist abolished the diurnal fluctuations 
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(Kang et al. 2009). The restoration of the diurnal rhythms following OX antagonist 
removal has suggested that OXRs are needed to maintain ISF Aβ diurnal 
fluctuations (Kang et al. 2009). Similarly, in a double mutant mouse model of AD, 
there was a diurnal fluctuation of ISF Aβ levels prior to plaque deposition in the 
hippocampus and striatum, which was lost in the middle-aged Tg mice which had 
loads of Aβ plaques (Fig. 1.10) (Roh et al. 2012). The accumulation of Aβ 
correlated with impairment of sleep in mice with prevention of Aβ plaque formation 
normalizing the sleep/wake structures (Kang et al. 2009; Roh et al. 2012). 
The circadian rhythmicity of CSF OX levels sampling at different time points 
during 24 h in AD patients and aged controls showed that the orexinergic system is 
significantly affected, with a decrease of mean OX CSF levels and increase of the 
OX circadian rhythm amplitude in AD compared to elderly controls. Nevertheless, 
lack of data on polysomnographic recordings does not allow a correlation between 
orexinergic system dysregulation and sleep–wake rhythm in AD (review in Liguori 
2016). Further evaluation of the circadian activity of AD patients (related to CSF 
OX levels changes and synaptic wiring of OX neurons) during the course of AD 
progression is needed (Liguori 2016). 
PD is the second most prevalent aging-related neurodegenerative disease after AD, 
affecting 1–2% of the aging population. Symptoms include tremor, muscular 
rigidity, akinesia, impairment of postural reflexes; sleep disorder is part of non-
motor symptoms of PD, which can precede the motor ones (McGeer et al. 2003; 
Takahashi et al. 2015). The disease is pathologically characterized by progressive 
loss of dopaminergic neurons in the substantia nigra pars compacta and appearance 
of Lewy bodies (intraneuronal inclusions containing abnormal aggregates of 
misfolded α-synuclein protein). Different brain regions and types of neurons can 
also be involved (review in Antony et al. 2013).  
It has been reported that the incidence of prior narcolepsy diagnosis is five times 
higher than expected in PD patients, suggesting that narcolepsy or narcolepsy 
treatments might influence the development of PD (Christine et al. 2012). Owing 
to the implication of this non-motor dysfunction, the involvement of the OX system 
in PD has raised considerable interest (Thannickal et al. 2007). 
Loss of OX neurons (about 50%) has been reported in post-mortem studies of PD 
victims (Fronczek et al. 2007). Also, the ventricular CSF levels of OX was found 
to be significantly reduced (25%), and this correlated positively with the number of 
OX neurons (Fronczek et al. 2007). Low levels of OX level in ventricular CSF have 
also been documented in late-stage PD patients (Drouot et al. 2003). A 40% 
reduction in OX levels was recorded in the prefrontal cortex of PD victims 
compared to healthy individuals (Fronczek et al. 2007). The correlation of OX CSF 
levels with OX cell number indicates that a dysfunction of the OX system is a factor 
in the pathogenesis of non-motor dysfunctions in PD. 
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MCH neurons were also found to be affected in PD (Thannickal et al. 2007): 12% 
of MCH neurons were found to be lost in stage I and 74% loss was recorded in stage 
V indicating the loss of MCH neurons correlates with the severity of PD 
(Thannickal et al. 2007). A similar reduction was recorded for OX neurons, with 
12% and 74% loss in stages I and V, respectively (Thannickal et al. 2007). 
However, there was an increase in MCH cell size which was not observed in OX 
neurons. A previous report had also reported an increase in the size of MCH neurons 
in PD (Cabello et al. 2002). 
It has been reported that drugs aimed at treating PD could selectively damage OX 
neurons (Katsuki and Michinaga 2012). However, OX has recently been shown to 
protect against 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity, which 
causes dopaminergic neuron death, through induction of HIF-1α (see 1.1) in a 
dopamine-producing neuronal cell line (Feng et al. 2014). 
Altogether these findings suggest that OX might protect against the development 
of neurodegenerative disease, and that OX loss in AD and PD could exacerbate 
disease progression by increasing susceptibility to oxidative damage (Nixon et al. 
2015). 
Although Huntington’s disease (HD) is not an aging-related neurodegenerative 
disease, it is worth mentioning in the present context that OX loss has been 
documented also in HD. This is a fatal hereditary neurodegenerative disorder 
characterized by motor abnormalities, psychiatric symptoms and cognitive deficits 
(Aziz et al. 2008). It is caused by a CAG repeat expansion in the huntingtin gene 
encoding a polyglutamine tract expansion in the huntingtin protein. 
Neuropathology includes cortical atrophy and loss of striatal medium spiny neurons 
(Ross et al. 2014; Lim et al. 2017). The age of symptom onset is highly variable, 
with a mean age around 45 years (Ross et al. 2014).  
Pathological studies in the brain of HD victims have shown a reduction in the 
number of OX neurons, with cell body atrophy, ranging from 10% (Petersén et al. 
2005) to 38% (Gabery et al. 2010) loss, with a normal level of OX-A in the CSF 
(Aziz et al. 2008). A 38% loss of OX neurons was documented in a transgenic 
model of HD, the R6/2 mice (Petersén et al. 2002; Peterseén et al. 2005).  
1.4 Extracellular matrix in the brain 
As mentioned at the beginning of this introductory chapter (see 1) and stated below 
in the study objectives (see 1.5), the findings herewith obtained on diurnal changes 
in the synaptic wiring of OX cell bodies brought to focus interest also on the ECM, 
since dynamic adaptation of the ECM can change forms of synaptic plasticity and 
organization in the adult brain (Frischknecht and Happel 2016). 
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The ECM constitutes the essential physical scaffolding for cells, and acts as a 
biomechanical and biochemical support required for tissue rearrangement, 
differentiation and homeostasis (Frantz et al. 2010). 
Neurobiology pioneers, Camillo Golgi and Santiago Ramón y Cajal discovered that 
neurons are surrounded by a mesh-like structure (Celio et al. 1998). In particular, 
the so-called “perineuronal nets” (PNNs) were first described as reticular structures 
by Golgi in the late 1800s (Spreafico et al. 1999). 
Before 1970, it was generally accepted that brain tissue is predominantly made of 
closely apposed neurons and glia, with a very minute amount of ECM. The 
emergence of several new techniques in the last decades has been of great help in 
the revision of this view, as it is known that the ECM molecules fill up significant 
amounts of the extracellular space (Tani and Ametani 1971; Yamaguchi 2000). 
Thus, initially, the ECM has been seen as a key component for guaranteeing the 
structural stability of neuronal tissue. Subsequent studies have recognized that the 
ECM undergoes significant changes during brain maturation (Frischknecht and 
Happel 2016). 
The extracellular space accounts for about 10-20% of the total volume of the mature 
brain (Nicholson and Sykova 1998). The highly organized ECM which fills the 
extracellular space is made of molecules already present in the embryo, with 
important roles in CNS development. These molecules are key players in the adult 
CNS, where they are present in almost every structure of the brain and spinal cord. 
The brain ECM is synthesized by neurons and glia (Dityatev et al. 2010a). It has 
been documented that the ECM is highly heterogeneous in the brain and throughout 
different developmental stages, including in the LH (Ruoslahti 1996; Köppe et al. 
1997; Horii-Hayashi et al. 2015, 2017). 
When compared to the systemic ECM, the ECM of the adult brain is unusual in at 
least two respects. First, the brain exhibits limited ultrastructural well-defined 
stromal space, unlike other organs and, second, common ECM components of 
systemic organs (e.g. fibronectin and collagen) are virtually absent from the adult 
brain ECM where different types of proteoglycans are abundantly expressed and 
localized to intercellular spaces (Bonneh-Barkay and Wiley 2009). 
In the late developmental phases, the ECM in the brain is composed of 
proteoglycans and glycoproteins like neurocan and tenascin-C, while these 
components are downregulated in the adult brain. The adult brain ECM is chiefly 
made of the glycoprotein tenascin-R (TN-R), chondroitin sulfate proteoglycans 
(CSPGs) such as brevican and aggrecan, with the unbranched polysaccharide 
hyaluronic acid (HA) as structural backbone (Frischknecht and Happel 2016). A 
large variety of other components of the ECM include reelins, laminins, 
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thrombospondins, heparin-sulfate proteoglycans, guidance molecules and 
transcription factors (Frischknecht and Happel 2016). 
The maturation of the ECM closely matches the end of the so-called developmental 
“critical periods” in the respective brain regions. The key study that elucidated the 
ECM as the regulatory switch between juvenile and adult plasticity came from the 
injection of the ECM-cleaving enzyme chondroitinase ABC into the visual cortex 
of adult rats combined with monocular deprivation. Local weakening of the ECM 
“re-juvenated” the visual cortex and restored the critical period of ocular dominance 
plasticity (Frischknecht and Happel 2016). In the follow-up study, visual acuity was 
restored in adult animals with long-term monocular deprivation by the same 
manipulation (Pizzorusso 2002). 
These and other studies led to the hypothesis that the brain ECM converts juvenile 
into adult plasticity by structural tenacity by limiting the reorganization of synaptic 
components (Gundelfinger et al. 2010). The adult brain has thus established an 
effective way to structurally stabilize neuronal networks shaped during experience-
dependent learning, which is fundamental for an effective long-term memory 
storage and recall (Frischknecht and Happel 2016). 
The ECM serves many functions including the regulation of synaptogenesis and 
synaptic plasticity, compartmentalization of the neuronal surface, neuroprotection, 
regulation of ion homeostasis and neuron-glia interactions (Frischknecht and 
Happel 2016). Data from experimental studies indicate that ECM molecules 
function as synaptic and perisynaptic scaffolds by directing the clustering of 
neurotransmitter receptors in the postsynaptic compartment and thereby present 
barriers to reduce the diffusion of membrane proteins away from synapses (Dityatev 
et al. 2010b). The ECM is thus recognized as a migration and diffusion barrier that 
allows the trapping and presentation of growth factors to their receptors at the cell 
surface (Dityatev et al. 2010b).  
The ECM also contributes to the migration and differentiation of stem cells in the 
brain neurogenic niches and organizes the polarized localization of ion channels 
and transporters at contacts between astrocytic endfeet and blood vessels (review 
in Dityatev et al. 2010a). 
At the synapses in the CNS, which are composed of distinct components, the ECM 
is present in the synaptic cleft and also extends extra-synaptically along the 
presynaptic terminal, postsynaptic cell, and perisynaptic process of astrocyte and 
processes of neighboring microglial cells which periodically make contact with the 
synaptic structure (Fig. 1.11). The concept of such ‘multi-partite synaptic assembly’ 
evolved over recent years, when it became clear that complex multidirectional 
relations exist between all the distinct components of synapses in the CNS 
(Verkhratsky and Nedergaard 2014). Advances in the understanding of the ECM 
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led also to progression from the tripartite view of synaptic signaling (Araque et al. 
1999) to the tetrapartite view (Dityatev and Rusakov 2011; Verkhratsky and 
Nedergaard 2014). 
 
 
Fig. 1.11: The majority of synapses in the CNS are composed of several 
components: the presynaptic terminal; the postsynaptic neuron; the 
perisynaptic process of the astrocyte; the process of a neighbouring 
microglia cell that periodically contacts the synaptic structure; and the 
ECM present in the synaptic cleft and also extending extra-synaptically. 
Adapted from Verkhratsky and Nedergaard, 2014. 
 
The molecular compositions and densities of ECM vary across the different regions 
of the CNS (Gundelfinger et al. 2010). While the organization of ECM/PNNs is 
well characterized in some brain regions, and especially in the cerebral cortex, there 
is dearth of information on the structural organization of the ECM of the 
hypothalamic circuitry. Certain hypothalamic neurons retain plasticity throughout 
adulthood (Horii-Hayashi et al. 2017). Analysis of the CGSP-components of the 
anterior-posterior hypothalamic regions have documented the presence of PNNs, as 
well as non-PNNs formed and loose ECM (Horii-Hayashi et al. 2017). The 
functional correlations of the structural variability of the hypothalamic ECM is not 
yet understood (Horii-Hayashi et al. 2017). 
1.4.1 Components of the brain extracellular matrix 
The functional attributes of the adult CNS ECM depend on its molecular 
composition. The ECM is located in three principal compartments: the basement 
membrane, the neural interstitial matrix and the PNNs. 
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The basement membrane is a sheet-like layer that serves as a boundary between 
CNS parenchymal tissue and endothelial cells and is predominantly made of 
collagen, fibronectin and proteoglycans such as perlecan (Lau et al. 2013). The 
fibrous protein most abundant within the interstitial ECM is collagen type IV. This 
molecule is essential for regulating cell adhesion and directing tissue development 
through its role in chemotaxis and cell migration, while also providing strength to 
the ECM (Rozario and DeSimone 2010). Perlecan is an essential component of the 
vascular ECM, interacts with various components of the ECM and has also a role 
in the endothelial barrier functioning (Farach-Carson et al. 2014). Fibronectin 
directs the reorganization of the interstitial ECM (Frantz et al. 2010). 
In the CNS, the most prominent accumulation of ECM molecules is found in the 
PNNs. They are made of HA, CSPGs belonging to the family ‘lecticans’, link 
proteins and TNR (Kwok et al. 2011). PNNs are a meshwork of ECM, highly 
elaborate and specialized ECM structure loosely wrapped around synapses and 
somata of a small proportion of neurons (Frischknecht and Happel 2016). They are 
especially rich in aggrecan and CSPGs and are found primarily around the fast-
spiking, GABAergic interneurons containing the calcium-binding protein 
parvalbumin (PV) in several brain regions (Dityatev et al. 2007). Recent evidence 
indicates that PNNs can be found around select group of neurons within the CNS, 
including glutamatergic neurons (Horii-Hayashi et al. 2015, 2017). PNNs have been 
found in the vicinity of glial processes that abut onto CNS synapses (Matthews et 
al. 2002; Brückner et al. 2004). These specialized structures create barriers to the 
diffusion of neurotransmitters and other signaling molecules (Frischknecht et al. 
2009), and limit plasticity of synapses and axonal processes (García-Alías and 
Fawcett 2012). 
During development and in adulthood, the molecules of PNNs are involved in 
synaptic regulating, including GABAergic and glutamatergic neurotransmission, 
through their effects on dendritic spines and other components of the synaptic 
structure (Faissner et al. 2010; Song and Dityatev 2017). 
The activities of neurons could facilitate and promote the formation of PNNs 
(Dityatev et al. 2007; Sorg et al. 2016) , which protect neurons from oxidative stress 
(Morawski et al. 2015), and are also involved in the modulation of the excitability 
of GABAergic interneurons (Sorg et al. 2016). They are able to alter the balance of 
the excitatory/inhibitory inputs to interneurons. The PNNs could regulate the 
plasticity playing a role in the development of synaptic contacts, as scaffolds for 
inhibitors of synapse formation and by limiting the motility of receptor on synaptic 
contacts (Fig. 1.12) (Sorg et al. 2016). 
The PNNs were observed to be largely normal in mice deficient in the key ECM 
proteins such as versican, brevican and neurocan (Dours-Zimmermann et al. 2009). 
However, the key ECM/PNNs marker Wisteria florunda agglutinin (WFA) (Härtig 
et al. 1994) was not reactive to the primary neurons cultured from the neocortex in 
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the aggrecan-deficient mice, illustrating they were abnormal (Giamanco et al. 
2010). This indicates a crucial role of aggrecan as a PNN component (Giamanco et 
al. 2010). 
 
 
Fig. 1.12: Limitation of plasticity by perineuronal nets (PNNs) via three mechanisms 
and reinstatement of plasticity by treatment with chondroitinase ABC (Ch-ABC). 
Plasticity involving PNN-surrounded neurons is limited via: (a) physical barrier by 
PNNs to incoming synaptic inputs; (b) binding of molecules via specific sites on CSPGs 
of PNNs (molecules, such as semaphorin 3A, inhibit new synaptic inputs); and (c) 
prevention of lateral diffusion of AMPA receptors, limiting the ability to exchange 
desensitized receptors in the synapse for new receptors from extrasynaptic sites. The 
treatment with Ch-ABC disrupts PNNs, thereby reinstates juvenile-like states of 
plasticity. HA, Hyaluronic acid; HAS, hyaluronic acid synthase. Reproduced from Sorg 
et al. 2016. 
 
HA, a unique glycosaminoglycan, is extruded extracellularly. It is the backbone of 
ECM in PNNs and in the perisynaptic extracellular space outside the PNNs. Also 
present in the CNS are hyaluronan synthases, the synthesizing enzymes of HA 
(HASs; HAS1 and HAS3). The different isoenzymes (HASs) possess different 
biochemical properties. HAS3 is the most active HAS and produces HA polymers 
with shorter chains (∼2×105 Da), whereas HAS1 and HAS2 synthesize HA 
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polymers with high MW chains (∼2×106 Da) (Itano et al. 1999; Itano and Kimata 
2002). Recent findings indicate that HAS1 is predominantly located in the 
membrane of the axon and may function in the maintenance of PNNs, although it 
is not the most abundant HAS in the brain (Li et al. 2017). 
HA binds and coordinates the CSPGs cross-linked glycoproteins for the formation 
of the ECM meshwork (Frischknecht and Happel 2016). Perisynaptic HA-based 
ECM may create barriers for diffusion of synaptic molecules and contributes to the 
compartmentalization of the synaptic machinery (Wlodarczyk et al. 2011). 
The combinations of numerous molecules create diverse biochemical properties on 
the PNNs. The HA-link proteins HAPLN 1, 3, and 4 bind to both the HA backbone 
and the CSPGs for stabilization of the PNNs in the CNS (Kwok et al. 2011). 
However, the loose interstitial ECM does not possess the HAPLN. (Galtrey et al. 
2008). 
CSPGs (>15 isoforms are identified in the CNS) consist of a protein core (Corvetti 
2005) and can be categorized based on the distinct properties of their core proteins, 
sulfation patterns, location, size and modular composition (Schaefer and Schaefer 
2010). Modular CPSGs have multiple protein domains and are the major 
constituents of the healthy CNS ECM. They are further subdivided into HA-binding 
and non-HA binding (mainly basement membrane CSPGs) (Rauch 2004). The 
major proteoglycans belong to the lectican family members and are represented by 
aggrecan, neurocan, brevican and versican. They function in promoting or 
inhibiting neuritic growth (Bandtlow and Zimmermann 2000). 
Studies have highlighted the essential roles of the sulfation patterns of CSPGs in 
PNNs formation. Tg mice with reduced chondroitin 6-sulfate (C6S) show poor 
regeneration after a lesion in the CNS (Lin et al. 2011), while Tg mice 
overexpressing chondroitin 6-O-sulfotransferase 1 (C6ST-1) retain a juvenile-like 
CS sulfation and show impaired PNN formation (Miyata et al. 2012). In addition, 
overexpression of C6ST-1 prevents the maturation of electrophysiological 
properties of PV-expressing interneurons and reduces the inhibitory effects of these 
cells because of impaired PNN formation. As a result, Tg mice overexpressing 
C6ST-1 retain a juvenile level of ocular dominance plasticity even in adulthood 
(Miyata et al. 2012). Interestingly, overexpression of C6ST-1 selectively decreases 
aggrecan in the aged brain without affecting other PNN components (Miyata et al. 
2012; Miyata and Kitagawa 2016). 
Heparan chondroitin sulfate proteoglycans (HSPGs) and CSPGs are prominent 
ECM constituents of the subependymal zone. An important role for CSPGs in the 
neurogenic niche has been suggested by the observation that collective removal of 
glycosaminoglycan chains from CSPGs by chondroitinase ABC leads to severe 
disturbances in the proliferation and neurogenic differentiation of stem cells 
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(Bradbury et al. 2002)ii. As a result of their extensive exposure on the protein 
backbone and their acidic nature, glycosaminoglycans have been suggested to 
accumulate and present growth factors to respective receptors on stem cell surfaces. 
Stem cell biology is essentially dependent on these soluble and highly diffusible 
molecules (Dityatev et al. 2010a). 
The composition of CSPGs in PNNs has been distinguished from that of the loose 
ECM with the use of extraction procedures (Deepa et al. 2006). The composition 
and appearance of PNNs varies across different regions of the CNS (Vitellaro-
Zuccarello et al. 2007). For instance, in some brain regions, PNNs appear as distinct 
structures separate from the loose ECM, whereas in the ventral spinal cord they are 
denser with higher intensity labeling of PNNs and the surrounding neuropil 
(Vitellaro-Zuccarello et al. 2007). Also, PNNs and the cell types surrounded by 
PNNs can be heterogeneous even within a single region (Sorg et al. 2016). 
The is dearth of information on the quantitative analysis of the distribution patterns 
and cell specificity of PNNs, which could perhaps shed light on their functional 
roles. In mice and rats, a recent study on PNN associated neurons in different brain 
areas shows their distribution and expression differs within the different brain areas 
(Lensjø et al. 2017). The most abundant expression was found in cortex (medial 
entorhinal and visual), while low level expression was observed in the dorsal 
hippocampus with intense expression in the CA2 subfield. Species differences in 
expression were found in the hippocampus (Lensjø et al. 2017). PNNs enwrapped 
PV neurons in the visual cortex, whereas they were found to enwrap mainly 
excitatory CamKII- expressing neurons in the hippocampal CA2 field. In the medial 
entorhinal cortex, in addition to PV cells, reelin-expressing cells colocalized with 
PNNs. Interestingly, following the enzymatic removal of PNNs, there was a 
considerable effect on the number of PSD-95 or gephyrin puncta (see Chapter 2) 
(Lensjø et al. 2017). 
Tenascins are a family of large ECM glycoproteins with four known members in 
the vertebrates: tenascin-W, tenascin-C (TN-C), tenascin-X and TN-R. The 
discovery of TN-R was a multistep process. It was originally described as low 
molecular weight J1 glycoprotein using an antibody recognizing both TN-C (the 
high molecular weight J1 glycoprotein) and TN-R (Kruse et al. 1985). TN-R was 
also discovered independently in the chicken and named ‘restrictin’, since its 
expression is restricted to the nervous system (Rathjen et al. 1991). TN-R is highly 
homologous between species: when compared with rat TN-R, the homology of the 
protein coding region of the human TN-R is 93% and 87% for amino acid and 
nucleotide sequences, respectively, and when compared with chicken TN-R, it is 
75% for both sequences. Functional regions of the molecule are the first 23 amino 
acids, a cysteine-rich N-terminal region corresponding to a typical signal peptide, 
4.5 epidermal growth factor-like domains, 8 or 9 fibronectin type III repeats, and a 
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carboxyl-terminal region globular domain resembling the β and γ chains of 
fibrinogen (Carnemolla et al. 1996).  
TN-R accumulates in large polymers at nodes of Ranvier and participates in the 
macromolecular organization of PNNs by assemblage of protein complexes of 
ECM proteins, glycosaminoglycans and proteoglycans (Kwok et al. 2011). The 
lecticans, including aggrecan, versican, neurocan and, brevican (with highest 
affinity) binds to TN-R. Interactions with lecticans can result in collaborative or 
inhibitory action depending on the developmental context. Lecticans share the same 
binding site on TN-R, namely, the fibronectin type repeats domains 3–5 (Lundell 
et al. 2004; Anlar and Gunel-Ozcan 2012). 
Some neuronal cells and type-2 astrocytes produce TN-R mRNA in vitro, while in 
vivo mRNA expression suggests synthesis by certain subpopulations of neurons, 
release into the ECM and probably receptor-mediated binding by PV neurons in 
cortical and deep gray matter (Wintergerst et al. 2001). During the embryonic 
period, TN-R is observed in many species and postnatally the expression decreases 
in oligodendrocytes but not in mature neurons in rodents where it is observed in 
particular cortical regions and layers and in the PNNs of the gray matter in the spinal 
cord (Galtrey et al. 2008). 
TN-R interacts with cell surface as well as ECM molecules homo- or 
heterophilically. TN-R has multiple, sometimes opposite roles. Its versatility 
includes adhesive or anti-adhesive, growth-promoting or inhibiting effects, 
depending on the type of targeted cells, receptors and signaling pathways, their 
location in the CNS, the composition of the surrounding ECM, and the time of 
interactions. It affects cell migration, differentiation and adhesion (Anlar and 
Gunel-Ozcan 2012). 
TN-R deficiency results in vitro in reduced oligodendrocyte differentiation and 
delayed myelin basic protein expression: this is corrected by addition of TN-R 
(Czopka et al. 2009). The autocrine role of TN-R on oligodendrocyte differentiation 
had earlier been documented (Pesheva et al. 1997). On the other hand, TN-R 
overexpression results in reduced migration in embryonic stem cells which travel 
shorter distances and differentiate more. TN-R also induces the generation of 
GABAergic neurons (Hargus et al. 2008). Although ECM molecules such as 
laminin, fibronectin, TN-C are involved in certain human diseases, TN-R has not 
been implicated in human diseases except oligodendrogliomas and gangliogliomas 
(El Ayachi et al. 2011). 
Mice deficient for TN-R display less developed PNNs, WFA staining that does not 
extend well to the dendritic shaft and a decrease in axonal conduction velocities in 
the CNS (Weber et al. 1999). In an experimental model of ischemic stroke in rats, 
in addition to neuronal loss, peri-infarct regions showed loss of PNNs WFA 
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labelling and, to a lesser degree, loss of CSPG core protein staining (Hobohm et al. 
2005). 
1.4.2 Involvement of the extracellular matrix in neuroinflammation 
and neurodegeneration 
As mentioned above, PNNs have been studied for their contributions to 
synaptogenesis, neuroprotection, and experience-dependent synaptic plasticity, 
including critical period plasticity (Soleman et al. 2013). However, little attention 
has been given to the ECM organization within the neuropil (interstitial ECM) 
during neuroinflammation. The ECM is, however, increasingly implicated in 
neurodegenerative conditions (Bonneh-Barkay and Wiley 2009). 
TN-R expression is affected by various molecules, is inhibited by tumor necrosis 
factor-α produced by activated microglia after peripheral nerve injury (Angelov et 
al. 1998) and upregulated by platelet derived growth factor, thyroid hormone and 
TN-R itself (Pesheva and Probstmeier 2000). Following spinal cord injuries, TN-R 
is upregulated around the lesions sites (Gaudet and Popovich 2014). Certain effects 
of TN-R on plasticity and repair are mediated by cytokines. By activating microglia, 
TN-R indirectly promotes the local secretion of cytokines and growth factors 
including, transforming growth factor-β and nerve growth factor (Liao et al. 2005).  
During excitotoxicity (in the kainic acid toxicity model), many of the associated 
neurodegenerative changes are linked to ECM alterations. ECM changes have been 
documented to include reduction in laminins and phosphocan, and increases in 
neurocan and brevican. However, it seems that degeneration of the ECM does not 
directly cause neurodegeneration but rather makes neurons susceptible to 
activation-associated cell death (Kaminska et al. 1997). 
In multiple sclerosis (MS), a demyelinating disease with neuroinflammatory 
stigmata, accumulation of laminins in active MS lesions, associated with the 
basement membrane of endothelial cells, has been reported (Van Horssen et al. 
2007). This laminin accumulation was not seen in inactive MS lesions. Also, high 
molecular weight HA synthesized by astrocytes in chronic lesions were evident 
(Van Horssen et al. 2007). There was matrix metalloproteinase (MMP)-19 
upregulation associated with microglia (Van Horssen et al. 2006). A striking loss 
of TN-R and TN-C was also documented in acute MS lesions, in contrast to the TN-
R and TN-C accumulation in chronic MS lesions (Gutowski et al. 1999). 
In chronic demyelinated MS lesions, accumulation of a high-molecular-weight HA 
synthesized by astrocytes has been reported (Back et al. 2005). This was thought to 
inhibit remyelination as oligodendrocyte progenitor cells do not mature into 
myelin-forming cells in demyelinating lesions where high-molecular-weight HA is 
present (Back et al. 2005).  
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Aberrant changes in ECM components have been documented to be associated with 
the pathological hallmarks of AD (Morawski et al. 2014) (see 1.3.2), and the 
remodelling could mediate cell proliferation, differentiation and apoptosis 
(Dityatev et al. 2010b; Soleman et al. 2013). The functional consequences of such 
remodelling may be dependent on the local specific organization of the ECM as 
established in animal models. During AD pathology, any or all of the key ECM 
components might be affected, though the reports on changes in ECM components 
in AD are contradictory  (Lepelletier et al. 2015).  
Proteoglycans such as the specific HSPG, perlecan have been shown to be present 
in both Aβ plaques and NFTs. They are thought to contribute to disease 
pathogenesis by accelerating the formation of Aβ through preventing proteolytic 
degradation. It has also been previously reported that high molecular fibronectin 
forms appear more frequently and at higher amounts in plasma in AD patients than 
in age-matched controls (Lemańska-Perek et al. 2009), and the levels of plasma 
fibronectin are higher in AD patients than in healthy controls and individuals with 
mild cognitive impairment (Muenchhoff et al. 2015). In contrast, unchanged plasma 
fibronectin concentrations have also been described in AD (Rattan et al. 1988). 
Collagen IV, perlecan and fibronectin expression has been reported to be increased 
in subclinical AD and AD patients in the frontal and temporal cortex, whereas no 
further increase was detected between subclinical AD and AD, supporting the 
hypothesis that significant ECM changes occur during the early stages of AD 
(Lepelletier et al. 2015). 
Although changes in ECM and PNNs are reported in the initial stages of AD, the 
relationship between the changes in ECM components and the 
hyperphosphorylation of tau is unclear. A recent report indicates that the 
overexpression of tau may break the balance of ECM components and structure of 
the PNNs by regulating HASs expression and HAS1 axonal localization. This has 
been suggested to promote AD progression by regulating neuronal plasticity (Li et 
al. 2017). 
Furthermore, a post mortem report in AD has indicated a loss of two-thirds of the 
PNNs labelled by WFA, with the PNNs intact in healthy control subjects (Baig et 
al. 2005). There was a granular disintegration of PNNs around some PV neurons in 
the cerebral cortex, though the density of PV neurons did not differ (Baig et al. 
2005). In another report, the cortical neurons associated with PNNs were largely 
spared from neurofibrillary changes in AD even in severely damaged regions 
(Brückner et al. 1999). 
Concerning neuroinflammatory paradigms, it is worth reporting that in a mouse 
model of American trypanosomiasis or Chagas disease, caused by the intracellular 
parasite Trypanosoma cruzi, immunohistochemical assays have shown an increase 
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in the level of expression of the ECM components fibronectin and laminins in the 
cerebellum of acute and chronic infected animals compared to uninfected controls 
(Silva et al. 1999). 
1.5 Specific objectives of the experimental studies 
The laboratory in which this thesis was performed has long been engaged in 
diencephalic mechanisms of regulation of state-dependent behavior (sleep and 
wake) in the adult and aged healthy brain (e.g. Palomba et al. 2008; Colavito et al. 
2015), and in rodent models of diseases in which the alternation of sleep and wake 
and/or the sleep structure are altered (Etet et al. 2012; Laperchia et al. 2016; 
Tesoriero et al. 2016).  
In this framework, the present investigations focused on the study of the synaptic 
wiring of orexinergic neurons and the surrounding ECM in normal conditions in 
the periods of sleep or wake predominance in mice, in a murine model of AD and 
in a murine model of sleeping sickness.  
The main specific aims of the thesis are as follows: 
1) Study of the synaptic wiring of OX cell bodies in the periods of sleep or wake 
predominance in adult mice 
2) Study of the synaptic wiring of OX cell bodies in the periods of sleep or wake 
predominance in aged mice, as well as in the AD model provided by adult and aged 
double-mutant TASTPM mice 
3) Study of the ECM of the LH of adult mice in the periods of sleep or wake 
predominance in basal conditions, and in a murine model of sleeping sickness 
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2. Study of the synaptic wiring of orexinergic neuron 
soma in the periods of sleep or wake predominance in 
adult mice   
 
This study has been published in the article indicated below, from which the text 
and figures are reproduced. The candidate's contribution to the findings has been 
substantial, as he has processed the tissue and performed the quantitative analyses 
for the entire part related to the visualization of presynaptic neurotransmitter 
transporter and related postsynaptic scaffold protein at excitatory and inhibitory 
synapses. 
 
 
 
2.1 Introduction 
Orexin (OX)/hypocretin-producing neurons represent a relatively small neuronal 
population which resides in the perifornical and lateral hypothalamus (LH). These 
cells give origin to a widely distributed innervation of the neuraxis, with an 
extensive connectivity with other hypothalamic and extrahypothalamic circuits 
(Peyron et al. 1998; Burt et al. 2011). The activity of OX neurons and related 
networks represents a key element in the regulation of wakefulness stability and 
arousal, energy homeostasis, as well as motivated behaviors including feeding, 
reward seeking, and responses to anxiety and stress (Kukkonen 2013; de Lecea and 
Huerta 2014; Mahler et al. 2014; Sakurai 2014). 
The local extracellular concentration of OX in the LH (Yoshida et al. 2001) and the 
level of OX-A in the cerebrospinal fluid of rats and primates (Fujiki et al. 2001; 
Zeitzer et al. 2003; Zhang et al. 2004) oscillate during 24 h, with higher values 
during the animal’s activity period than during the rest period. Studies based on 
cFos immunoreactivity, a marker of neuronal activation, indicate that in basal 
conditions in rats (Estabrooke et al. 2001; Modirrousta et al. 2005) and mice 
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(Marston et al. 2008; Palomba et al. 2015a), the activity of OX neurons increases at 
night (the activity/wake period) and decreases at daytime (the rest/sleep period) in 
rodents, which are nocturnal. 
Electrophysiological recordings in rats have shown that OX neurons discharge 
during wake and are silent during sleep (Lee 2005; Mileykovskiy et al. 2005). 
Altogether, these findings point to a daily change in the activity of orexinergic cells. 
Different paradigms have pointed out synaptic plasticity phenomena in OX neurons 
in response to challenges. In particular, reorganization of excitatory/inhibitory 
inputs onto OX perikarya after food restriction and in obesity (Horvath and Gao 
2005; Cristino et al. 2013) and increased excitatory innervation after prolonged 
wakefulness (Rao et al. 2007a) have been reported in mice. In larvae of zebrafish, 
a diurnal vertebrate, it has been evaluated that the number of inhibitory synapses on 
OX dendrites peaks during the night (Elbaz et al. 2017b). However, it has not been 
hitherto investigated whether the excitatory/inhibitory balance in the innervation of 
OX cell bodies undergoes daily changes in basal conditions. Here, in mice not 
subjected to any manipulation, we tested the hypothesis that the 
excitatory/inhibitory wiring of OX cell bodies is remodeled during the periods of 
wake and sleep predominance.  
To this purpose, we used established methodological approaches based on multiple 
immunofluorescent labeling of presynaptic terminals and postsynaptic scaffolding 
proteins (Henny and Jones 2008; Ippolito and Eroglu 2010; Cristino et al. 2013; 
Inan et al. 2013). We first identified and quantified with epifluorescence 
neurochemical excitatory (glutamatergic) and inhibitory (GABAergic) appositions 
on OX-A cell bodies. Using presynaptic vesicular transporters combined with 
synapse scaffold proteins as postsynaptic markers, we then verified and quantified 
with confocal laser-scanning microscopy that the contacts of these varicosities with 
OX-A cell bodies formed synapses. 
2.2 Materials and methods 
2.2.1 Animals and experimental design 
Adult (3–6 months old) male C57BL/6J mice were maintained under a 12/12-h 
dark/light or light/dark cycle (lights on time corresponding to Zeitgeber time, ZT, 
0), under veterinarian control and controlled environmental (temperature and 
humidity) conditions, with free access to food and water. Mice were destined for 
analyses with epifluorescence and confocal microscopy (n = 28), or 
electroencephalography (EEG) recording (n = 8). The animals destined for 
microscopic analyses were left undisturbed, avoiding any potential stressful 
condition and tissue damage and/or inflammatory reaction due to electrode implant 
for EEG recording. They were randomly divided in two groups sacrificed during a 
2-h period during the day (ZT 3–4, n = 14), or night (ZT 15–16, n = 14). For 
sacrifice, the mice were deeply anesthetized with tribromoethanol (20 mg/kg, ip) 
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and transcardially perfused with 0.01-M phosphate-buffered saline, pH 7.2 (PBS), 
followed by 4% paraformaldehyde in PBS. The brains were removed, postfixed for 
2 h, and cryoprotected in 30% sucrose in PBS at 4 ͦ C. These experiments were 
performed twice, using first five mice per day or night group destined for 
epifluorescence, and then replicated using nine mice per group (three for 
epifluorescence and six for confocal microscopy). Additional mice, matched with 
the first experimental session, were destined for EEG recording to assess sleep and 
wake states in the 2 h period used for the sampling for microscopic analyses, and 
during two consecutive days. 
All procedures received approval by the Animal Care and Use Committee of the 
University of Verona (CIRSAL) and authorization by the Italian Ministry of Health, 
in strict adherence to the European Communities Council (86/609/EEC) directives 
and the ARRIVE guidelines, in accordance with the National Institute of Health 
Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23), 
minimizing the number of animals used and avoiding their suffering. 
2.2.2 Electroencephalography recording 
For EEG and electromyography (EMG) monitoring, mice were chronically 
implanted with electrodes under isoflurane anesthesia. Four epidural electrodes 
were used for EEG recordings. One was placed over the left frontal zone (AP: +1.7, 
L: -1.5, DV: +0.0 mm from bregma), two over the right and left parietal zones (AP: 
-2.5, L: ±2.0, DV: +0.0 mm from bregma), respectively, and one over the 
cerebellum (AP: -5.8, L: 0.0, DV: +0.0 mm from bregma). All electrodes were 
soldered to a connector secured to the skull with dental cement. In addition, a pair 
of wires acting as electrodes was sutured to the nuchal muscle for the acquisition of 
EMG signals. After surgery, the animals were allowed at least 10 days of recovery; 
EEG and EMG signals were then recorded in undisturbed conditions for 48 h 
(starting from ZT 0). Post-acquisition determination of vigilance states at ZT3–4 
and ZT 15–16 was done by visual inspection in consecutive 10-s epochs according 
to standard criteria (Baracchi and Opp 2008) (Fig. 2.1). Briefly, wakefulness was 
attributed on the basis of low-amplitude, mixed-frequency (theta and delta) EEG 
accompanied by EMG activation. Slow-wave sleep (SWS) was identified by 
increased absolute EEG amplitude, integrated values for the delta frequency band 
greater than those for theta, and a reduction of the EMG signal. Paradoxical sleep 
(PS) was characterized by low-amplitude EEG, with integrated values for the delta 
frequency band lower than those for the theta frequency band and muscle atonia. 
2.2.3 Tissue processing and immunofluorescence 
Varicosities apposed to OX perikarya were analyzed with triple 
immunofluorescence using epifluorescence and confocal microscopy. The primary 
antibodies listed in Table 1.1 were used to visualize OX-immunopositive cells, 
together with the presynaptic marker synaptophysin (Syn) combined with either the 
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vesicular glutamate transporter (VGluT)2 as marker of glutamatergic elements, or 
the vesicular GABA transporter (VGAT) as marker of GABAergic elements. 
Notably, among glutamatergic vesicular transporters, VGluT2 is predominant in 
brain regions regulating energy balance and behavioral/homeostatic integration, 
including the LH (Liguz-Lecznar and Skangiel-Kramska 2007). For the analyses of 
varicosities and postsynaptic scaffold proteins with confocal microscopy, the 
postsynaptic density (PSD) protein 95 was used for excitatory synapses and 
gephyrin (Geph) for inhibitory synapses (Table 1). 
The brains destined for epifluorescence were embedded in OCT matrix, cut on a 
cryostat into 10-mm-thick coronal sections, and mounted on slides in three adjacent 
series. Every 12th section through the anteroposterior extent of the LH was stained 
with cresyl violet for cytoarchitectonic reference, and sections from the two 
adjacent series were processed for triple immunostaining to visualize OX/ 
VGluT2/Syn or OX/VGAT/Syn. The brains of the mice destined for confocal 
microscopy were serially cut with a freezing microtome into coronal sections at a 
30-mm thickness. Four series of adjacent sections through the anteroposterior 
extent of the LH were processed free floating for triple immunofluorescence to 
visualize OX/VGAT/Syn, and OX/VGluT2/Syn, or OX/VGluT2/PSD95 and 
OX/VGAT/Geph. For the immunofluorescence procedure, all sections were pre-
incubated in a solution of 0.3% Triton X-100 in 0.1-M phosphate buffer, pH 7.4, 
for 1 h, and then incubated overnight in a mixture of primary antibodies and diluted 
in the pre-incubation solution (Table 1). After rinsing in PBS, sections were 
incubated for 2 h in a mixture of secondary antibodies: Alexa Fluor 350-conjugated 
donkey anti-goat IgGs or Alexa Fluor 594-conjugated donkey anti-goat IgGs; Alexa 
Fluor 594-conjugated donkey anti-rabbit IgGs or Alexa Fluor 647-conjugated 
donkey anti-rabbit IgGs; and Alexa Fluor 647 donkey anti-mouse IgGs (all from 
InVitrogen, Carlsbad, CA, USA). The sections were then incubated for 2 h with 
Alexa Fluor488-conjugated goat anti-guinea pig IgGs (InVitrogen). After rinsing in 
PBS, the sections processed free-floating were mounted on slides. All sections were 
coverslipped with Aquatex mounting medium (Merck, Darmstadt, Germany). 
To further control antibody specificity, additional sections were processed omitting 
each of the primary or secondary antibodies. No signal of the omitted reagent was 
detected in these control sections. 
2.2.4 Microscopy and quantitative analyses 
In epifluorescence microscopy, the method used by Cristino et al. (2013) was 
followed to determine the colocalization of Syn+/VGluT2+ and Syn+/VGAT+ in 
varicosities apposed to OX perikarya. In brief, triple immunostained sections were 
observed with a DMI6000 (Leica, Manheim, Germany) microscope equipped with 
x–y–z motorized stage, a digital camera Leica DFC 340FX, and the Leica 
Metamorph imaging software (Leica Meta-Morph AF, Manheim, Germany). 
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Multichannel images were acquired and analyzed using the Leica Application Suite 
(LAS) AF 2.2.0 software. OX- cell bodies with the full extent of the nucleus were 
randomly sampled through the perifornical area, where these cells are densely 
distributed, using the fornix as landmark. Sixty cells per vesicular transporter 
(VGlut2 or VGAT) and per animal were analyzed, and four images per cell in serial 
Z planes (1.6 mm step size) were acquired. Images were deconvolved using the 
Metamorph imaging deconvolution software by application of ten iterations. 
Varicosities were examined in single optical slices and considered as appositions to 
cell bodies when overlap among the elements was evident upon full rotation of the 
images. Counts of appositions were performed with a semi-automated method using 
the Metamorph Imaging Investigator software. 
To verify whether appositions of varicosities represented axosomatic contacts, the 
analysis was repeated with the confocal microscope Leica SP5 (Leica, Mannheim, 
Germany) using a 63X oil-immersion objective (numerical aperture 1.4). Serial Z 
planes (0.5 µm) images were captured with the LAS software, and collapsed into a 
single maximum projection image to which colors were assigned. Twenty cells per 
antibody combination and per animal were analyzed. The cell body profile of OX 
neurons was drawn at each single plane on the basis of the OX signal channel. For 
each plane, a contact was identified as the clusters of pixels (green: VGluT2+ or 
VGAT+; red: Syn+) adjacent to an OX soma profile in which at least one pixel (x 
= 98.47; y = 98.47 nm; z = 503.54 nm) showed merging (yellow) in all the 
orthogonal views of imaged stacks. Clusters of pixels visible in adjacent z levels 
were not counted twice. 
To verify whether the contacts represented synapses, the same method of 
acquisition and analysis was applied to sections processed for pre- and postsynaptic 
markers. A synapse was identified as a continuum between presynaptic (VGluT2+ 
or VGAT+) and postsynaptic (PSD95+ or Geph+) elements in OX-A+ cell profiles, 
with no evident separation among the three elements. 
For the representative 3D image in three dimensions, synaptic boutons on OX-A 
neurons were reconstructed from images stacks with the Imaris software 7.4 
(Bitplane, Zurich, Switzerland) on merged images, in which only the OX-A signal 
and the VGluT2+/Syn+ or VGAT+/Syn+ colocalization were visualized. Levels, 
contrast, and brightness were adjusted with the Imaris software to optimize the 
images. 
2.3 Statistical analyses 
For the analysis of neurophysiological recordings, a two way (days x time points) 
repeated analysis of variance (ANOVA) followed by post hoc testing with 
Bonferroni’s correction was performed to compare the average proportions of time 
spent in the different vigilance states during the sampled 2 h periods. Multivariate 
ANOVA (MANOVA) was used to determine the statistical interaction between the 
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number of excitatory and inhibitory synapses in the day/night groups (IBM SPSS 
software; Chicago, IL, USA). The significance threshold was set at p<0.05. 
2.4 Results 
2.4.1 Sleep and wake states 
The neurophysiological recordings showed a definite prevalence of sleep states 
during the sampled day period and of wakefulness during the sampled night period 
(Fig. 2.1b, c). In particular, the average proportion of time spent in the different 
vigilance states at ZT 3–4 and ZT 15–16 was significantly different (wakefulness: 
F1,7 = 46.071, p B 0.001; SWS: F1,7 = 42.071, p < 0.001; PS: F1,7 = 41.222, p < 
0.001; Fig. 2.1c). Mice slept (summing up SWS and PS) significantly more during 
day than during night in both the analyzed days. On day 1, mice slept about two 
times more during the analysed daytime period (ZT 3–4: 64.90 ± 4.55% of total 
time, mean ± standard error of the mean) than at night in antiphase (ZT 13–15: 
32.55 ± 7.11% of total time, p < 0.001, Fig. 1c). The finding was replicated by the 
analysis of day 2 when the total sleep time was about three times higher in the 
analyzed daytime period (ZT 3–4: 70.14 ± 4.11%) than in the analyzed night period 
(ZT 13–15: 24.81 ± 6.95%, p = 0.001). Wakefulness significantly prevailed during 
the analyzed night periods (day 1: ZT 13–15: 67.45 ± 7.11% of total time; day 2: 
75.19 ± 6.95%) and its relative proportion was lower in the analyzed daytime 
periods (ZT 3–4: day 1: 35.10 ± 4.55% of total time; day 2: 29.86 ± 4.11%) (Fig. 
2.1c). 
The findings were very consistent across animals (Fig. 2.1c). Of note, the 
percentage of time spent in each vigilance state was similar in the analyzed periods 
of the 2 days of recording (day 1 and day 2; Fig. 2.1c) with no significant difference 
between the 2 days (wakefulness: F1,7 = 0.042, p = 0.844; SWS: F1,7 = 0.063, p = 
0.809; PS: F1,7 = 0.003, p = 0.959). 
2.4.2 Excitatory and inhibitory presynaptic elements 
Triple immunofluorescence resulted in the effective visualization of OX- cell 
bodies together with Syn+ immunosignal and VGluT2+ or VGAT+ immunosignal 
in varicosities during both the sampled day and night periods (Fig. 2.2). At the 
observation, the intensity of immunofluorescence of OX- somata appeared higher 
at night than at day. The main diameter of OX- cell bodies sampled for the analysis 
ranged from 25.6 ± 3.73 to 28 ± 2.83 lm, in agreement with the previous 
observations (Peyron et al. 1998). 
In both epifluorescence and confocal microscopy, Syn+/VGAT+ (Fig. 2.2a, b) and 
Syn+/VGluT2+ (Fig. 2.2g, h) varicosities appeared to contact OX- cell bodies in 
sections from both the sampled periods, and were also seen around immunonegative 
somata intermingled with the OX- ones (Fig. 2.2a, c, e, f). Confocal images were 
further viewed using 3D rotation with magnification to confirm that the presynaptic 
elements were in contact with the OX-A+ cell profile through three spatial axes. By 
67 
 
this examination, the Syn+/VGluT2+ or Syn+/VGAT+ varicosities appeared to be in 
contact with OX- cell bodies, since no space was observed between the two with 
rotation through three axes (Fig. 2.2, small images).  
 
 
Fig. 2.1: Sleep–wake states analyses. a. Representative 20-s epochs of 
electroencephalography (EEG) and electromyography (EMG) signals during each 
vigilance state. b. Representative hypnograms during the light period (ZT 3–4, on 
the left) and the dark period (ZT 15–16, on the right); PS paradoxical 
sleep, SWS slow-wave sleep. c. Percentages (mean ± SEM) of the total time 
(120 min) spent in each vigilance state. Note that the percentages are consistent in 
the first (day 1) and second (day 2) days of recording used for the analyses 
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Fig. 2.2: Inhibitory or excitatory varicosities apposing orexinergic cell bodies in the 
sampled light and dark periods. a, c, e, g Confocal microscopy images (maximum 
intensity projections) of triple immunostained sections showing Syn+ (red) varicosities 
together with VGAT+ or VGluT2+ (green) varicosities (the merging is in yellow) in 
relation to orexinergic neurons (blue). The asterisks indicate the OX cells shown at 
higher magnification in the matched images. Varicosities surrounding non-orexinergic 
(OX-immunonegative) neurons are also evident. b, d, f, h Contacts (arrows) between 
inhibitory (VGAT+/Syn+) or excitatory (VGLUT2+/Syn+) varicosities with OX soma 
visualized in a single optical section (xy). The intersection between the white lines 
identifies the contacts shown in orthogonal projections, at higher magnification, in the 
lateral insets. Inhibitory or excitatory varicosities are defined as the apposition between 
the presynaptic elements (VGAT+/ Syn+; VGluT2+/Syn+) in three dimensions, i.e., in 
all the combination of the axes (xy; yz; xz) as double immunostaining and in merged 
image. Scale bars 5 µm 
 
At the quantitative analysis of pairs of 10-µm-thick sections in epifluorescence, the 
mean total number of presynaptic appositions per OX- soma during day (18.74 ± 
2.81) and night (19.86 ± 3.01) was not significantly different (Fig. 2.3a). 
Differences were, however, found between the mean number of glutamatergic or 
GABAergic varicosities per OX- soma during day and night (Fig. 2.3a). In 
particular, a prevalence of glutamatergic (Syn+/ VGluT2+) varicosities was found 
in the animals sampled at night (mean number of appositions per OX- cell body: 
13.83 ± 2.81) vs those sampled at day (4.62 ± 1.84). A prevalence of the mean 
number of GABAergic (Syn+/ VGAT+) varicosities per OX- soma was instead 
documented in the animals sampled during day (14.11 ± 1.94) vs night (6.03 ± 
1.39). This resulted in a ratio of VGluT2/ VGAT varicosities per OX- soma of ⁓3:1 
in the mice sacrificed during the night, and a ratio of ⁓1:3 in those sacrificed during 
the day. In terms of relative proportion of Syn+ varicosities per OX- soma, the data 
indicated that VGluT2+ elements accounted for 24.20 ± 7.00% and VGAT+ 
elements for 75.82 ± 7.00% at daytime, whereas VGluT2+ elements accounted for 
70 ± 5.62% and VGAT+ elements for 30 ± 5.62% at night. The results were very 
consistent across animals of each group (Fig. 2.3b). The statistical analysis showed 
that the above differences were highly significant: MANOVA showed a significant 
multivariate main effect for the time of sacrifice (Wilk’s λ = 0.065; F(2,13) = 93.97; 
p<0.001, partial ղ2 = 0.935; power to detect the effect: α = 0.05). Given the test 
significance, the univariate effects were also examined: the mean number of 
Syn+/VGluT2+ Varicosities per OX- cell body was significantly higher at night 
(F(1,14) = 76.54), and that of Syn+/VGAT+ varicosities at daytime (F(1,14) = 91.38) 
(Fig. 2.3a). 
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Fig. 2.3: Quantitative analyses of excitatory and inhibitory varicosities apposing 
orexinergic cell bodies in the sampled light and dark periods. a Mean number (±SEM) 
of excitatory (VGluT2+/Syn+) or inhibitory (VGAT+/Syn+) varicosities apposed to OX-
A+ cell bodies (n = 60 cells per mouse; n = 8 mice per group). ***p<0.001, multivariate 
analysis of variance (MANOVA), F = 2,13. b Scatter plots of the mean number of 
excitatory and inhibitory varicosities per OX-A soma in each of the animals. Note that 
the individual data sets are very consistent across animals. 
 
Quantitative analysis of confocal microscopy images confirmed that the mean 
number of VGluT2+/Syn+ varicosities per OX- soma was higher during night 
(9.833 ± 0.519) than during day (3.867 ± 0.519). Conversely, the mean number of 
VGAT+/Syn+ varicosities per OX- soma was higher during day (9.833 ± 0.422) 
than during night (4.033 ± 0.422) and, therefore, a ratio VGluT2/VGAT of ⁓4:1 
during night and ⁓1:4 during day was found in the mean number of appositions per 
OX- cell body in confocal microscopy, matching the results obtained with 
epifluorescence. 
In the statistical analysis of this confocal microscopy data set, one-way MANOVA 
confirmed a significant multivariate main effect for the time of sacrifice (Wilks’ λ 
= 0.004, F(2,3) = 62.602, p = 0.004, partial ղ2 = 0.977; power to detect the effect 
was 0.999). Significant univariate main effects for the time of sacrifice were 
obtained for both VGAT (F(1,4) = 94.613, p = 0.001, partial ղ2 = 0.959) and 
VGluT2 (F(1,4) = 66.064, p = 0.001, partial ղ2 = 0.943). 
2.4.3 Postsynaptic markers 
To further assess in detail whether the Syn+ varicosities formed GABAergic or 
glutamatergic synapses, sections triple immunostained for vesicular transporters, 
and the postsynaptic scaffold proteins Geph and PSD95, respectively, were 
analyzed in confocal microscopy (Fig. 2.4). In series triple stained for OX, VGAT, 
and Geph, staining for Geph appeared punctate and could be detected opposite to 
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the VGAT+ varicosities and associated with the surface of OX- cell bodies (Fig. 
2.4b, f). In series triple stained for OX, VGluT2, and PSD95, VGlut2+ varicosities 
appeared to abut PSD95+ puncta associated with OX- cell bodies (Fig. 2.4d, h). 
Confocal images were further viewed using 3D rotation with magnification, and 
confirmed that the pre- and postsynaptic elements were in contact through three 
spatial axes during both the day and night sampled periods (Fig. 2.4, small images).  
Quantitative analysis (Fig. 2.5a) showed a significant prevalence at night of the 
mean number of excitatory VGluT2+ varicosities in contact with PSD95 per OX- 
soma (17 ± 0.349) with respect to daytime (4.9 ± 0.348). The mean number of 
VGAT+ in contact with Geph per OX- soma was instead significantly lower during 
night (5.1 ± 0.945) and higher at daytime (14.933 ± 0.945). 
The findings were consistent across animals (Fig. 2.5d), showing a ratio VGluT2 + 
PSD95/VGAT + Geph of ⁓3:1 at night and of ⁓1:3 at daytime. 
One-way MANOVA revealed a significant multivariate main effect for the time of 
sacrifice (Wilks’ k = 0.023, F(2,3) = 346.150, p<0.001, partial ղ2 = 0.996). 
Significant univariate main effects for the time of sacrifice were obtained for VGAT 
(F(1,4) = 54.187, p<0.001, partial ղ 2 = 0.931), and for VGluT2 (F(1,4) = 601.685, 
p<0.001, partial ղ2 = 0.993). 
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Fig. 2.4: Inhibitory or excitatory synaptic contacts in orexinergic cell bodies in the 
sampled light and dark periods. a, c, e, g Confocal images (maximum intensity 
projections) of triple immunostained sections showing VGAT+ or VGluT2+ (green) 
varicosities, the postsynaptic scaffold proteins gephyrin (Geph) or PSD95 (red; the 
merging is in yellow) and orexinergic neurons (blue), shown at higher magnification 
in each matched image (indicated in a and b by asterisks). b, d, f, h Contacts visualized 
at high magnification in a single optical section (xy) show that VGAT+ Varicosities 
abut a Geph+ punctum (arrows in b and f); VGluT2+ varicosities abut a PSD95+ 
punctum (arrows in d and h); the postsynaptic puncta are located on the surface of the 
OX-A+ cell bodies. The intersection between the white lines identifies the contacts 
analyzed along their orthogonal projections, shown at higher magnification in the 
lateral insets. Inhibitory or excitatory synaptic contacts are defined as a continuum 
between presynaptic and postsynaptic elements in three dimensions, i.e., along all the 
combination of the axes (xy; yz; xz) as double immunostaining and in merged image. 
Scale bars 5 µm 
 
 
 
 
Fig. 2.5: Quantitative analyses of excitatory and inhibitory synaptic contacts in 
orexinergic cell bodies in the sampled light and dark periods. a Mean number (±SEM) 
of excitatory (VGluT2+/PSD95+) or inhibitory (VGAT+/Gephyrin+) synapses per OX-
A+ cell body (n = 20 cells per mouse; n = 3 mice per group). ***p<0.001, MANOVA, 
F = 2,3. b Scatter plots of the mean number of excitatory and inhibitory contacts per OX-
A+ soma in each of the animals, showing that the results are consistent 
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Fig. 2.6: Summary of the day/night switch of excitatory and inhibitory synaptic contacts 
with orexinergic cell bodies. Examples of orexinergic cell bodies (shown in 3D 
reconstructions) summarize the day/ night variation of the excitatory/inhibitory input 
observed in the present study 
 
2.5 Discussion 
The present findings provide novel evidence of a switch in the innervation of 
orexinergic cell bodies, in basal conditions, from a prevalence of excitatory inputs 
at night, during a period we demonstrated to correspond to wakefulness 
predominance, to a prevalence of inhibitory inputs in the antiphase, during a period 
we demonstrated to correspond to sleep predominance (Fig. 2.6). As expected in 
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nocturnal animals, the analysis of vigilance states in the matched mice (a strategy 
here adopted to avoid any possible perturbation caused by EEG recording in the 
mice used for microscopic analyses) indicated that in the 2 h periods of sampling, 
the animals were predominantly asleep during the day and predominantly awake 
during the night. The data obtained with EEG recordings were remarkably 
consistent across animals as well as in the 2 analyzed days. The percentages of time 
spent in each vigilance state were similar to those previously reported in mice 
(Tobler et al. 1997). The multiple presynaptic labeling strategy adopted here with 
epifluorescence has been previously validated at the ultrastructural level with the 
visualization of asymmetric and symmetric synaptic boutons on OX cell bodies 
(Horvath and Gao 2005; Cristino et al. 2013). In the present study, the findings were 
consistent in the epifluorescence and confocal microscopy analyses, and were 
replicated and validated by the use of presynaptic and postsynaptic markers in 
confocal microscopy, showing that they formed synaptic contacts. Day/night 
plasticity of the orexinergic network has been described in the larval zebrafish, 
related to rhythmic changes in synapse density (Appelbaum et al. 2010) rather than, 
as in our study in mice, to neurotransmitter phenotype. 
In addition, recent findings based on live imaging of single synapses in zebrafish 
larvae have reported an increase in the number of inhibitory synapses in the 
dendrites of orexinergic neurons during the night, corresponding to sleep as 
assessed on the basis of behavioural parameters in this diurnal model organism 
(Elbaz et al. 2017b). Such findings support the present data, obtained in cell bodies, 
on the increase of inhibitory axosomatic synapses in orexinergic neurons during a 
period corresponding to sleep in mice. Moreover, taking also into account 
excitatory synapses, we here reveal a daily reorganization of the overall 
excitatory/inhibitory balance in the innervation of orexinergic cell bodies in mice. 
Different sets of previous data in mice have pointed out a remarkable synaptic 
plasticity in the wiring of OX cell bodies in different paradigms: food deprivation 
(Horvath and Gao 2005), genetic and diet-dependent murine models of obesity 
(Cristino et al. 2013), and prolonged wakefulness (Rao et al. 2007a). Altogether, 
these data have indicated dynamic changes of the wiring of OX neurons to face 
internal and external challenges (Horvath and Gao 2005). 
The present findings show that a dynamic daily fluctuation of the 
excitatory/inhibitory innervation of OX somata is part of the repertoire of adaptive 
properties of these neurons in basal, unperturbed conditions. Of note, the previous 
ultrastructural and multiple immunolabeling analyses have identified a high number 
of asymmetric, excitatory synapses on the soma of orexinergic neurons (Horvath 
and Gao 2005), at variance with other neuronal cell types in which excitatory 
synapses prevail on dendrites, and it has been proposed that the prevalent excitatory 
innervation of orexinergic perikarya could facilitate the responses of these neurons 
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to environmental demands (Gao and Hermes 2015). Chronic administration of 
modafinil for 7 days, inducing elevated locomotor activity taken as behavioral 
measure of prolonged wakefulness, led to an increased number of asymmetric 
synaptic contacts on orexinergic cell bodies and increased strength at glutamatergic 
synapses (Gao and Hermes 2015). Our data, which are extended to the analysis of 
postsynaptic scaffold proteins in basal conditions, show that a reorganization of 
excitatory synapses occurs daily in a dynamic balance with inhibitory ones. The 
neuronal cell body is the critical subcellular domain for action potential generation 
and the control of neuronal spiking (Spruston 2008). Our data are, therefore, in line 
with the previous finding that the firing of OX neurons is highest in rats during 
active wake and virtually ceases during sleep (Lee 2005). The silence of OX 
neurons during sleep could be caused by inhibitory input from GABAergic sleep-
active neurons in the basal forebrain and/or preoptic area and tuberal posterior 
hypothalamus (Lee 2005; Saito et al. 2013). The perifornical area, on which the 
present analyses have been focused, is innervated mainly by hypothalamic sources, 
with the heaviest input from the ventrolateral and preoptic nuclei (Yoshida et al. 
2006), in which GABAergic sleep-active neurons are located. Taken together with 
these previous data sets, the present findings suggest that the sleep-promoting 
synaptic network oscillates to silence OX neurons during sleep. Shifts in the 
presynaptic wiring of OX neurons could also account for the day/night changes 
reported for the OX effect on the suprachiasmatic nucleus, in which predominantly 
GABA-mediated presynaptic OX actions during the day switch to direct 
postsynaptic actions during the night (Belle et al. 2014). 
The day/night switch of the synaptic wiring of OX somata here observed could 
gradually occur during 24 h and could be under circadian regulation or due to 
homeostatic mechanisms to be verified in future studies with experiments under 
constant light or dark conditions and with sleep deprivation. By means of the latter 
manipulations in zebrafish larvae, the rhythmic plasticity of inhibitory synapses in 
the dendrites of orexinergic neurons was found to be independent of the circadian 
clock and homeostatically regulated by vigilance states (Elbaz et al. 2017b). 
Concerning the postsynaptic plasticity of orexinergic neurons, sleep deprivation 
experiments in mice have shown that the immunostaining of GABA receptors on 
orexinergic cell bodies increases as a function of enforced wakefulness during the 
day, thus stimulating homeostatic downscaling of OX neuron activity (Toossi et al. 
2016). 
This type of homeostatic adaptation also occurs in a reciprocal manner in melanin-
concentrating hormone neurons, a sleep-active peptidergic cell population 
intermingled with OX neurons, in which GABA receptor immunoreactivity 
decreases with increasing wakefulness (Toossi et al. 2016). Such data on GABA 
receptors further strengthen the present findings on the plasticity of the postsynaptic 
component of orexinergic cell bodies, and suggest that daily changes in cell body 
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innervation could be a property of different populations of sleep/wake-regulatory 
neurons in the LH. On the other hand, the oscillation of OX- release in the 
cerebrospinal fluid is under the circadian control of the suprachiasmatic nucleus 
and sleep homeostatic mechanisms (Deboer et al. 2004; Zhang et al. 2004). 
The present data open many other questions. Inputs to orexinergic neurons originate 
from a variety of sources in the forebrain and brainstem, and from an abundant local 
network within the hypothalamus, including orexinergic synapses (Sakurai et al. 
2005; Yoshida et al. 2006; Yamanaka et al. 2010; Burt et al. 2011), contingents of 
cholinergic terminals (Henny and Jones 2006), glycinergic inhibitory terminals 
(Hondo et al. 2011), and serotonergic terminals which inhibit directly and indirectly 
orexinergic neurons (Chowdhury and Yamanaka 2016), as well as somatostatin 
varicosities which can release GABA (Toossi et al. 2012), thus showing complex, 
multiple interactions in the afferent regulation of OX cell activity. VGAT is the 
transporter for both GABA and glycine (Wojcik et al. 2006), and the present 
investigation remains to be extended to other neurotransmitter-identified terminals, 
although very few non GABAergic or glutamatergic varicosities apposed to 
orexinergic cell bodies were here observed. 
Different mechanisms could account for the remarkable, spontaneous daily changes 
in the excitatory/inhibitory wiring of OX- somata here identified. These 
mechanisms could involve presynaptic determinants (Ettorre et al. 2012), as well 
as cytoskeletal proteins, as reported for myosin phosphorylation under rhythmic 
Rho1 activity in the daily expansion and retraction of axon terminals in Drosophila 
clock neurons (Petsakou et al. 2015). Synaptic proteins, such as Syn itself, could 
also be implicated, given the role of Syn in the regulation of activity-dependent 
synapse formation and competition (Tarsa and Goda 2002). 
Furthermore, synaptic plasticity could involve extracellular matrix (Dityatev et al. 
2010a; Dityatev and Rusakov 2011) and phenomena of neurotransmitter switching 
(Spitzer 2015). Perisynaptic glia could also be involved in synaptic wiring changes, 
considering the key role of astrocytes ensheathing presynaptic terminals (Heller and 
Rusakov 2015; Papouin et al. 2017), and the local role of astrocyte derived lactate 
as critical energy substrate of OX firing activity (Parsons and Hirasawa 2010). Of 
note, dynamic microglial cell processes are new players in the synaptic 
microenvironment (Miyamoto et al. 2013; Xavier et al. 2014), and microglial cells 
isolated from the murine cerebral cortex are endowed with an intrinsic molecular 
clock which can modulate synaptic strength (Hayashi et al. 2013). 
Opening such intriguing questions, our findings add day/night changes of 
innervation to the key role of orexinergic signaling in the timing of behavioral 
states, supporting the view of OX neurons as ‘‘a hub’’ (Sakurai 2014) which links 
internal and external drives. 
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2.6 Tables 
 
Table 1: Antibodies used in this study. 
Antigen Host Immunogen Supplier Catalog# Dilution References 
Orexin Goat Purified goat polyclonal 
antibody raised against a 
peptide mapping at the 
C-terminus of Orexin-A 
of human origin 
Santa Cruz sc-8070 1:100 Blanco- 
Centurion 
et al. 
(2013) 
VGluT2 Guinea pig Purified recombinant 
protein of rat VGluT2 
(aa510-582) 
Synaptic 
Systems 
135 404 1:100 Perederiy et 
al. (2013) 
VGAT Guinea pig Strep-Tag fusion protein 
of rat VGAT (aa2-115) 
Synaptic 
Systems 
131 004 1:100 Fekete et al. 
(2015) 
Gephyrin Mouse Purified rat gephyrin Synaptic 
Systems 
147 011 1:50 Schneider 
Gasser et al. 
(2006) 
PSD95 Rabbit Synthetic peptides 
corresponding to 
residues surrounding 
Gln53 of human PSD95 
Cell 
Signaling 
3450T 1:100 Saunders et 
al. (2015) 
Synaptop
hysin 1 
Rabbit Synthetic peptide 
GPQGAPTSFSNQM 
(aa 301 - 313 in human 
synaptophysin 1) 
coupled to key-hole 
limpet hemocyanin via 
an added N-terminal 
cysteine residue. 
Synaptic 
Systems 
101 002 1:200 Wimmer et 
al. (2006) 
Synaptop
hysin 
Mouse Purified mouse 
monoclonal IgG1k 
Millipore MAB5258 1:500 Gokhale et 
al. (2012) 
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2B. Addendum: preliminary data on astrocytes in the 
lateral hypothalamus during day and night 
2B.1 Purpose 
The purpose for implementing the published findings (Laperchia et al. 2017) with 
this additional material is to present preliminary data on astrocytes in the same 
conditions of such previous study (basal conditions at two time points in antiphase 
during day and night). 
The interest in astrocytes in the LH is motivated not only by the wealth of data on 
the partnership of astrocytes in synaptic transmission (Fig. 1.11), and especially in 
excitatory glutamatergic transmission (Verkhratsky and Butt 2007), but also by 
findings indicating “time-keeping” properties of astrocytes. In particular, clock 
gene expression has been reported in astrocytes, which maintain in vitro a circadian 
oscillation (Prolo 2005), and release ATP in vitro with a circadian rhythmicity 
(Womac et al. 2009), which depends on clock gene expression (Marpegan et al. 
2011). Astrocytes are components of the local network of regulation of OX neuron 
activity (Burt et al. 2011) (Fig. 1.6B), and their role in supplying energy to OX 
neurons (Parsons and Hirasawa 2011) is critical also for the wake-promoting 
activity of these cells (Clasadonte et al. 2017) which is mediated by connexin-43 
gap junctional coupling (Clasadonte et al. 2017). 
On this basis, the study on the diurnal fluctuation of the excitatory/inhibitory 
balance in the synaptic wiring of OX cell bodies is currently being extended to 
astrocytes surrounding OX neurons. Data on the methodological approach set up 
for these analyses and preliminary observations are here presented. 
2B.2 Materials and methods 
2B.2.1 Animals 
Male CX3CR1-GFP mice of 3 months of age were used. In these mice microglial 
cells are tagged with green fluorescent protein (GFP) by tagging of the chemokine 
fractalkine receptor CX3CR expressed by microglia (Mizutani et al. 2012). The use 
of these animals was motivated by the objective to analyze also microglia in the 
same paradigm, which is ongoing in a separate study.  
The mice were maintained under the same conditions as described in section 2.2.1. 
Four mice were used for this pilot study based on confocal microscopy, and were 
sacrificed during a 2 h period during the day (ZT 3–4, n = 2) and at night (ZT 15–
16, n = 2), with ZT 0 corresponding to the lights-on time. Animal perfusion was 
carried out using the same protocol described in section 2.2.1. The experimental 
procedures were pursued under the same ethical approval stated in section 2.2.1.  
2B.2.2 Tissue processing and immunofluorescence 
A freezing sliding microtome was used for sectioning, and 30 µm-thick coronal 
sections were collected in adjacent series through the anteroposterior extent of the 
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LH. The sections were processed free-floating for triple immunofluorescence with 
primary antibodies: goat anti-orexin-A (Santa Cruz; 1:100) to visualize OX-
immunopositive cells, together with mouse anti- synaptophysin (Syn) (Millipore; 
1:500) as presynaptic marker and rabbit anti-glial fibrillary acid protein (GFAP) 
Merck; 1:500) to visualize astrocytes (information on these antibodies is provided 
in Table 3.2 of Chapter 3). The immunofluorescence procedures described in 
section 2.2.3 were followed. Sections were incubated in the following secondary 
antibodies: Alexa Fluor 405-conjugated donkey anti-goat IgG; Alexa Fluor 568-
conjugated donkey anti-rabbit IgGs and Alexa Fluor 647 donkey anti-mouse IgGs 
(all from InVitrogen, Carlsbad, CA, USA). The sections were then mounted on 
gelatinized slides and coverslipped with 0.1% paraphenylenediamine in a glycerol-
based medium (90% glycerol and 10% PBS). Additional sections were processed 
omitting either the primary or secondary antibody to control for antibody 
specificity. No signal of the omitted reagent was detected in these sections. 
2B.2.3 Microscopy and data analysis 
The confocal microscope Leica SP5 (Leica, Mannheim, Germany) was used for 
tissue section analysis using a 63X oil-immersion objective with a constant zoom 
factor 1.0 (numerical aperture 1.3). Serial Z planes (0.50 µm) images were captured 
with the LAS software, and collapsed into a single maximum projection image to 
which colors were assigned. Acquired images were minimally and equally modified 
with the Imaris software for contrast and brightness. The filter channel visualizing 
GFP (i.e., microglia) was suppressed for the present observations. 
The 3D reconstructions of astrocytes together with Syn+ presynaptic elements were 
done according to previous approaches (Verbich et al. 2012; Fogarty et al. 2013). 
For the 3D reconstruction images of astrocytes, the Imaris software 7.4 (Bitplane, 
Zurich, Switzerland) tools for filaments was used in identifying astrocytic 
ramifications, while the software tools for surface was used for reconstructing the 
soma of astrocytes from merged images, using first image stacks of astrocytes only, 
and then in combination with the OX soma and Syn signals. Pre-installed MATLAB 
software on the Imaris tool was used to detect axosomatic contact on OX neuron 
membrane colocalized with astrocytic processes. The Imaris software was also used 
in adjusting minimally the levels, contrast, and brightness for the optimization of 
images.  
The analyses of the colocalization of presynaptic appositions to OX somata and the 
astrocytic processes were done as described by Fogarty et al. (2013) and Belmer et 
al. (2017), using the Imaris imaging software for surface rendering/ reconstruction. 
Briefly, the smoothing, surface rendering and surface creation tools were applied to 
the reconstruction of the astrocytic cell bodies and their processes. A matching 
morphology of the astrocytes acquired at the confocal microscope was created using 
the slice view tool. The line tool was used in measuring the minimum and maximum 
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diameter of their processes which were then subsequently reconstructed from the 
filament tool. In the course of the reconstruction procedure, the raw image acquired 
was compared with the reconstructed image to ensure that the structures present 
were preserved and no structure was introduced that was not present in the raw 
image. 
The presynaptic appositions on OX soma and astrocytic processes were filtered 
based on OX neuron and astrocytic surfaces. Presynaptic (Syn+) fluorescence 
signals unrelated to the OX soma or astrocytic processes were masked and filtered 
out, to visualize only presynaptic contacts associated with both the OX soma and 
astrocytic processes. Following the mathematical calculations of smallest diameter 
of Syn+ terminals (using the line tool as above), the spot diameter of the Syn 
terminal was calculated using the spot layering tool. The spot detection tool was 
individually applied to axosomatic terminals on OX and astrocyte processes, 
respectively. The pre-installed MATLAB plugin was used in the detection and 
selection of Syn+ terminals of a diameter of 0.3 µm as in previous protocols 
(Fogarty et al. 2013; Belmer et al. 2017). Spot colocalization tool was used for the 
localization of ‘Syn+ on OX soma’ or ‘Syn+ on astrocyte processes’ pairs within a 
distance of a 0.6 µm to identify the appositions of presynaptic terminals colocalized 
on OX soma and the astrocytic processes, respectively.   
2B.3 Results 
Confocal images of single optical slices of OX neurons in serial Z planes (0.5 µm 
step size) allowed the effective visualization of OX neurons when collapsed into 
the maximum intensity projections (Fig. 2B.1). The main diameter of OX soma was 
within the same range described by Laperchia et al. (2017). The presynaptic Syn+ 
elements on OX soma and in the LH neuropil were visible during both the day and 
night sampled periods (Fig. 2B.1). Syn+ elements surrounded, as expected, both 
OX-immunopositive and OX-immunonegative neurons (Fig. 2B.1). A fluctuation 
of Syn immunofluorescence was seen in the LH neuropil, with higher intensity at 
night than at daytime. This was adjusted for optimal visualization of the maximum 
intensity projection images of Syn at both time points, as shown in Fig. 2B.1. 
Three-dimensional reconstruction of GFAP immunofluorescence resulted in the 
visualization of the highly ramified astrocytic processes (Fig. 2B.2). These showed 
a bushy phenotype, with dense filling of the neuropil, especially at the night time 
point (Fig. 2B.2B). When the 3D GPAP immunosignal was viewed together with 
OX and Syn immunofluorescence in merged images, astrocytic processes were seen 
to extend over OX cell bodies at both the day and night time points (Fig. 2B.3). The 
merging also showed overlap of astrocytic processes with Syn+ elements apposed 
to OX cell bodies (Fig. 2B.3). 
Analyses with 3D surface reconstruction of GFAP together with 3D spot detection 
of Syn showed appositions of Syn+ presynaptic elements to OX somata (Fig. 2B.4). 
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The merge also revealed the colocalization of Syn+ presynaptic terminals in contact 
with OX somata and the distal portion of astrocytic processes extending on OX 
somata and proximal dendrites (Fig. 2B.4). 
All the adopted visualization approaches (Figs 2B.2, 2B.3, 2B.4) showed that the 
processes of astrocytes surrounding OX neurons were much more extended at night 
than at day. This finding is now being confirmed with additional data. It will also 
be determined whether the arrangement of astrocyte processes at night and day 
resulted in a different spatial covering of the OX neuron membrane, and in 
quantitative differences in the merge of astrocyte distal endings with axosomatic 
contacts.  
 
 
 
Fig. 2B.1: Maximum intensity projections confocal microscopy images of orexinergic 
(OX-A) neurons and presynaptic (Syn-immunopositive) terminals in apposition to OX 
soma in the sampled light and dark periods. Presynaptic elements surrounding OX-
immunonegative neurons are also evident in the neuropil. The same field is presented 
also in the following figures and the asterisks indicate the spatial reference (in A and B, 
respectively) for Figs. 2B.2 and 2B.3. Scale bar = 30 µm. 
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Fig. 2B.2: 3D reconstruction confocal microscopy images of astrocytes in the same field 
shown in Fig. 2B.1 and shown at higher magnification in Fig. 2B.3 (asterisks are for 
spatial reference). Maximum intensity projections images showing the different 
organization of astrocyte ramifications. Scale bar = 30 µm. 
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Fig. 2B.3: Higher magnification of the field marked by asterisks in Fig. 2B.2 showing 
astrocytes and presynaptic (Syn-immunopositive) elements and orexinergic neurons in 
the sampled light and dark periods. Note that processes of astrocytes extend onto OX 
somata and overlap spots of presynaptic elements. Scale bar = 15 µm. 
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Fig. 2B.4: Merged images showing the overlap of axosomatic (Syn-immunopositive) 
terminals on orexinergic neurons with astrocytic processes in the sampled light and dark 
periods. A, B: maximum intensity projections confocal microscopy images of triple 
immunolabelling. C, D: following 3D reconstruction, higher power images of A, B 
(asterisks are for spatial landmarks) clearly show distal astrocytic processes onto the OX 
soma colocalized with axosomatic terminals. The Syn+ fluorescence signals within the 
neuropil not related to the OX soma/processes and astrocytic processes were masked and 
filtered out. Scale bars =  30 µm in A, 10 µm C. 
 
87 
 
2B.4 Comments 
These preliminary observations suggest that diurnal changes occur in the spatial 
arrangement of astrocytes which surround OX neurons in the LH, in terms of the 
extent, orientation, and, possibly, degree of ramification of astrocytic processes.  
It is known that astrocytic processes can undergo rapid morphological changes even 
in physiological conditions by the remodelling of their soma and processes 
(Theodosis et al. 2008). Such modifications have been documented in the SCN (see 
1.1.4) according to circadian rhythmicity (Theodosis et al. 2008). It has also been 
reported that in the rat SCN GFAP immunoreactivity increases during the period of 
darkness and decreases during the light period with a circadian variation (Becquet 
et al. 2008). In mice, however, there are conflicting reports, since no circadian 
variation of GFAP immunoreactivity was found in the SCN in one study (Moriya 
et al. 2000), while in another study GFAP immunoreactivity was found to be highest 
in the middle of the light phase and lowest at the beginning of the dark phase (Santos 
et al. 2005). Furthermore, this oscillation was found to be maintained in total 
darkness conditions, indicating an endogenous rhythm (Santos et al. 2005).  
Modifications of the astrocytic processes in other brain areas including the 
neocortex, hippocampus, cerebellum and brain stem, have been described in 
different conditions (review in Theodosis et al. 2008), but it is unclear whether 
plastic changes in astrocyte structure affect neuronal activity (Theodosis et al. 
2008).   
It has been proposed that glutamate release at synaptic sites could stimulate the 
protrusions or retractions of perisynaptic astrocyte processes (Lavialle et al. 2011). 
Other neurotransmitters could also be involved in the dynamics of astrocyte 
processes, which express receptors for most of CNS transmitters (Verkhratsky and 
Butt 2007). There are also suggestions that the diurnal remodelling of synapses by 
astrocytes could be related to their release of tumor necrosis factor-α (Lee and 
Haydon 2011), owing to the implication of this cytokine in sleep-wake modulation 
(Krueger 2008). 
Astrocytes are a major source of extracellular adenosine, as such, there are 
suggestions regarding their involvement in sleep modulation (Schmitt and Wimmer 
2015). Following SD, the level of adenosine derived from astrocytes was observed 
to increase in the hippocampus and cortex (Schmitt et al. 2012). However, 
following chronic SD, there was reduction in the elevated levels of adenosine 
observed in hippocampus during acute SD, suggestive of a positive feedback in 
preserving normal hippocampal functions (Clasadonte et al. 2014). 
The most peripheral astrocytic processes, though quite small and thin for 
microscopic resolutions and rarely examined in electrophysiological studies, 
constitute about 80% of its cell membrane (Lavialle et al. 2011). It is important to 
recall in this context that the cytoskeletal protein GFAP may not actually reveal the 
full extent of perisynaptic glia, which instead express ezrin, a membrane-
cytoskeleton linker (reviews in Derouiche et al. 2002; Theodosis et al. 2008; 
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Bernardinelli et al. 2014). In the brain, ezrin is exclusively expressed by astrocytes 
(Derouiche and Frotscher 2001) and ependymal cells (Berryman et al. 1993). 
Although the present preliminary findings need to be confirmed, the adopted 
approaches for 3D reconstruction analyses of multiple immunofluorescence seem 
promising for the revelation of the relationships between GFAP-immunoreactive 
distal astrocytic processes and the inputs to OX neurons. Further ongoing analyses 
will clarify eventual time-related changes of this organization. 
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3. Synaptic wiring of orexinergic neuronal cell bodies 
during day and night: from adult to aged mice and study 
of a murine model of Alzheimer’s disease 
3.1 Introduction 
The previous data (Chapter 2; Laperchia et al. 2017) provided evidence, in adult 
mice, of a fluctuation of the input to orexinergic neurons from a prevalent excitatory 
innervation at night, during a period of predominant wakefulness, to a prevalent 
inhibitory innervation at daytime, during a period of sleep predominance. The 
finding opens questions on the potential variations of this process during aging and 
in synaptopathies such as AD. The present study was aimed at the investigation of 
these issues to test the hypotheses that the diurnal fluctuation in the 
excitatory/inhibitory balance of the innervation of OX cell bodies could be modified 
by aging and by the pathological process underlying AD.  
As discussed in Chapter 1, physiological functions controlled by the hypothalamus, 
including circadian rhythms, vary with age (see 1.2.1; see also Bonaconsa et al. 
2013). Impairment of orexinergic signalling has been associated with aging-related 
dysfunctions (see 1.2.1; see also Foley et al. 2004; Corrada et al. 2010; Zink et al. 
2014). 
Of note, an aging-related reduction in the number of orexinergic neurons has been 
reported in the human and rodent brain (see 1.2.1). It has also been reported that the 
release of OX and OXR activation in the CNS decline with advancing age (see 
1.2.1). No data is available, however, on the synaptic wiring of OX neurons during 
aging. 
Concerning AD, as dealt with in Chapter 1 (see 1.2.3), not only disruption of 
circadian rhythmicity, but also sleep fragmentation have been reported in up to 40% 
of AD patients with mild to moderate dementia, and dysregulation of orexinergic 
signalling has been implicated in this functional disruption (reviews in Videnovic 
and Zee 2015; Liguori et al. 2016). Pathophysiological mechanisms that underlie 
alterations of circadian rhythmicity in AD have been described, with neuronal cell 
loss in the SCN and loss of pineal gland function considered as main contributors 
(Stopa et al. 1999; Wu et al. 2003), correlating positively with AD progression 
(Stopa et al. 1999; Liu et al. 2000; Videnovic and Zee 2015) (see 1.3.1; see also 
Bonaconsa et al. 2013). 
Seminal studies have shown in the last years that the sleep-wake cycle can influence 
Aβ pathology which, in turn, can disrupt the sleep-wake cycle in a bidirectional 
relationship (Ju et al. 2014) (see 1.3.2). Of special interest are findings pointing to 
a regulatory role of OX on Aβ plaque deposition in amyloid precursor protein (APP) 
Tg mice during the sleep-wake cycle (Kang et al. 2009) (see 1.3.2). 
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Loss of about 40% OX neurons in post-mortem analyses of AD brains, and 14% 
reduction in CSF OX levels in AD patients compared to healthy control individuals 
have been reported (Fronczek et al. 2012) (see 1.3.2). However, the synaptic wiring 
of OX neurons has not been hitherto investigated in the brain of AD victims or in 
murine models of this disease. 
The present study utilized as AD model double mutant mice carrying the TAS10 
thy1-APP695swe x TPM thy1 PS1.M146 mutations (TASTPM mice). In these mice, 
the deposition of Aß is progressive and age-related and is accompanied by 
astrocytosis and phosphotau accumulation, providing a useful model of AD 
(Howlett and Richardson 2009b). 
The manuscript concerning the data presented in this chapter is in preparation. This 
manuscript will include the neurophysiological study of TASTPM mice of the age 
groups here used for the analysis of the diurnal fluctuation of OX soma innervation. 
Such neurophysiological part of the study has appeared in abstract form (Colavito 
et al. 2014) and is here shown in a figure (Fig. 3.1), presented as a premise to the 
present investigation. The study, performed in TASTPM mice and matched WT 
mice of 5 months and 21 months of age (n= 3 or 4 per group and per genotype; 
Colavito et al. 2014), showed that TASTPM mice do not exhibit the classical 
rhythmicity associated to phase and documented in WT mice (Fig. 3.1). In 
particular, 5 month-old TASTPM mice tended to present a lower amount of sleep 
(Fig. 3.1A) and a higher amount of wakefulness (Fig. 3.1B) compared to WT mice 
during light phase. The aged TASTPM mice tended to present a higher amount of 
sleep (Fig. 3.1A) and a lower amount of wake during the dark phase (Fig. 3.1B). 
Both WT and TASTPM 21 month-old mice showed an increase in the number of 
transitions between vigilance stages, independent of genotype (Colavito et al. 
2014). 
Another set of data, obtained previously in our lab, which will be included in the 
manuscript in preparation and has appeared in abstract form (SINS Congress 2015), 
concerns the number of OX neurons evaluated by stereological cell counts in young 
(3 month-old) and aged (18 month-old) TASTPM mice and matched WT mice. This 
investigation showed an aging-related reduction of OX neurons in the 18 month-
old WT mice, which was significantly exacerbated in the 18 month-old Tg mice 
(SINS Congress 2015). In the work for the present thesis, OX cell counts have been 
performed in 15 month-old TASTPM mice and matched WT mice together with 
the evaluation of immunosignal intensity, as presented below. The reason for the 
analysis of OX immunosignal, which is indicative of the peptide expression, stems 
from experimental data indicating that partial loss of OX neurons in rats could be 
compensated by increased OX release (Gerashchenko et al. 2003). 
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Fig. 3.1: Data from electroencephalographic recordings in adult and aged transgenic (Tg) 
TASTPM mice and matched wild-type (WT) mice (n= 3 or 4 per group). Note that 
compared to 5 month (m)-old WT mice, aged (21 m-old) WT mice and Tg mice of both 
age groups did not exhibit the classical rhythmicity associated to light or dark phase. 
Repeated measures ANOVA for sleep duration exhibited a phase-age interaction 
[F(1,20)=8.08, p<0.05] and a phase-genotype interaction [F(2,20)=3.73, p<0.05], and 
for wakefulness duration an age-phase interaction [F (1,20)=8.41, p<0.05] and a 
genotype-phase interaction [F(2,20)=4.46, p<0.05]. From Colavito et al. 2014. 
 
3.2 Materials and methods 
3.2.1 Experimental design and animals 
The present study included different experimental groups (Table 3.1) for: i) 
observation of OX neurons and neurotransmitter transporter-characterized 
presynaptic terminals during day and night in adult C57BL/6J mice; ii) quantitative 
analyses of the diurnal fluctuation of the excitatory and inhibitory innervation of 
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orexinergic cell bodies in aged mice and in the AD model provided by TASTPM 
mice; iii) investigation of OX neurons in TASTPM mice; iv) neuropathological 
study of TASTPM mice. 
The study of the diurnal organization of OX neuron input was pursued in TASTPM 
mice and WT mice of two age groups (Table 3.1): 3 month-old animals, an age 
which corresponds to early plaque formation in TASTPM mice (Howlett et al. 
2004) and 20 month-old animals, which corresponds in TASTPM mice to an 
advanced stage of the pathological process (Howlett et al. 2008; Howlett and 
Richardson 2009a).  
Male mice were used. WT and TASTPM mice of all age groups (Table 3.1) were 
maintained under a 12 h/12 h dark/light or light/dark cycle, under veterinarian 
control and controlled environmental (temperature and humidity) conditions, with 
free access to food and water. The animals were left undisturbed, avoiding any 
potential stressful condition. The experimental groups destined to the study of the 
diurnal fluctuation of OX neuron innervation (Table 3.1) were randomly divided in 
two groups sacrificed during a 2 h period during the day (ZT 3–4), or night (ZT 15–
16), i.e. at the same time points adopted in our previous study (Chapter 2; Laperchia 
et al. 2017). The other experimental groups (destined for OX neuron analyses and 
for the neuropathological study of TASTPM mice; Table 3.1) were sacrificed 
during daytime. For sacrifice, the mice were deeply anesthetized with 
tribromoethanol (20 mg/kg, ip) and transcardially perfused with 0.01M phosphate-
buffered saline, pH 7.2 (PBS), followed by 4% paraformaldehyde in PBS. The 
brains were removed, postfixed for 2 h, and cryoprotected in 30% sucrose in PBS 
at 4 ͦ C.  
All procedures received approval by the Animal Care and Use Committee of the 
University of Verona (CIRSAL) and authorization by the Italian Ministry of Health, 
in strict adherence to the European Communities Council (86/609/EEC) directives 
and the ARRIVE guidelines, in accordance with the National Institute of Health 
Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23), 
minimizing the number of animals used and avoiding their suffering. 
3.2.2 Tissue processing and immunofluorescence 
In three mice of the day or night groups, destined for the observation in confocal 
microscopy (Table 3.1), sections through the diencephalon were cut at a 30 μm 
thickness with a freezing microtome. Every second section through the LH was 
collected and processed free-floating for triple immunofluorescence to visualize 
OX-immunopositive cells, the presynaptic marker synaptophysin (Syn) and the 
vesicular glutamate transporter (VGluT)2 as marker of glutamatergic elements, or 
the vesicular GABA transporter (VGAT) as marker of GABAergic elements. 
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The brains of the above mice destined to the quantitative analyses of the daily 
organization of the synaptic input to OX cell bodies (Table 3.1) were embedded in 
OCT matrix, cut on a cryostat into 10 µm-thick coronal sections, and mounted on 
slides in three adjacent series. Every 12th section through the anteroposterior extent 
of the LH was stained with cresyl violet for cytoarchitectonic reference, and the 
adjacent series of sections were processed for triple immunolabelling to visualize 
OX/VGluT2/Syn or OX/VGAT/Syn. 
For the multiple immunofluorescence procedure, the sections were processed free-
floating (30 µm-thick sections) or on slide (10 µm-thick sections). They were 
preincubated in a solution of 0.3% Triton X-100 in 0.1M phosphate buffer, pH 7.4, 
for 1 h, and then incubated overnight in a mixture of primary antibodies (Table 3.2) 
diluted in the preincubation solution. After rinsing in PBS, the sections were 
incubated for 2 h in a mixture of secondary antibodies: Alexa Fluor 350-conjugated 
donkey anti-goat IgGs or Alexa Fluor 594-conjugated donkey anti-goat IgGs; Alexa 
Fluor 594-conjugated donkey anti-rabbit IgGs or Alexa Fluor 647-conjugated 
donkey anti-rabbit IgGs (all from InVitrogen, Carlsbad, CA, USA). The sections 
were then incubated for 2 h with Alexa Fluor488-conjugated goat anti-guinea pig 
IgGs (InVitrogen). After rinsing in PBS, the sections processed free-floating were 
mounted on slides. All sections were coverslipped with Aquatex mounting medium 
(Merck, Darmstadt, Germany). 
To control antibody specificity, additional sections were processed as controls by 
omitting either the primary or secondary antibodies. No signal of the omitted 
reagent was detected in these control sections. 
3.2.3 Microscopy and quantitative analyses 
The 30 μm-thick sections processed for triple immunofluorescence were observed 
with the confocal microscope Leica SP5 (Leica, Manheim, Germany). Quantitative 
analyses of presynaptic terminals were performed in 10 μm-thick sections using 
epifluorescence: counts of Syn-immunopositive presynaptic terminals in contact 
with OX soma, and analyses of the diurnal fluctuation of their excitatory or 
inhibitory phenotype (Table 3.1). The other material (Table 3.1) was analyzed in 
bright-field light microscopy. Quantitative analyses were performed blindly of the 
experimental group assignment, and in all animals of each group. 
The method used by Cristino et al. (2013), further validated by Laperchia et al. 
(2017), was followed to determine the mean number of presynaptic (Syn+) terminals 
apposed to OX cell bodies, and the colocalization of Syn+/VGluT2+ and 
Syn+/VGAT+ in these terminals. Briefly, triple immunostained sections were 
observed with a DMI6000 (Leica, Manheim, Germany) microscope equipped with 
an x–y–z motorized stage, a digital camera Leica DFC 340FX, and the Leica 
Metamorph imaging software (Leica Meta-Morph AF, Manheim, Germany). 
Multichannel images were acquired and analyzed using the Leica Application Suite 
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(LAS) AF 2.2.0 software. OX cell bodies were randomly sampled from 3 to 5 
sections through the perifornical area, where these cells are densely distributed, 
using the fornix as landmark.  
For the analysis of the number of presynaptic terminals per OX soma (based on Syn 
and OX immunostaining), animals sacrificed at the day time point were used. The 
study of excitatory and inhibitory terminals (VGlut2 or VGAT, each colocalized 
with Syn) was pursued in pairs of sections, and in animals sacrificed at two time 
points in antiphase (Table 3.1; Laperchia et al. 2017). Sixty OX cells, sampled 
through the full extent of the nucleus, were used in each animal for these analyses 
(Syn immunolabeling on OX soma, or vesicular transporter + Syn immunolabeling 
on OX soma). Four images per cell in serial Z planes (1.6 mm step size) were 
acquired. Images were deconvolved using the Metamorph imaging deconvolution 
software by application of ten iterations. Terminals were examined in single optical 
slices and considered as appositions to cell bodies when overlap among the 
elements was evident upon full rotation of the images. Counts of appositions were 
performed with a semi-automated method using the Metamorph Imaging 
Investigator software. 
Furthermore, as shown in Table 3.1, 15 month-old WT and matched Tg mice were 
used for counts of OX cells and densitometric analyses of OX immunosignal 
intensity. Unbiased stereological counts of OX-immunoreactive neurons were done 
with an Olympus BX63 microscope connected to a digital camera and equipped 
with the Neurolucida microstereo-investigator software with an optical fractionator 
work flow (MBF Bioscience, Williston, VT USA). The densitometric analysis of 
immunosignal intensity of OX-immunoreactive cells was performed using the same 
Olimpus microscope and the Image Pro Plus 7.0 software (Media Cybernetics, 
Silver Spring, MD, USA). OX neurons were sampled throughout the rostrocaudal 
extent of the LH, in sections regularly spaced (at 125 μm intervals), as done in 
previous studies (King et al. 2002; Nair-Roberts et al. 2008; Palomba et al. 2015a). 
3.2.4 Amyloid-β deposition and glia immunophenotyping 
Tg mice and matched WT mice of different age groups were used for this part of 
the study (Table 3.1). Brain sections were processed for the visualization of Aβ 
plaques, microglia and astrocytes. Information on the antibodies used for the 
immunohistochemistry procedures is presented in Table 3.2. Briefly, sections were 
first reacted in 0.3% H2O2 (MallincKrodt Baker Inc., Deventer, The Netherlands) 
in PBS for 20 min for inactivation of the endogenous peroxidase activity, and then 
washed 3 x 5 min. Sections were then preincubated in a blocking solution 
containing 0.3% Triton X-100 and 3% normal goat serum (NGS) in PBS, for 1 hr 
at room temperature. The incubation in the primary antibodies (Table 3.2) diluted 
in preincubation solution was performed overnight at 4◦C. The following day, 
sections were rinsed 3 x 5 min and incubated for 2 h in the appropriate secondary 
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antibodies: biotinylated goat anti-rabbit and goat anti-rat secondary antibodies 
(Vector Labs, Burlingame, CA, USA), respectively, diluted 1:200 in 1% NGS. The 
sections were then reacted in avidin-biotin-peroxidase solution (ABC kit, 
Vectastain, Vector Labs) for 30 min, followed by 3 x 5 min rinses in PBS. 
Visualization of the reaction products was achieved with a chromogenic solution of 
3,3'-diaminobenzidine. The stained sections were dehydrated in graded alcohols, 
cleared in xylene, mounted on gelatinized glass slides and allowed to air dry 
overnight. They were then coverslipped with the water free-mounting medium 
Entellan. 
3.3 Statistical analyses 
The data were statistically evaluated by two-way analysis of variance (ANOVA) 
followed by Bonferroni post-hoc testing to compare the mean number of synaptic 
varicosities apposed to OX soma at each time point using Graph pad Prism 5 System 
(San Diego, CA). Multivariate ANOVA (MANOVA) was used to determine the 
statistical interaction between the number of excitatory and inhibitory inputs in the 
day/night groups (IBM SPSS software; Chicago, IL, USA). The Student’s t-test was 
used to analyze the data generated from OX cell counts and densitometric 
evaluation. In all statistical analyses, significance threshold was set at p<0.05. 
3.4 Results 
3.4.1 Triple immunofluorescence of orexinergic neurons and 
glutamatergic or GABAergic presynaptic terminals  
In adult mice sampled at day or night, triple immunofluorescence resulted in the 
effective visualization, in confocal microscopy, of OX-immunopositive cell bodies 
together with Syn immunosignal and VGluT2 or VGAT immunosignal (Fig. 3.2). 
At the observation, the intensity of immunofluorescence of OX+ somata appeared 
higher at night than at day. To achieve uniformity in the observation, a threshold 
for OX signal saturation was used in both conditions (Fig. 3.2).  
Syn+, VGluT2+ and VGAT+ elements were seen throughout the neuropil in both the 
day and night groups (Fig. 3.2). In the merged images, triple immunolabeling 
allowed the visualization of Syn+VGluT2+ (Fig. 3.2c,i) and Syn+VGAT+ (Fig. 
3.2f,l) presynaptic terminals in contact with the membrane of OX+ cell bodies, with 
a dense perisomatic distribution. A dense distribution was also observed around 
OX-immunonegative somata intermingled with OX-immunopositive ones. 
Furthermore, it could be observed that very few presynaptic (Syn+) elements in 
apposition to OX-immunopositive cell bodies did not show VGlut2 or VGAT 
immunolabelling. 
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Fig. 3.2: Confocal microscopy images of triple immunofluorescence at daytime 
(Zeitgeber time, ZT, 3-4) and night (ZT 15-16). Neurons containing orexin-A (OX) are 
in blue. Excitatory (vesicular glutamate transporter, VGluT2 -immunopositive) or 
inhibitory (vesicular GABA transporter, VGAT -immunopositive) elements are in green 
(left column). Synaptophysin (Syn) immunopositivity is in red (middle column). Merged 
images (right column) show Syn+/VGlut2+ or Syn+/VGAT+ terminals in apposition to 
OX neuron membrane, or surrounding OX-immunonegative cell bodies. Scale bar: 20 
μm. (Images collected in collaboration with Dr. Claudia Laperchia). 
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3.4.2 Quantitative analyses of the input to orexinergic cell bodies 
The evaluation of the mean number of presynaptic terminals in apposition to OX 
somata (Fig. 3.3) showed highly significant age- and genotype-dependent 
variations. Concerning age, about 38% loss was documented in the aged (20 month-
old) WT mice vs young (3 month-old) ones, and this reduction was more marked 
(about 48%) when evaluated between young and aged Tg mice. In the comparison 
between genotypes, very striking was the reduction of the input in the Tg mice of 
both age groups with respect to the matched WT groups, with a decrease to about 
half (about 48%) in the young Tg mice with respect to the young WT ones. Such 
reduction was about 57% in the aged Tg mice vs the aged WT ones (Fig. 3.3). 
 
 
 
Fig. 3.3: Quantitative evaluation of presynaptic terminals (synaptophysin-
immunopositive, Syn+) in apposition to cell bodies containing orexin-A (OX) from 
transgenic (Tg) TASTPM mice of two age groups (3 months and 20 months) and 
matched wild-type (WT) mice. The animals were sampled during the light period. 
**p<0.01, ***p<0.001, one way ANOVA with Bonferroni post hoc test. 
 
  
98 
 
 
In all experimental groups, the mean total number of presynaptic (Syn+) terminals 
per OX soma during day and night was not significantly different (Figs. 3.4, 3.5) (3 
month-old WT mice: 20.30 ± 1.13 at daytime, 18.50 ± 0.79 at night; 20 month-old 
WT mice: 12.60 ± 0.91 at daytime, 12.90 ± 0.49 at night; 3 month-old Tg mice: 
10.50 ± 0.36 at daytime; 20 month-old Tg mice: 5.45 ± 0.22 at daytime, 5.51 ± 0.10 
at night). This indicated that at both ages and in both genotypes the overall input to 
OX somata remained quantitatively stable, not showing diurnal fluctuations. 
As mentioned above, pairs of 10-µm-thick sections were used for the evaluation of 
neurotransmitter transporter-characterized input to OX cell bodies. A prevalence of 
glutamatergic (Syn+/VGluT2+) terminals was found in the young WT mice sampled 
at night (mean number of appositions per OX cell body: 12.80 ± 0.79) vs those 
sampled at day (4.90 ± 0.55) (Fig. 3.4a). A prevalence of GABAergic 
(Syn+/VGAT+) terminals per OX soma was documented in the young animals 
sampled during daytime (mean: 14.20 ± 0.83) vs night (5.66 ± 0.44) (Fig. 3.4a). 
This resulted in a ratio of VGluT2/VGAT terminals of about 3:1 in the young mice 
sampled at night, and about 1:3 in those sampled at daytime.  
In terms of relative proportion of Syn+ varicosities per OX soma, in young WT mice 
the data indicated that VGluT2+ elements accounted for 25.50 ± 2.94% and VGAT+ 
elements for 74.50 ± 2.94% at daytime, whereas VGluT2+ elements accounted for 
69.00 ± 5.04% and VGAT+ elements for 31.00 ± 5.04% at night. The results were 
very consistent across the young WT mice (Fig. 3.4b). The statistical analysis 
showed that the above differences were highly significant: MANOVA showed a 
significant multivariate main effect for the time of sacrifice (Wilk’s λ = 0.027; 
F(2,3) = 53.526; p=0.005, partial ղ2 = 0.973; power to detect the effect: α = 0.05). 
The prevalence of glutamatergic (Syn+/ VGluT2+) terminals found at night in the 
young animals was drastically dampened in the aged WT mice at night (mean 
number of excitatory appositions per OX cell body: 4.55 ± 0.34) vs day (2.74 ± 
0.09), (Fig. 3.4c). In the evaluation of GABAergic (Syn+/VGAT+) terminals in the 
aged WT animals, similar numbers were found at the two time points (9.46 ± 0.64 
day; 8.02 ± 0.80 night) (Fig. 3.4c). The findings were consistent across the aged 
WT mice (Fig. 3.4d). The statistical analysis showed that these differences were not 
significant (MANOVA: main effect for the time of sacrifice was not significant; 
Wilk’s λ = 0.065; F(2,3) = 7.339; p=0.070, partial ղ2 = 0.830; power to detect the 
effect: α = 0.05). 
Thus, in the evaluation of excitatory and inhibitory terminals in aged WT mice the 
findings resulted in a ratio of VGluT2/VGAT terminals per OX soma of 1.0:1.7 at 
night, and 1.0:3.4 at daytime. In terms of relative proportion of Syn+ terminals per 
OX soma, the data indicated that VGluT2+ elements accounted for 22.50 ± 2.28% 
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and VGAT+ elements for 77.50 ± 2.28% at daytime, whereas VGluT2+ elements 
accounted for 36.44 ± 6.56% and VGAT+ elements for 63.56 ± 6.56% at night. 
Therefore, in aged WT mice inhibitory (VGAT+) terminals were relatively more 
prevalent over excitatory (VGluT2+) terminals at both day and night, without a 
significant diurnal fluctuation.  
 
 
 
Fig. 3.4: Quantitative analyses of excitatory and inhibitory varicosities in contact with cell bodies 
containing orexin-A (OX) in the sampled light and dark periods in young adult (3 months, M, of age; 
a,b) and aged (20 M; c,d) wild-type (WT mice. a,c: Mean number (±SEM) of excitatory 
(VGluT2+/Syn+) or inhibitory (VGAT+/Syn+) terminals (n = 60 cells per mouse; n = 3 mice per 
group). ***p<0.001, ns, not significant; multivariate analysis of variance (MANOVA), F = 2,3. b,d 
Scatter plots of the mean number of excitatory and inhibitory varicosities per OX soma in each of 
the animals. Note that the individual data sets are very consistent across animals. 
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The same analyses showed interesting findings also in TASTPM mice. In the young 
Tg mice, a prevalence of glutamatergic (Syn+/VGluT2+) terminals was found in the 
animals sampled at night (mean number of appositions per OX cell body: 5.52 ± 
0.31) vs those sampled at day (3.04 ± 0.25) (Fig. 3.5a). A prevalence of GABAergic 
(Syn+/VGAT+) terminals per OX soma was documented in the mice sampled during 
day (6.07 ± 0.45) vs night (2.96 ± 0.28) (Fig. 3.5a). The statistical analysis showed 
that the above differences were significant (MANOVA: significant multivariate 
main effect for the time of sacrifice (Wilk’s λ = 0.122; F(2,3) = 10.800; p=0.043, 
partial ղ2 = 0.878; power to detect the effect: α = 0.05). Thus, the diurnal fluctuation 
documented in young WT mice was replicated in the matched Tg mice.  
The ratio between excitatory and inhibitory terminals was, however, different in 
young Tg mice with respect to young WT ones, due to the overall decrease of the 
number of terminals in Tg mice. The ratio of VGluT2/ VGAT terminals per OX 
soma was about 2:1 in young Tg mice sacrificed at night, and about 1:2 in those 
sacrificed during the day. In terms of relative proportion of Syn+ terminals per OX 
soma, the data indicated that in young Tg mice VGluT2+ elements accounted for 
34.16 ± 5.89% and VGAT+ elements for 65.84 ± 5.89% at daytime, whereas 
VGluT2+ elements accounted for 66.23 ± 0.76% and VGAT+ elements for 33.77 ± 
0.76% at night. The results were very consistent across the animals (Fig. 3.5b).  
In the aged Tg mice (Fig. 3.5c), the mean number of glutamatergic (Syn+/ VGluT2+) 
terminals in the animals sampled at night (2.48 ± 0.25) was very similar to that 
documented at daytime (2.59 ± 0.25). Also the mean number of GABAergic (Syn+/ 
VGAT+) terminals was similar at night (2.29 ± 0.28) and day (2.40 ± 0.13). The 
statistical analysis confirmed that these differences were not significant 
(MANOVA: multivariate main effect for the time of sacrifice was not significant 
(Wilk’s λ = 0.170; F(2,3) = 0.429; p=0.686, partial ղ2 = 0.222; power to detect the 
effect: α = 0.05). 
Therefore, in the aged Tg mice, the ratio of VGluT2/ VGAT terminals was equal 
(about 1:1) at both the sampled time points. The relative proportion of excitatory 
and inhibitory terminals was also about equal at day and night: VGluT2+ elements 
accounted for 51.74 ± 1.89% of Syn+ terminals and VGAT+ elements for 48.26 ± 
1.89% at daytime, while VGluT2+ elements accounted for 52.07 ± 1.60% and 
VGAT+ elements for 47.93 ± 1.60% at night. The results were very consistent 
across animals also in the aged Tg group (Fig. 3.5d).  
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Fig. 3.5: Quantitative analyses, as in Fig. 3.4, in transgenic TASTPM mice of two age groups (n = 60 
cells per mouse; n = 3 mice per group). ***p<0.001, ns, not significant; multivariate analysis of 
variance (MANOVA), F = 2,3. b,d Scatter plots of the mean number of excitatory and inhibitory 
terminals per OX-A soma in each of the animals. Note that the individual data sets are very consistent 
across the transgenic animals. 
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3.4.3 Orexinergic cell counts and immunosignal intensity 
The observation of OX neuron immunoreactivity in 15 month-old Tg mice 
(sampled during daytime) showed marked alterations with respect to matched WT 
mice. OX neurons appeared sparser in Tg mice than in WT ones at low power 
observation (Fig. 3.6A,B). A marked reduction of immunostained dendritic 
arborizations (Fig. 3.6C,D) and shrinkage of some OX neurons, though with intense 
immunoreactivity of cell bodies (Figs. 3.6D, 3.7B) were seen in the Tg mice.  
 
 
Fig. 3.6: Immunoreactivity of neurons containing orexin-A in a wild-type (WT) mouse 
(A,C) matched with a transgenic (Tg) TASTPM mouse (B,D) of 15 months of age 
(sampled in the light phase); fx indicates fornix. Note in the Tg mouse the decreased 
density of immunoreactive neurons, the shrinkage of intensely immunostained cell 
bodies, the swelling of proximal dendrites with a limited extent of dendritic 
immunoreactivity. Scale bars: 50 μm in A (and B), 20 μm in C (and D). 
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The stereological cell counts indicated a significant loss (34%) of OX-
immunoreactive neurons in Tg mice vs matched WT ones (Fig. 3.7C). The 
evaluation of OX neuron immunosignal intensity by densitometric analysis 
confirmed that the immunostaining was significantly enhanced in the Tg mice with 
respect to the WT ones (Fig. 3.7D). 
 
 
Fig. 3.7: A,B: Immunoreactivity of neurons containing orexin-A (OX) in a wild-type 
(WT) mouse (A) matched with a transgenic (Tg) TASTPM mouse (B) of 15 months of 
age (sampled during the light phase). Note in B the features shown also in Fig. 3.6B,D, 
and in particular the intense immunostaining. Scale bar: 20 μm. C,D: quantitative 
analyses. The bar graphs in C illustrate the results of stereological counts of orexinergic 
(OX+) neurons in 15 month (m)-old WT and Tg mice. Note the significant reduction in 
the number of orexinergic neurons in the Tg mice (ROI, region of interest). The bar 
graphs in D illustrate the results of the densitometric analysis (OD, optical units). Note 
the significant increase of immunosignal intensity in the Tg mice. *p<0.05, Student’s t-
test. 
 
3.4.4 Neuropathological features of TASTPM mice  
Deposition of Aβ and immunophenotyping of microglia and astrocytes were 
investigated in TASTPM mice of different age groups (Table 3.1). Aβ aggregates 
were found in many brain regions of the 15 month-old TASTPM mice (Fig. 3.8B-
104 
 
D). A progression of Aβ plaque load was found in the frontal and parietal cortices 
and hippocampal CA1 with increasing age. Aβ plaque deposits were 20-100 μm in 
diameter, mostly round-shaped and well demarcated, with marked intense 
immunostaining and a central core in the thalamus, while in the neocortex and 
hippocampus the Aβ deposits were weakly demarcated and irregularly shaped (Fig. 
3.8B-D). Aβ plaques were relatively sparse in the hypothalamus, with a low 
intensity diffuse plaque phenotype. 
 
 
Fig. 3.8: Amyloid β plaque (visualized by amyloid precursor protein immunoreactivity) 
deposition in the neocortex (B), hippocampus (C) and thalamus (D) of 15 month-old 
TASTPM mice. No plaque deposits were seen in the cortex of an age-matched wild-type 
mouse (A). Scale bar: 50 μm. 
 
GFAP immunoreactivity showed changes also in the astrocyte phenotype in the 
brain of Tg mice (Fig. 3.9B-D). Astrocytes were especially prominent around Aβ 
plaques (Fig. 3.9B,C). There was a generalized hypertrophy of the astrocytes (Fig. 
3.9B-D), with increased reactivity which correlated with the amyloid plaque load. 
As shown in Fig. 3.9B, the diffuse Aβ deposits in the hippocampus were surrounded 
by astrocytes and astrocytes not associated to plaques were also present. The core 
of neuritic plaques in the thalamus was bordered and surrounded by astrocytes, 
which were also present in the damaged tissue halo (Fig. 3.9C). The astroglia 
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profiles in the hypothalamus appeared relative different, with shrinkage of cell 
bodies and prominent stout processes (Fig. 3.9D). 
 
 
 
Fig. 3.9: Glial fibrillary acidic protein (GFAP) immunoreactivity in different brain 
regions of wild-type (A) and transgenic (Tg) TASTPM (B-D) mice of 15 months. 
Astrocyte immunolabeling shows marked cell hypertrophy in the hippocampus (B), 
thalamus (C) and hypothalamus (D) of Tg mice. Scale bar: 50 μm. 
 
Ramified microglial cells, stained by CD11b immunoreactivity, were observed in 
the WT mice (Fig. 3.10A), but appeared hypertrophic, intensely immunostained and 
clustered especially around plaque deposits, delineating them in the age-matched 
Tg mice (Fig. 3.10B-D). All these features were very prominent in the thalamus of 
Tg mice, where tissue damage by Aβ plaques was especially marked, with 
hypertrophic bushy and amoeboid microglial cells scavenging the damaged tissue 
halo (Fig. 3.10C). Microglia with hypertrophic cell bodies and thick stout processes 
were prominent also in the hypothalamus of the Tg mice (Fig. 3.10D). 
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Fig. 3.10: Microglia immunophenotyping (CD11b immunoreactivity) in different brain 
regions of wild-type (WT) and transgenic (Tg) TASTPM mice of 15 months of age. 
Ramified microglial cells were observed in WT mice (hippocampus in A). Note the 
bushy aspect of microglial cells and their clustering (indicative of activation) in Tg mice 
in the hippocampus (B), thalamus (C) and hypothalamus (D). The inset in D shows at 
higher magnification the area indicated by the asterisk. Note in B-D the hypertrophy and 
increased immunostaining intensity of microglial cells. Note also the marked clustering 
around plaque deposits, especially in the thalamus (C), in the Tg mice. Scale bar: 50 μm. 
 
3.5 Discussion  
The main findings of the present study revealed alterations of the wiring of OX cell 
bodies during aging as well as murine AD.  
The data on the balance between excitatory and inhibitory terminals in contact with 
OX cell bodies at day and night showed in the young WT mice a switch from a 
prevalent excitatory innervation during the period of predominant activity and wake 
of the animals to a prevalent inhibitory innervation during the period of 
predominant rest and sleep, consistently with our previous study (Chapter 2; 
Laperchia et al. 2017). Interestingly, the present investigation showed that such 
diurnal fluctuation was lost in the aged WT animals. The statistical power might 
have been influenced by the limited sample size. However, the present analyses also 
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showed that in the aged WT mice the input to OX cell bodies was predominantly 
inhibitory at both time points. 
The same analyses in the AD murine model provided by TASTPM mice showed 
that the diurnal fluctuation was maintained in the young Tg animals and lost in the 
aged ones, in which the trend towards a prevalent inhibitory innervation, 
documented in the aged WT mice, was also lost, configurating a similar 
organization during both day and night.  
The use of multiple presynaptic labeling strategy in epifluorescence for the 
visualization of excitatory and inhibitory synaptic boutons on OX somata here 
adopted has been previously validated at the ultrastructural level (Horvath and Gao 
2005; Cristino et al. 2013), and with the use of presynaptic markers combined with 
postsynaptic scaffold proteins (Laperchia et al. 2017). 
Previous reports of alterations in the orexinergic system during aging in rats and 
other species have documented a decrease in the OX innervation of target regions 
(Downs et al. 2007), as well as in the expression of OX or OXRs in rodents (Terao 
et al. 2002; Porkka-Heiskanen et al. 2004), and alterations in the pattern of OX 
release across the diurnal cycle (Desarnaud et al. 2004) (see 1.3.1). Of note, the 
physiological aging process affects the number of OX-immunoreactive neurons, 
with an overall decrease of about 25% from infancy to older age in humans (Hunt 
et al. 2015b), and aging-related decreases in rodents (Porkka-Heiskanen et al. 2004; 
Sawai et al. 2010; Kessler et al. 2011) (see 1.3.1).  
The present study adds to such previous findings a decline in the density of the 
innervation of OX cell bodies, with a 38% reduction in the number of presynaptic 
terminals in the aged WT mice compared to the young ones. Though the density of 
the innervation of OX neuron dendrites remains to be investigated, such finding 
suggests that the afferent control of OX neurons varies considerably with aging. 
Aging-related changes in OX neuron regulation are also strengthened by the present 
observation of a prevalent inhibitory input to OX cell bodies during both day and 
night. The absence in the aged WT mice of the fluctuation documented in young 
WT mice could be involved in weakened sleep-wake stability and changes in 
energy homeostasis during aging (see 1.3.1).    
Concerning the AD model provided by TASTPM mice, our data point out sleep-
wake alterations (Colavito et al. 2014; Fig. 3.1). Normal sleep/wake cycle has been 
described in the double mutant (APPswe/PS1dE9) mouse model of AD, with a 
normal diurnal fluctuation of interstitial fluid (ISF) Aβ prior to Aβ plaque 
formation. However, increase in amyloid plaque deposition has been reported to 
represent a factor in sleep-wake cycle deterioration and diurnal fluctuation of ISF 
Aβ alterations (Roh et al. 2012) (see 1.3.1). 
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The present findings point out a marked decrease of OX axosomatic innervation in 
TASTPM mice. Synaptic loss is a key feature of neocortical and hippocampal 
pathology in AD (Davies et al. 1987; Scheff and Price 2003). Loss of the 
presynaptic terminal marker Syn has been reported in many APP Tg mouse lines 
(Games et al. 1995; Hsia et al. 1999; Richardson et al. 2003; Rutten et al. 2005). In 
single mutant PDAPP mice, synaptotoxicity has been reported prior to plaque 
formation (Mucke et al. 2000). The present results are, however, the first 
documenting synaptic loss at hypothalamic levels in murine AD pathology, and the 
data here obtained in TASTPM mice point to a vulnerability of the orexinergic 
synaptic network since the early phases of the AD pathological process.  
The present cell counts revealed a significant loss (34%) of OX neurons in 
TASTPM mice. Such loss could indicate, as in the data related to physiological 
aging, cell death and/or decrease of peptide production below the threshold for 
immunohistochemical visualization. The upregulation of immunosignal intensity of 
OX neurons in the Tg mice could, on the other hand, indicate a compensatory 
production of the peptide by OX neurons in response to immunostained neuron loss. 
Compensatory release of OX has also been hypothesized for the maintenance of 
OX-A level in the CSF after partial destruction of OX neurons in rats 
(Gerashchenko et al. 2003). 
Concerning the neuropathological features of TASTPM mice, the present data have 
shown an age-related increase of Aβ plaque load in the sampled neocortical regions 
and hippocampal CA1 field which is in agreement with previous data on a 
progression of Aβ deposition throughout the animal’s life, accompanied by reactive 
astrocytosis and phosphotau accumulation (Howlett et al. 2008). Aβ plaque 
formation in TASTPM mice follows a temporal series of events, with plaque load 
correlating positively with neuroinflammation (Howlett et al. 2004). Their genetic 
promoters (APPxPS1 genes) drive the formation of Aβ plaques, first beginning in 
the cortex and hippocampus, before spreading to other regions of the brain. Besides 
the extracellular deposits represented by Aβ plaques, we here observed 
intraneuronal deposits especially in the neocortex and in the pyramidal cell layer of 
the hippocampus. In line with the present observations is the previous report of a 
close association of activated astrocytes with amyloid plaque deposits (Matsuoka 
et al. 2001), which, in our material, was especially evident in the thalamus. In 
TASTPM mice, astrocytes have been reported to infiltrate the cell layers of the 
dentate gyrus (Howlett et al. 2008), similarly to the present observation of astrocytic 
infiltrates in the hippocampal CA1 field. 
A marked clustering of microglia was here observed around Aβ plaque deposits, 
especially in the thalamus, consistently with previous reports in which microglia 
appeared closely apposed to plaque deposits in AD (Mandrekar-Colucci and 
Landreth 2010), and concentrated around plaque deposits in murine models 
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(Balducci and Forloni 2011). A previous study in aged (20 month-old) TASTPM 
mice has reported a highly enhanced expression of the microglial protein Iba-1 in 
contrast with relatively mild enhancement in CD11b immunolabelling (Howlett et 
al. 2008). It has been suggested that microglial cells in the vicinity of Aβ plaques 
are undergoing degenerative processes (Howlett et al. 2008). 
Overall these results provide for the first time evidence of physiological aging-
related changes and AD pathology-related alterations in diurnal, state-dependent 
organization of the input that regulates the orexinergic network. 
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3.6 Tables 
 
Table 3.1 Experimental design and material 
 
Genotype Age/ Number Purpose/s of the study 
WT 5 m 
n=3 day; 3 night 
Observation of triple immunofluorescent 
labeling in confocal microscopy (30 μm-thick 
sections) 
Quantitative analyses: day/night sampling (10 μm-thick sections)  
WT 3 m 
n=3 day; 3 night  
- Counts of Syn+ terminals on OX somata 
compared to young TASTPM mice 
- Diurnal fluctuation of excitatory and 
inhibitory terminals on OX somata compared 
to young TASTPM mice 
WT 20 m 
n=3 day; 3 night  
- Counts of Syn+ terminals on OX somata in 
aging and comparison with aged TASTPM 
- Diurnal fluctuation of excitatory and 
inhibitory terminals on OX somata in aging 
and comparison with aged TASTPM  
TASTPM  3 m 
n=3 day; 3 night  
- Counts of Syn+ terminals on OX somata in 
young AD mice 
- Diurnal fluctuation of excitatory and 
inhibitory terminals in young AD mice 
TASTPM 20 m 
n=3 day; 3 night  
- Counts of Syn+ terminals on OX somata in 
aged AD mice 
- Diurnal fluctuation of excitatory and 
inhibitory terminals on OX somata in aged AD 
mice 
Quantitative analyses: OX neurons 
TASTPM 
 
 
WT 
n=4; 15 m 
(daytime) 
 
" 
- OX cell counts and analysis of immunosignal 
intensity in murine AD (30 μm-thick sections) 
 
- Matched controls  
Neuropathological analyses 
TASTPM 
 
WT 
n=4; 15 m 
 
" 
- A deposition and immunophenotyping of 
astrocytes  
- Matched controls 
TASTPM 
 
 
WT 
n=4 per age 
group; 9 m, 14 
m, 15 m 
" 
- Microglia immunophenotyping 
 
 
- Matched controls  
 
Abbreviations Table 3.1: A, -amyloid; AD, Alzheimer's disease; m, months; 
OX, orexin-Syn, synaptophysin; WT, wild-type; OD, optical density 
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Table 3.2 Antibodies used in this study 
Antigen Host Immunogen Supplier Catalog
# 
Dilution References 
Orexin-
A 
Goat Purified goat 
polyclonal antibody 
raised against 
peptide at the C-
terminus of Orexin-
A of human origin 
Santa Cruz sc-8070 1:100 Blanco- 
Centurion 
et al. 
(2013) 
VGluT2 Guinea pig Purified recombinant 
protein of rat 
VGluT2 (aa510-582) 
Synaptic 
Systems 
135 404 1:100 Perederiy et 
al. (2013) 
VGAT Guinea pig Strep-Tag fusion 
protein of rat VGAT 
(aa2-115) 
Synaptic 
Systems 
131 004 1:100 Fekete et al. 
(2015) 
Synapto 
physin 1 
Rabbit Synthetic peptide 
GPQGAPTSFSNQ
M (aa 301 - 313 in 
human 
synaptophysin 1 
coupled to key-hole 
limpet hemocyanin 
via an added N-
terminal cysteine 
residue 
Synaptic 
Systems 
101 002 1:200 Wimmer et 
al. (2006) 
β-APP Rabbit 22 amino acid 
synthetic peptide 
derived from the C-
terminus of the 
human β-APP 
Invitrogen 
Corps 
51-2700 1:1000 Stone et al. 
(2000) 
CD11b Rat Thioglycollate-
elicited peritoneal 
macrophages (TPM) 
Serotec MCA711 1:500 Sato et al. 
(2012) 
GFAP Rabbit Purified bovine 
GFAP 
Merck AB5804 1:500 Perriard et 
al. (2015) 
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4. Extracellular matrix in the lateral hypothalamus and 
other brain regions: diurnal organization in basal 
conditions and in experimental sleeping sickness 
 
4.1 Introduction 
Knowledge acquired on the ECM in the CNS (see 1.4) has highlighted that brain 
plasticity is not only dependent on neurons and glial cells, but also on what 
surrounds them (Sorg et al. 2016). Diverse molecules, secreted by neurons and non-
neuronal cells, accumulate in the extracellular space and form the ECM, which 
accounts for 10-20% of the brain volume (Nicholson and Sykova 1998) (see 1.4). 
These molecules, their receptors and remodeling proteases regulate the induction 
and maintenance of synaptic modifications (Wlodarczyk et al. 2011). 
The advances in the understanding of the ECM have led to the progression from 
atripartite view of synaptic organization (in which perisynaptic astrocytes have 
been involved in bipartite synaptic mechanisms of pre- and postsynaptic elements) 
(Araque et al. 1999) to a tetrapartite view in which the ECM has also been involved 
(Dityatev et al. 2006, 2010; Dityatev and Rusakov 2011; Verkhratsky and 
Nedergaard, 2014), besides a possible involvement also of microglia (Verkhratsky 
and Nedergaard 2014) (Fig. 1.11). 
As dealt with previously (see 1.4), the ECM in the CNS is organized according to 
three main patterns: 1) the ‘loose’ ECM, present throughout the brain and spinal 
cord, 2) membrane-bound molecules, and 3) lattice-like structures that wrap the 
soma and dendrites of neuron subtypes in the brain and spinal cord, known as 
PNNs; these structures interdigitate with synaptic contacts on neuronal soma and 
proximal dendrites (Celio et al. 1998; Deepa et al. 2006; Soleman et al. 2013). 
Of the ECM structures, PNNs are the most widely studied so far (see: 1.4.1). They 
are highly heterogeneous because of the variety of glycosaminoglycan chains 
(hyaluronans) attached to the core proteins (chondroitin sulfate proteoglycans), TN-
R and linked proteins (see 1.4.1). On one hand, PNNs may play a beneficial role by 
stabilizing the extracellular milieu and protecting enveloped neurons; on the other 
hand, PNNs may create a barrier which limits plasticity and counteracts 
regeneration (Karetko and Skangiel-Kramska 2009). Little attention has been 
devoted instead the loose interstitial ECM within the CNS. 
In particular, information on the ECM organization in the hypothalamus is 
relatively limited. Two main patterns of organization have been reported in the 
CSPG-based ECM in different hypothalamic regions (grossly subdivided by the 
location of the fornix): a lateral zone in which the ECM is mainly organized in 
PNNs, and a medial zone in which PNNs are relatively loose PNN or the ECM is 
not organized in PNNs (Horii-Hayashi et al. 2017). These observations have been 
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based on differences in histochemical reactivity to Wisteria floribunda agglutinin 
(WFA) (Horii-Hayashi et al. 2017). This lectin binds glycoprotein residues (N-
acetyl-D-galactosamine) in carbohydrates (e.g. Seeger et al. 1996) and is a widely 
used marker of ECM in the CNS (Brückner et al. 1996), and in particular of 
chondroitin sulfates. WFA labeling has become a standard method for identifying 
CSPGs-containing elements in the CNS (Ajmo et al. 2008). 
The finding of a day/night reorganization of synapses onto OX neuron somata (see 
Chapter 2) opens key questions on the regulation of plasticity in the neural network 
of the LH. As the ECM is one of the key components involved in neural plasticity, 
the present study was aimed at testing the hypothesis that the diurnal remodeling of 
the synaptic wiring of OX cell bodies could involve the ECM. The study was based 
on double immunofluorescence of WFA and OX neurons in the LH. Furthermore, 
Western blotting analysis was done to quantify the levels of WFA expression in 
tissue extracts of the LH. 
Since the data on the LH revealed a diurnal fluctuation of ECM organization, other 
brain areas were also examined, namely the SCN, the master circadian pacemaker 
located in the anterior hypothalamus (see 1.1.4), the neocortex and the 
hippocampus.  
On the basis of the findings obtained in the LH of healthy mice, the present study 
was extended at verifying a second hypothesis, i.e. that the day/night features of 
ECM organization in the LH could be affected in a murine model of African 
trypanosomiasis. 
The extracellular parasite Trypanosoma brucei (T. b.) is the causative agent of 
human African trypanosomiasis (HAT), also called sleeping sickness. The parasite 
subspecies T. b. gambiense and T. b. rhodensiense cause two different forms of 
HAT (Büscher et al. 2017). A third subspecies, T. b. brucei (T. b. b.) is infectious 
in animals but not in humans, and is widely used in animal models of HAT 
(Kristensson et al. 2010).  
HAT is still endemic in sub-Saharan Africa, though the number of reported cases 
has considerably declined in recent years (Büscher et al. 2017). The disease evolves 
from a systemic (hemolymphatic) stage to an encephalitic stage when the  
parasites, which are able to cross the blood-brain barrier, invade the CNS 
parenchyma (Kristensson et al. 2010). The infection leads to a chronic, progressive 
neuroinflammatory condition, causing a severe neuropsychiatric  disease which is 
fatal if left untreated (Kristensson et al. 2010; Büscher et al. 2017). The clinical 
picture is dominated by sleep/wake disturbances, with disruption of the sleep/wake 
cycle leading to somnolence during the day and nocturnal insomnia, as well as 
alterations of the structure of sleep, with narcoleptic-like changes in humans and in 
animals (Kristensson et al. 2010; Seke-Etet et al., 2012; Laperchia et al. 2016). 
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A previous study in rodent models (mice and rats) of T. b. b. infection has pointed 
out a progressive damage of OX neurons as well as of MCH neurons (see 1.1.1), 
with functional dysregulation of OX neurons as revealed by alterations of the 
spontaneous day/night oscillation of Fos expression in these cells (Palomba et al. 
2015b). These findings prompted further studies on the LH in African 
trypanosomiasis, and the present investigation is, as mentioned above, focused on 
the ECM. 
4.2 Materials and methods 
4.2.1 Animals and infection 
Healthy adult (3–5 month-old) male C57BL/6J mice were maintained under a 
12/12-h dark/light or light/dark cycle, under veterinarian control and controlled 
environmental (temperature and humidity) conditions, with free access to food and 
water. The animals (n = 12) were destined for analyses with confocal microscopy, 
and Western blotting from tissue sampled from brain sections (see below) at two 
different time points in antiphase (see Chapters 2 and 3). They were therefore 
randomly divided in two groups sacrificed during a 2-h period during the day 
(Zeitgeber time, ZT, 3–4, n = 4), or night (ZT 15–16, n = 4) (ZT 0 corresponds to 
the lights-on time). 
Male CX3CR1-GFP mice (3 month-old) were used for the study of the ECM in 
African trypanosomiasis. In these mice microglial cells are GFP-tagged, via GFP 
tagging of the chemokine fractalkine receptor CX3CR expressed by microglia 
(Mizutani et al. 2012). The use of these mice for the infection paradigm was 
motivated by interest in analyses of microglia, that are being pursued in a separate 
study. These animals were kept uninfected as controls (n = 6) or infected (n= 6) by 
ip injection of T. b. b. as described by Laperchia et al. (2016). Briefly, T. b. b. AnTat 
1/1E, a pleiomorphic clone derived from stabilate EATRO (East African 
Trypanosomiasis Research Organization) 1125, supplied by the Laboratory of 
Serology, Institute of Tropical Medicine Prince Leopold, Antwerp, Belgium), were 
injected intraperitoneally (100 parasites/g body weight). Parasitaemia was assessed 
at 3 and 5 days post-infection (dpi) in a blood sample from the tail vein. The mice 
were sacrificed at 14 dpi together with the matched control mice, during day or 
night, at the same time points as above ( n =3 control and infected mice per time 
point).  
For sacrifice, the animals were deeply anaesthetized with Avertin (2, 2, 2-
tribromoethanol, Sigma-Aldrich, St Louis, MO; 0.2 ml/10 g body weight, ip) and 
transcardially perfused with cold 0.01M phosphate-buffered saline (PBS), followed 
by 4% paraformaldehyde in phosphate buffer, pH 7.6. The brains were dissected 
out, postfixed in the same fixative for 2-3 h at room temperature, and then kept in 
PBS containing sodium 0.1% azide at 4◦C until processing.  
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All procedures received approval by the Animal Care and Use Committee of the 
University of Verona (CIRSAL) and authorization by the Italian Ministry of Health, 
in strict adherence to the European Communities Council (86/609/EEC) directives 
and the ARRIVE guidelines, in accordance with the National Institute of Health 
Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23), 
minimizing the number of animals used and avoiding their suffering. 
4.2.2 Brain tissue processing and immunofluorescence 
Before sectioning, the brains were soaked in 30% sucrose in PBS for 24 h for 
cryoprotection. The brains were then cut in the coronal plane in adjacent series at a 
30 μm thickness with a freezing microtome.  
Sections through different brain structures were sampled for immunofluorescence 
processing. In each experimental group, 3 adjacent brain sections per level and per 
animal were sampled at the two anteroposterior levels through the SCN (Bregma -
0.34 to – 0.82) and the LH (Bregma -1.70 to - 2.46). Sections of the first series were 
stained with cresyl violet for cytoarchitectonic reference (http://mouse.brain-
map.org). The adjacent series were processed free-floating for multiple 
immunofluorescence. These sections were preincubated in a blocking solution of 
2% normal donkey serum (NDS) with 0.2% Triton X-100 in PBS for 1 h. The 
sections were subsequently incubated overnight at 4°C in either of the following 
primary antibodies diluted in PBS containing 1% NGS and 0.2% Triton X-100: goat 
polyclonal antibodies which recognize OX-A (Santa Cruz Biotech; diluted 1:100); 
goat polyclonal antibodies which recognize parvalbumin (PV) (PVG-214; Swantz, 
Marly 1, Switzerland; diluted 1:500) and biotinylated WFA (Sigma Aldrich; 1:200), 
was used to visualize ECM. Following incubation in primary antibody, the sections 
were thoroughly rinsed and incubated for 2 h in the following secondary antibodies; 
biotin-conjugated Alexa Fluor 488 or streptavidin-conjugated Alexa Fluor 633, 
Alexa Fluor- 405 and 568 donkey anti-goat (all from InVitrogen, Carlsbad, CA, 
USA), diluted 1:1000 in 1% NDS. The sections were then reacted with fluorescent 
nuclear marker, 4’-6’-diamino-2-phenylindole (DAPI), and then rinsed in PBS. 
Sections were mounted on gelatinized slides and coverslipped with 0.1% 
paraphenylenediamine in a glycerol-based medium (90% glycerol and 10% PBS). 
Additional sections were used for control, omitting each of the primary antibodies, 
and no specific immunostaining was observed in these sections.  
4.2.3 Microscopy and quantitative analyses 
Sections were viewed with the confocal microscope Leica SP5 (Leica, Mannheim, 
Germany) using X40 (zoom factor 1.9) or 63X (zoom factor 1.8) oil-immersion 
objective (numerical aperture 1.25). Serial Z planes (0.70 µm) images were 
captured with the LAS software, and collapsed into a single maximum projection 
image to which colours were assigned. Acquired images were minimally and 
equally modified with the Imaris software 7.4 (Bitplane, Zurich, Switzerland) for 
contrast and brightness. 
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4.2.4 Western blot 
Sections adjacent to those used for the immunofluorescence study (3 sections per 
animal) were used for the study of ECM expression by Western blotting. Proteins 
were extracted from the LH tissue sections using a previously validated technique 
(Tanca et al. 2014; Azeez et al. 2016). Protein concentration was determined using 
the PierceTM Detergent Compatible Bradford Assay (Thermo Fisher Scientific). 
Each protein extract (25 µg) was applied to two 10% nongradient sodium dodecyl 
sulfate (SDS)-gels and immunoblotted on Trans-Blot Turbo polyvinylidene 
fluoride (PVDF) transfer (BioRad Labs, Hercules, CA). The protocol of Ajmo et al. 
(2008) was followed for WFA blotting. Briefly, the blotted membrane was blocked 
in a solution in 2% bovine serum albumin (BSA) diluted in 0.1% PBS-Tween 
(PBST) for 2 h and incubated with biotinylated WFA (Sigma Aldrich; 1:500) 
overnight at 4°C. Biotinylated WFA was detected with specific secondary antibody, 
avidin conjugated to horseradish peroxidase (Sigma Aldrich, Steinheim, Germany; 
1:2000). Chemiluminescent reagent (ECL, WBLUR050, Luminata Crescendo 
Western HRP substrate, Merck) was used for visualization. 
4.3 Statistical analyses 
For Western blotting, nonsaturated data were analysed with the ImageJ software 
using the Gel Analysis method (http://rsbweb.nih.gov/ij/docs/guide/146-
30.html#toc-Subsection-30.13; Analyze 30.13 Gels). The WFA optical density 
(OD) units were expressed as mean ± SEM per group and were statistically 
evaluated with the Student’s t-test using the Graph pad Prism 5 System (San Diego, 
CA). The significance threshold was set at p<0.05. 
4.4 Results 
4.4.1 Diurnal organization of the extracellular matrix in the lateral 
hypothalamus and other regions in basal conditions  
In the field of the LH where OX neurons are distributed, and which were 
investigated in the present study, the ECM was revealed by WFA immunoreactivity 
in the neuropil, and very few PNNs were observed (Fig. 4.1A). These PNNs 
surrounded OX-immunonegative neurons (Fig. 4.1A), and were not observed 
around OX somata or dendrites.  
Dramatic differences in the organization of the ECM were seen in the LH between 
the sampled time points. WFA immunofluorescence appeared diffusely distributed 
in the neuropil during daytime, with punctate labelling in close proximity, and 
frequently apposed, to OX cell bodies and proximal dendrites (Fig. 4.1A). At night, 
WFA immunofluorescence appeared considerably increased, with a more compact 
organization and a condensation around cell bodies, both around OX-
immunopositive and OX immunonegative neurons (Fig. 4.1B,D). 
In the SCN, the ECM was not structurally organized into PNNs, and was seen to be 
diffusely distributed in the neuropil (Fig. 4.2C,D). A similar organization ws 
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observed in the major subdivisions of the SCN (i.e. the dorsomedial shell and the 
ventrolateral core). Interestingly, no overt variations were seen in the ECM 
phenotype, as revealed by WFA immunofluorescence, in the SCN (Fig. 4.2C,D). 
However, OX fibers within the SCN appeared denser and more intensely 
immunolabelled at night compared to daytime (Fig. 4.2E,F). 
In the neocortex, the ECM appeared essentially organized in PNNs, which 
surrounded the somata and proximal dendrites of PV-containing neurons (Fig. 
4.3). No overt changes in the intensity and organization of PNN 
immunofluorescence at day and night were observed (Fig. 4.3). Interestingly, 
however PV immunofluorescence was more intense at night compared to daytime 
(Fig. 4.3). 
The ECM was organized in PNNs also in the hippocampus (Fig. 4.4). As in the 
neocortex, PNNs were equally intensely labelled and structurally organized at night 
and day (Fig. 4.4). OX fibers were seen to reach the cells enwrapped by PNNs (Fig. 
4.4). 
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Fig. 4.1: Organization of the ECM, as revealed by WFA immunofluorescence in the LH 
field containing OX neurons (also visualized by immunofluorescence) in basal 
conditions. The sections are stained also with DAPI, revealing cell nuclei. Note at 
daytime (A,C) the sparse, diffuse distribution of WFA immunolabelling, with intense 
PNN labelling around an OX-immunonegative neuron, and the more compact 
organization and condensation around OX cell bodies at night (B,D). Scale bars; A-B = 
30 m, C-D = 10 m 
 
119 
 
 
120 
 
 
Fig. 4.2: ECM organization in the SCN in basal conditions revealed by WFA 
immunofluorescence (C,D) together with DAPI staining of cell nuclei (A,B), and OX 
immunofluorescence (E,F). The images include both the ventrolateral (so-called "core") 
and dorsomedial (so-called "shell") of the SCN (see 1.1.4). Note in A and B the high cell 
density typical of the SCN, in C and D the similar organization of WFA labelling at day 
and night, and in F the orexinergic network evident in the SCN at night and its dampening 
at daytime (due to a diurnal fluctuation of OX synthesis and release (see 1.1.3). Note 
also in C and D the absence of PNNs within the SCN. Scale bar = 30 m 
 
 
 
 
 
Fig. 4.3 ECM labelling WFA immunofluorescsnce in the somatosensory cortex, 
combined with parvalbumin (PV) immunofluorescence in basal conditions, and DAPI 
staining of cell nuclei. Note the abundance of PNNs around PV-immunopositive 
neurons, and note the absence of overt fluctuation of the PNN labelling between day and 
night. Note, however, a fluctuation in the PV immunosignal, which is dampened at 
daytime (A) compared to the night (B). Scale bar = 30 m 
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Fig. 4.4: ECM labelling by WFA immunofluorescence in the hippocampal CA1 field in 
basal conditions. Note the abundance of PNNs, and note that their labellig is similar 
during day (A) and night (B). Note also in many instances the close proximity to PNNs 
of orexinergic fibers. Scale bar = 20 m 
 
4.4.2 Western blot analysis 
As mentioned above, Western blotting was performed on the LH tissue extracts 
from sections in basal conditions. LH homogenates were subjected to SDS-PAGE 
and probed with biotin-WFA to identify the molecular species in mouse brain 
detected by the N-terminal region. The high molecular weight isoform of WFA 
described in detail by Ajmo et al. (2008) showed a higher expression in the animals 
sacrificed at night compared to daytime (Fig. 4.5). Quantitative analysis showed a 
significant difference in the levels of WFA expression at the two time points (Fig. 
4.5). 
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Fig. 4.5: Western blotting of the WFA protein expression in the LH. Top: gel blots from 
mice sacrificed during day (Zeitgeber time, ZT, 3-4) and night (ZT15-16) (n=4 per time 
point). Bottom: Quantitative analysis of WFA expression (OD, optical density) shows a 
significant difference with higher levels of expression at the night time point compared 
to the day. **P<0.01, Student’s t-test. 
 
 
4.4.3 Diurnal organization of the extracellular matrix in the lateral 
hypothalamus of Trypanosoma brucei brucei-infected animals 
ECM organization was investigated in the LH of CX3CR1-GFP mice infected with 
T. b. b. sampled during day and night, and compared with uninfected controls. The 
observations showed that the CX3CR1-GFP mice sacrificed in basal conditions 
replicated the observations from the C57BL/6J mice, i.e., a diffuse ECM phenotype 
was observed during daytime while a condensed ECM was observed at night (Fig. 
4.6A.B). Interestingly, there were instead no overt differences in the intensity of 
ECM immunofluorescence between day and night in the T. b. b.-infected mice 
((Fig. 4.6C.D). Thus, a diffuse, punctate ECM phenotype was observed at both the 
sampled time points in the infected mice (Fig. 4.6C,D). PNNs around OX-
immunonegative neurons were observed in the LH of infected and controld mice 
(Fig. 4.6A-D), as observed in the C57BL/6J counterparts. 
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Fig. 4.6: ECM organization in the LH field containing OX neurons at 14 days post-
infection (dpi) of CX3CR1-GFP mice infected with Trypanosoma brucei brucei (the 
parasites African trypanosomes) (C, D) compared with uninfected CX3CR1-GFP mice 
(A, B). In CX3CR1-GFP mice microglia is fluorescently labelled. Microglial changes 
are observed in the infected mice, but will be examined in a separate study. Note in A-D 
that, besides the ECM distributed in the neuropil, some PNNs are evident, and they 
surround OX-immunonegative neurons. Note also that the observed phenomenon of 
day/night oscillation of ECM organization in the LH, as revealed by WFA 
immunolabelling (see Fig. 4.1) is also here evident in uninfected mice (A, B). However, 
no day/night variations in ECM organization are evident in the infected mice (C, D). 
Scale bar = 50 m 
 
  
124 
 
4.5 Discussion 
To our knowledge, this is the first study of the diurnal organization of the ECM in 
the brain. It was focused on the LH, and in particular in the LH fields in which OX 
neurons are distributed, and it was extended to the SCN and to cortical regions 
(neocortex and hippocampus).  
The findings obtained in healthy mice showed a striking diurnal fluctuation in the 
ECM organization in the LH, which was confirmed by the study of WFA expression 
in the LH, and which was at variance with the findings observed in the SCN, 
neocortex and hippocampus, where no day/night overt changes have been here 
observed. 
In the present study, no PNNs were found in the LH around OX cell bodies, and 
this could potentially represent a factor favoring plasticity in orexinergic networks. 
It remains to be verified if the ECM in the LH is organized in PNNs enwrapping 
other groups of neurons, and in particular MCH neurons. 
In the neocortex, PNNs were observed around the somata and processes of PV-
immunopositive interneurons, in agreement with previous reports (Wegner et al. 
2003; Alpár et al. 2006; Deepa et al. 2006). The PV-immunopositive neurons have 
been proposed as key regulators of plasticity, both during development and in 
adulthood (Hensch 2005; Donato et al. 2013), and PNNs may support the high 
activity of PV neurons (Morawski et al. 2015). Thus, PNNs, which have a variable 
distribution in the neocortex and hippocampus (Lensjø et al. 2017b), may restrict 
plasticity directly by acting as structural barrier inhibiting synapse remodelling or 
indirectly through their effects on PV-immunopositive neurons (Lensjø et al. 
2017a). 
Although no day/night differences were here observed in the PNNs in the neocortex 
and hippocampus, an overt oscillation of PV immunoreactivity was seen in PV cell 
bodies investigated in the neocortex. Further studies are needed to confirm the 
diurnal differences in PV expression here observed.  
While there are reports on ECM in the neocortex and hippocampus, to the best of 
our knowledge, this is the first documentation of the ECM organization in the SCN. 
The finding of a lack of day/night oscillation of WFA immunofluorescent labelling 
in the SCN may be somewhat surprising and needs to be confirmed and extended 
to other ECM components.  
In future studies, it will be important to investigate individual ECM proteins such 
as the brevican, aggrecan and Tenascin-R, and also ECM-modifying proteins such 
as disintegrin, metallopeptidase and metalloreductase, in the different brain regions 
here studied. Of note, ECM molecules such as brevican, thrombospondins and 
Tenascin-C are secreted by astrocytes (Faissner et al. 2010). 
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In a chronic neuroinflammatory condition represented by African trypanosome 
infection, which causes circadian disturbances in humans and animals, the diurnal 
fluctuation observed in basal conditions in the LH in healthy mice was found to be 
severely perturbed. This is the first observation of the ECM organization in animal 
models of this parasitic infection. The findings suggest a circadian control of ECM 
variations with disruption during experimental sleeping sickness. On the other 
hand, a wealth of clinical and experimental data point to circadian dysfunction in 
African trypanosome infection (Kristensson et al. 2010), which has also been 
supported by recent experimental findings (Rijo-Ferreira et al. 2018).  
The study of synaptic wiring of OX neurons in this paradigm of neuroinflammation 
is at present in progress, so that correlations with the daily pattern of ECM 
organization in the LH and the synaptic wiring of OX neurons cannot be done at 
present. Previous analyses in rodent models of T. b. b. (Palomba et al. 2015) and T. 
b. gambiense (Laperchia et al. 2018) infection have shown partial and progressive 
loss of OX and MCH neurons during the infection. Functional alterations of the 
activity OX neurons, based on the daily fluctuation of spontaneous Fos expression 
in these cells, have also been reported in T. b. b. infection (Palomba et al. 2015), 
indicating that peptidergic sleep-wake-regulatory neurons of the LH are vulnerable 
to this chronic neuroinflammatory condition.   
Insults to the CNS result in alterations of the ECM, and the extent of this depends 
on the severity or chronicity of the insult (Lau et al. 2013). ECM alterations have 
been mostly associated with inflammatory lesions and have been described in  
pathological conditions including AD (Karetko et al. 2009) and in demyelinating 
diseases such as MS (Van Horssen et al. 2006).  
In conclusion, the findings point to day/night oscillation of ECM organization and 
WFA expression in the LH, but not in PNNs in the neocortex and hippocampus. 
The results thus indicate a regionally selective and marked day/night variation of 
ECM organization in the LH, which could be involved in synaptic plasticity 
phenomena, and the disruption of this organization in a chronic neuroinflammatory 
pathology which leads to sleep-wake dysregulation and to the alterations of sleep 
structure. 
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5. Summary and conclusions 
Overall, the main findings of each experimental series can be summarized as 
follows: 
Question Answer (main findings) 
 OX soma wiring in adult (3-5 m) mice  day/night fluctuation of the 
inhibitory/excitatory synaptic 
input  
 OX soma wiring in aged (20 m) mice  decreased innervation 
 no day/night fluctuation 
 OX soma wiring in young (3 m) 
TASTPM mice (Tg AD model) 
 decreased innervation 
 dampened day/night fluctuation  
 OX soma wiring in aged (20 m) 
TASTPM mice  
 decreased innervation 
 no day/night switch 
 ECM structural organization in the LH 
in adult (3-5 m) mice  
 day/night rearrangement 
 ECM structural organisation in adult 
(3-5 m) after African trypanosome 
infection  
 no day/night rearrangement 
 
Altogether the findings show a striking daily oscillation in the axosomatic wiring 
of orexinergic neurons during day/night in adult mice, with a switch from a 
prevalence of excitatory innervation during wakefulness to a prevalence of 
inhibitory innervation during sleep.  
Preliminary observations here presented also suggest a possible rearrangement of 
the spatial orientation of astrocytic ramifications in the LH at day and night.  
The prevalence of excitatory terminals found at night in young adult animals was 
drastically dampened in aged mice at night, and the evaluation of the relative 
proportion of inhibitory terminals in aged mice showed similar values at night and 
day. This resulted in the lack of a diurnal fluctuation in excitatory/inhibitory balance 
of OX soma innervation and in a prevalence of inhibitory innervation in the aged 
mice. The data thus show striking changes during the physiological aging process, 
which could be involved in aging-related changes of sleep-wake stability, arousal, 
energy metabolism.   
The same analyses showed interesting findings also in the murine model of AD 
provided by TASTPM Tg mice. In the young Tg mice, despite a decrease in OX 
cell body innervation compared to young WT mice, the day/night fluctuation was 
maintained, though dampened. In the aged Tg mice, loss of synaptic contact on OX 
cell bodies was especially marked, and the number of excitatory terminals on OX, 
as well as that of inhibitory terminals, at night and day were very similar. 
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In addition to marked significant reduction in the presynaptic terminals apposed to 
OX somata in aged WT mice and in TASTPM mice of both age groups, 
degenerative cell features of OX neurons were observed, and in particular in the 
AD mice.  
The findings that OX soma wiring is altered in physiological and pathological aging 
process open a novel perspective in the understanding of the changes in the aging 
brain.  
Furthermore, experimental evidence is here provided of a diurnal rearrangement of 
the ECM structural organization in the LH, which seems to be regionally selective. 
Of note, such oscillation is lost in experimental sleeping sickness. 
All these sets of findings are here reported for the first time, and open many 
questions on the underlying mechanisms of molecular and cellular regulation in 
health and disease, on their vulnerability to physiological aging, on their 
susceptibility to neuroinflammatory and neurodegenerative conditions, on the 
influence from and on other brain regions, on the crosstalk between neurons, glia 
and ECM, on the plasticity of neural networks in state-dependent behavior. 
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